
<html lang="en"     class="pb-page"  data-request-id="3b3944f4-e5a2-46ea-b185-589d6e35862b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-2;article:article:10.1021/jm800940u;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease" /></meta><meta name="dc.Creator" content="Srikanth  Venkatraman" /></meta><meta name="dc.Creator" content="Francisco  Velazquez" /></meta><meta name="dc.Creator" content="Wanli  Wu" /></meta><meta name="dc.Creator" content="Melissa  Blackman" /></meta><meta name="dc.Creator" content="Kevin X.  Chen" /></meta><meta name="dc.Creator" content="Stephane  Bogen" /></meta><meta name="dc.Creator" content="Latha  Nair" /></meta><meta name="dc.Creator" content="Xiao  Tong" /></meta><meta name="dc.Creator" content="Robert  Chase" /></meta><meta name="dc.Creator" content="Andrea  Hart" /></meta><meta name="dc.Creator" content="Sony  Agrawal" /></meta><meta name="dc.Creator" content="John  Pichardo" /></meta><meta name="dc.Creator" content="Andrew  Prongay" /></meta><meta name="dc.Creator" content="Kuo-Chi  Cheng" /></meta><meta name="dc.Creator" content="Viyyoor  Girijavallabhan" /></meta><meta name="dc.Creator" content="John  Piwinski" /></meta><meta name="dc.Creator" content="Neng-Yang  Shih" /></meta><meta name="dc.Creator" content="F. George  Njoroge" /></meta><meta name="dc.Description" content="Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combin..." /></meta><meta name="Description" content="Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combin..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 22, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800940u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800940u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800940u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800940u" /></link>
        
    
    

<title>Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800940u" /></meta><meta property="og:title" content="Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0020.jpeg" /></meta><meta property="og:description" content=" Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combination therapy of interferon-α and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virological response. Herein, the SAR leading to the discovery of a series of ketoamide derived P1−P3 macrocyclic inhibitors that are more potent than the first generation clinical candidate, boceprevir (1, Sch 503034), is discussed. The optimization of these macrocyclic inhibitors identified a P3 imide capped analogue 52 that was 20 times more potent than 1 and demonstrated good oral pharmacokinetics in rats. X-ray structure of 52 bound to NS3 protease and biological data are also discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800940u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800940u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800940u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800940u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800940u&amp;href=/doi/10.1021/jm800940u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 336-346</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8008663" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm800994j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Structure−Activity Relationship of P<sub>1</sub>−P<sub>3</sub> Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srikanth++Venkatraman">Srikanth Venkatraman</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Velazquez">Francisco Velazquez</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wanli++Wu">Wanli Wu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Blackman">Melissa Blackman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+X.++Chen">Kevin X. Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephane++Bogen">Stephane Bogen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Latha++Nair">Latha Nair</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao++Tong">Xiao Tong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Chase">Robert Chase</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Hart">Andrea Hart</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sony++Agrawal">Sony Agrawal</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Pichardo">John Pichardo</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Prongay">Andrew Prongay</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Chi++Cheng">Kuo-Chi Cheng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Viyyoor++Girijavallabhan">Viyyoor Girijavallabhan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Piwinski">John Piwinski</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neng-Yang++Shih">Neng-Yang Shih</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+George++Njoroge">F. George Njoroge</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 908-740-3758. Fax: 908-740-7152. E-mail: <a href="/cdn-cgi/l/email-protection#4f1c3d26242e213b2761192a21242e3b3d2e222e210f3c3f2c203d3f612c2022"><span class="__cf_email__" data-cfemail="d281a0bbb9b3bca6bafc84b7bcb9b3a6a0b3bfb3bc92a1a2b1bda0a2fcb1bdbf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800940u&amp;href=/doi/10.1021%2Fjm800940u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 336–346</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 22, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 July 2008</li><li><span class="item_label"><b>Published</b> online</span>22 December 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 January 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800940u" title="DOI URL">https://doi.org/10.1021/jm800940u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D336%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSrikanth%2BVenkatraman%252C%2BFrancisco%2BVelazquez%252C%2BWanli%2BWu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D2%26contentID%3Djm800940u%26title%3DDiscovery%2Band%2BStructure%25E2%2588%2592Activity%2BRelationship%2Bof%2BP1%25E2%2588%2592P3%2BKetoamide%2BDerived%2BMacrocyclic%2BInhibitors%2Bof%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D346%26publicationDate%3DJanuary%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800940u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1956</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800940u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Structure−Activity Relationship of P1−P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Srikanth&quot;,&quot;last_name&quot;:&quot;Venkatraman&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Velazquez&quot;},{&quot;first_name&quot;:&quot;Wanli&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Blackman&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;X. Chen&quot;},{&quot;first_name&quot;:&quot;Stephane&quot;,&quot;last_name&quot;:&quot;Bogen&quot;},{&quot;first_name&quot;:&quot;Latha&quot;,&quot;last_name&quot;:&quot;Nair&quot;},{&quot;first_name&quot;:&quot;Xiao&quot;,&quot;last_name&quot;:&quot;Tong&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Chase&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Hart&quot;},{&quot;first_name&quot;:&quot;Sony&quot;,&quot;last_name&quot;:&quot;Agrawal&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Pichardo&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Prongay&quot;},{&quot;first_name&quot;:&quot;Kuo-Chi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Viyyoor&quot;,&quot;last_name&quot;:&quot;Girijavallabhan&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Piwinski&quot;},{&quot;first_name&quot;:&quot;Neng-Yang&quot;,&quot;last_name&quot;:&quot;Shih&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;George Njoroge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;336-346&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800940u&quot;},&quot;abstract&quot;:&quot;Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combination therapy of interferon-α and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virological response. Herein, the SAR leading to the discovery of a series of ketoamide derived P1−P3 macrocyclic inhibitors that are more potent than the first generation clinical candidate, boceprevir (1, Sch 503034), is discussed. The optimization of these macrocyclic inhibitors identified a P3 imide capped analogue 52 that was 20 times more potent than 1 and demonstrated good oral pharmacokinetics in rats. X-ray structure of 52 bound to NS3 protease and biological data are also discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800940u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800940u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800940u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800940u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800940u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800940u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800940u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800940u&amp;href=/doi/10.1021/jm800940u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800940u" /></input><a href="/doi/pdf/10.1021/jm800940u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (940 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800940u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800940u%26sid%3Dliteratum%253Aachs%26pmid%3D19102654%26genre%3Darticle%26aulast%3DVenkatraman%26date%3D2009%26atitle%3DDiscovery%2Band%2BStructure%25E2%2588%2592Activity%2BRelationship%2Bof%2BP1%25E2%2588%2592P3%2BKetoamide%2BDerived%2BMacrocyclic%2BInhibitors%2Bof%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D2%26spage%3D336%26epage%3D346%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/2" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide. Although combination therapy of interferon-α and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virological response. Herein, the SAR leading to the discovery of a series of ketoamide derived P<sub>1</sub>−P<sub>3</sub> macrocyclic inhibitors that are more potent than the first generation clinical candidate, boceprevir (<b>1</b>, Sch 503034), is discussed. The optimization of these macrocyclic inhibitors identified a P<sub>3</sub> imide capped analogue <b>52</b> that was 20 times more potent than <b>1</b> and demonstrated good oral pharmacokinetics in rats. X-ray structure of <b>52</b> bound to NS3 protease and biological data are also discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An estimated 200 million people worldwide are infected with HCV, making it an impending public threat that leads to liver cirrhosis, carcinoma, or liver failure.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The slow progression of the disease in combination with mild symptoms has made early detection difficult. Pegylated α-interferon alone or in combination with ribavirin is the preferred treatment for HCV viral infection.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although 80% of genotype-2 infected patients respond initially, only 40% of genotype-1 infected patients show sustained response to interferon treatment. Lack of effective methods to treat genotype-1 HCV infections and patients relapsing from interferon therapy necessitates discovery of new drugs. Significant efforts are now directed toward development of therapies that target key enzymes vital to HCV replication and maturation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Hepatitis C virus is a positive strand RNA virus with a single open frame of ∼9600 nucleotides. It encodes a single polypeptide of ∼3000 amino acids that is post-translationally modified to produce mature virions.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The single polypeptide contains all the structural and nonstructural proteins C-E1-E2-P7-NS2-NS3-NS4A-NS4B-NS5A-NS5B. NS3, a trypsin-like serine protease, catalyzes cis cleavage of the NS3-NS4A junction, followed by trans cleavage of the NS4A-NS4B, NS4B-NS5A, and NS5A-NS5B to produce functional proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The central role played by NS3 protease in the development of mature hepatitis C virus makes it an excellent target for drug discovery. Development of small molecule inhibitors for this enzyme would potentially arrest the processing of the aforementioned polyprotein required for viral replication. This has been a field of intense investigation by various groups worldwide.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> BILN-2061, Sch 503034 (<b>1</b>), VX-950, ITMN-191, TMC435350, and MK-7009 are novel protease inhibitors that have been advanced into clinical studies in humans and demonstrated to be efficacious.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> X-ray crystal structure of the enzyme reveals a featureless, shallow, highly solvent exposed active site located near the surface in a cleft between two β-barrel subdomains.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Characteristic residues of the catalytic triad, histidine-57, and aspartic acid-81 are located in the N-terminal, whereas Ser-139 forms part of the C-terminal subdomain. Cysteine is conserved in P<sub>1</sub> position of natural substrate of NS3 protease in all three trans-cleavage sites and is replaced by threonine in the cis-cleavage event. The P<sub>1</sub>′ is a small amino acid, either a serine or alanine. The P<sub>2</sub>, P<sub>3</sub>, and P<sub>4</sub> sites are hydrophobic amino acids, and P<sub>5</sub> and P<sub>6</sub> usually contain acidic amino acids such as aspartic acid or glutamic acid. We recently disclosed the synthesis and development of <b>1</b>, a selective, potent, orally bioavailable HCV NS3 protease inhibitor that is currently undergoing phase III clinical trials.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">As outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <b>1</b> had a <i>K</i><sub>i</sub><i>*</i> = 14 nM in the continuous binding assay<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and an EC<sub>90</sub> = 350 nM in the replicon based cellular assay<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> with excellent selectivity against the human neutrophil elastase (HNE), an enzyme that structurally resembles HCV NS3 protease. In an effort to develop a potential backup to <b>1</b>, we explored various novel scaffolds, most of them directed toward depeptidization. Macrocyclization has been a novel approach that has been widely explored to depeptidize inhibitors. In some cases it has resulted in realizing compounds with improved potency and better physiochemical properties resulting in improved PK and bioavailability.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> On examination of the X-ray structure of acyclic inhibitors of type <b>1</b> bound to NS3 protease, we observed the proximity of the P<sub>2</sub> and P<sub>4</sub> residues and P<sub>1</sub> and P<sub>3</sub> residues (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). We hypothesized that syntheses of macrocylic inhibitors that connected these residues would produce depetidized macrocyclic inhibitors that would bind to the NS3 enzyme mimicking the acyclic conformation. Earlier in this project we reported novel macrocyclic P<sub>2</sub>−P<sub>4</sub> inhibitors and optimized their enzyme binding potencies to the low nanomolar range.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Herein, we describe the development and SAR of P<sub>1</sub>−P<sub>3</sub> series of macrocyclic inhibitors that demonstrate excellent enzyme binding (<i>K</i><sub>i</sub>*), replicon cellular potency (EC<sub>90</sub>) and PK. Concomitant to our efforts in optimization of these ketoamide derived inhibitors, researchers from Boehringer Ingelheim disclosed the discovery and optimization of BILN-2061, a potent P<sub>1</sub>−P<sub>3</sub> macrocyclic inhibitor of HCV NS3 protease that had a carboxylic acid at P<sub>1</sub> and mimicked the natural substrate.<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of acyclic inhibitors of type <b>1</b> bound to NS3 protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examination of X-ray structures of acyclic inhibitors bound to the NS3 protease and modeling initially suggested that a 17-membered macrocycle would possibly be appropriate for binding. We therefore chose this ring size to investigate our first generation of P<sub>1</sub>−P<sub>3</sub> macrocyclic series of inhibitor. In addition to this, we had previously established from our acyclic series of inhibitors that a 3,4-dimethylcylopropyl fused proline was an excellent P<sub>2</sub> residue.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Even though our previous studies had shown a <i>tert</i>-butylglycine or cyclohexylglycine as the preferred P<sub>3</sub>, we decided to have an aliphatic straight chain P<sub>3</sub> for ease of synthesis. Therefore, we embarked on the synthesis of our first P<sub>1</sub>−P<sub>3</sub> macrocyclic inhibitor, compound <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In general, inhibitors were synthesized following the procedures previously reported.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Syntheses of macrocycle were accomplished using olefin metathesis with Grubbs first generation catalyst.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The P<sub>1</sub> and P<sub>3</sub> amino acid required for the synthesis of macrocyclic precursor was achieved using the method of Burk with asymmetric hydrogenation as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) AcHNCH(COOH)COOC<sub>2</sub>H<sub>5</sub>, Ac<sub>2</sub>O, pyridine, room temp, 24 h; (b) H<sub>2</sub>, Rh(Et-Duphos]OTf, ethanol, room temp, 0.5 h; (c) Boc<sub>2</sub>O, DMAP, THF, reflux; (d) aq LiOH, room temp; (e) PCC, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (f) (i) Boc<sub>2</sub>O, DMAP, THF reflux; (ii) N<sub>2</sub>H<sub>4</sub>, ethanol, room temp; (g) 4 M HCl in dioxane, room temp, 1 h.</p></p></figure><div class="NLM_p">Thus, condensation of pentenal <b>3</b> with ethyl acetamidomalonate monoester in CH<sub>2</sub>Cl<sub>2</sub>, in the presence of acetic anhydride and pyridine, resulted in enamide <b>4</b>. Enantioselective reduction of enamide <b>4</b> was accomplished by treatment with 0.002 mol % of chiral rhodium catalyst and selective hydrogenation of the proximal double bond to yield amino acid <b>5</b>. The required amino acid was thus obtained in high stereoselectivity and chemoselectivity. The nitrogen of the acetamide group was Boc protected using Boc<sub>2</sub>O and DMAP to form <b>6</b>, which on treatment with aqueous LiOH resulted in hydrolysis of the ethyl ester and the acetamide group to form Boc protected amino acid <b>7</b>. A similar scheme was used for the synthesis of the homologous amino acid <b>13</b>. Thus, oxidation of 5-hexenol with PCC resulted in formation of 5-hexenal <b>9</b>, which was converted to the amino acid <b>11</b> using similar conditions outlined for the synthesis of <b>5</b>. The acetamide compound <b>11</b> was once again treated with Boc<sub>2</sub>O, and further treatment of the Boc protected derivative with hydrazine resulted in selective deprotection of the acetamide group in the presence of ethyl ester to form compound <b>12</b>. Treatment of <b>12</b> with 4 M HCl in dioxane yielded amine salt <b>13</b> that was used for the syntheses of desired inhibitors as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0004.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF, NMM; (b) (i) aq LiOH, THF, room temp; (ii) <b>13</b>, HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF, NMM; (c) (Cy<sub>3</sub>P)<sub>2</sub>RuCl<sub>2</sub>CHC<sub>6</sub>H<sub>5</sub>, toluene, 60 °C; (d) (i) H<sub>2</sub>, Pd/C, EtOAc; (ii) LiBH<sub>4</sub>, THF, room temp; (e) Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, room temp; (f) RNC, AcOH, room temp; (g) aq LiOH, THF, room temp; (h) when R = H, DMSO, EDCI·HCl, Cl<sub>2</sub>CHCOOH, toluene; (i) when R ≠ H, Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, room temp; (j) (i) 4 M HCl dioxane; (ii) R<sup>1</sup>NCO, NMM, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p last">Coupling of Boc protected amino acid <b>7</b> with 3,4-dimethylcylopropylproline amino acid <b>14</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> using HATU<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and NMM resulted in dipeptide <b>15</b>. Alkaline hydrolysis of dipeptide <b>15</b> yielded an intermediate acid, which was coupled with amine salt <b>13</b> to yield <b>16</b>. Treatment of macrocyclic precursor <b>16</b> with Grubbs first generation metathesis catalyst resulted in formation of macrocycle <b>17</b> as a mixture of two isomeric olefinic compounds. The first generation catalyst proved to be as good as the more active carbene ligand derived catalysts. The inseparable cis and trans mixture of compound <b>17</b> was catalytically hydrogenated using Pd/C and further reduced with LiBH<sub>4</sub> to yield alcohol <b>18</b>. Oxidation of alcohol <b>18</b> with Dess−Martin’s reagent<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> yielded aldehyde <b>19</b>, which on treatment with alkyl isocyanide and acetic acid yielded hydoxyamide derivative <b>20</b>. Analysis of the aldehyde by NMR showed no epimerization of the aldehyde. Basic hydrolysis with aqueous lithium hydroxide followed by oxidation with either Moffat conditions or Dess−Martin’s reagent affords ketoamide <b>22</b>. The P<sub>3</sub>-capped analogues of <b>22</b> were obtained by deprotection of Boc group first using 4 M HCl/dioxane and further treatment with various isocyanates to form inhibitors of type <b>23</b>. Synthesized inhibitors were assayed for enzyme binding (<i>K</i><sub>i</sub>*) and replicon cellular potency (EC<sub>90</sub>). In addition, selected interesting compounds were evaluated for their ability to inhibit human neutraphil elastase. The ratio of <i>K</i><sub>i</sub>*(HNE)/<i>K</i><sub>i</sub>*(HCV) was taken as a measure of selectivity. Compounds with good enzyme binding and cellular activity were also evaluated in a rapid rat assay to assess compound plasma levels in rats.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the first set of compounds synthesized were those that spanned from P<sub>3</sub>−P<sub>2</sub>′. As established from our earlier acyclic series, we reasoned that these types of compounds were more likely to be active and provide an excellent model to test the utility of our new scaffold.</div><div class="NLM_table-wrap" id="tbl1">Table 1<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0006.gif" alt="" id="gr7" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0007.gif" alt="" id="_i4" /></img></td></tr></tbody></table></div></div><div class="NLM_p">The double bond containing inhibitor <b>24</b> as an (<i>E,Z</i>)-mixture had excellent enzyme binding (<i>K</i><sub>i</sub>* = 0.005 μM) and desirable HNE/HCV selectivity. It was encouraging to observe that this compound had a good cellular activity in the replicon cellular assay (EC<sub>90</sub> = 0.3 μM). The saturated macrocyclic analogue <b>25</b> was equipotent in the enzyme binding assay (<i>K</i><sub>i</sub>* = 0.006 μM) with cellular potency of EC<sub>90</sub> = 0.6 μM. Replacement of the Boc group with <i>tert</i>-butylurea resulted in compound <b>26</b> with <i>K</i><sub>i</sub>* = 0.006 μM and EC<sub>90</sub> = 1.0 μM. The P<sub>1</sub>−P<sub>3</sub> macrocyclic scaffold provided inhibitors that were as potent as those derived from acyclic series. From our previous experience in the discovery and development of boceprevir (<b>1</b>), we hypothesized that truncation would provide inhibitors with improved PK and cellular potencies. The effects of these modifications are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0008.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0009.gif" alt="" id="_i5" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Results from Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> demonstrate that truncations had a profound effect on the enzyme binding of these inhibitors. Replacement of P<sub>1</sub>′−P<sub>2</sub>′ glycine−phenylglycine fragment of compound <b>25</b> with Gly-NHBn yielded compound <b>27</b> with <i>K</i><sub>i</sub>* = 0.089 μM and EC<sub>90</sub> = 2.0 μM resulting in a 20-fold loss in activity compared to <b>25</b>. Further truncation by replacement of P<sub>1</sub>′−P<sub>2</sub>′ glycine−phenylglycine with <i>tert</i>-butylamide resulted in compound <b>28</b> with <i>K</i><sub>i</sub>* = 6.0 μM. However, replacement of P<sub>1</sub>′−P<sub>2</sub>′ glycine−phenylglycine with primary amide resulted in compound <b>29</b> with <i>K</i><sub>i</sub>* = 0.059 μM and EC<sub>90</sub> = 0.9 μM. This modification resulted in a 10-fold loss in enzyme activity compared to inhibitor <b>25</b> and in less than 2-fold loss in cellular potency. Similarly, replacement of <i>tert</i>-butyl carbamate P<sub>3</sub> capping of compound <b>29</b> with <i>tert</i>-butylurea resulted in compound <b>30</b>, which had a similar activity as the Boc derivative <b>29</b>. To further improve binding and cellular activity, we explored the replacement of P<sub>3</sub>-<i>tert</i>-butyl carbamate of <b>29</b> with α-methylcyclohexylurea, resulting in compound <b>31</b> with <i>K</i><sub>i</sub>* = 0.036 μM and EC<sub>90</sub> = 0.40 μM. This was encouraging because the cellular activity of compound <b>31</b> was similar to our first generation clinical compound <b>1</b>. Similarly, the introduction of <i>tert</i>-butylglycine derivative as P<sub>3</sub> capping resulted in compound <b>32</b> (<i>K</i><sub>i</sub>* = 0.037 μM and EC<sub>90</sub> = 0.40 μM), which had a binding activity similar to <b>39</b>, clearly indicating that modification of P<sub>3</sub> capping in the primary amide series of inhibitors would allow improvement in enzyme and cellular activity.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Effect of Macrocyclization</h3><div class="NLM_p">In order to evaluate the effect of macrocyclization, the binding efficiency of the acyclic compound compared to cyclic derivative (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>) was evaluated. The acyclic derivative <b>33</b> had <i>K</i><sub>i</sub>* = 0.25 μM, whereas the 17-membered cyclic compound <b>27</b> had <i>K</i><sub>i</sub>* = 0.059 μM. Thus, macrocyclization of <b>33</b> resulted in ∼5-fold improvements in binding activity. Macrocyclization of the P<sub>1</sub> and P<sub>3</sub> residues resulted in preorganizing the binding conformation of the inhibitor, thus contributing to improved potency.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0010.jpeg" id="gs3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Effect of Ring Size</h3><div class="NLM_p">In an effort to identify the optimal ring size, macrocyclic inhibitors ranging from 14 to 17 membered rings were synthesized and evaluated for their enzyme activity. Inhibitors containing 14, 15, and 17 membered ring were synthesized using similar methods outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> by appropriately changing the combination of P<sub>1</sub> and P<sub>3</sub> amino acids. Results from these compounds are tabulated in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3">Table 3<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0011.gif" alt="" id="_i8" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0012.gif" alt="" id="_i9" /></img></td></tr></tbody></table></div></div><div class="NLM_p">From Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> it was evident that the 15- and 16-membered rings were the most preferred. Thus, the 15-membered compound <b>35</b> had a <i>K</i><sub>i</sub>* = 0.036 μM and EC<sub>90</sub> = 1.0 μM. Similarly the 16-membered compound <b>36</b> had <i>K</i><sub>i</sub>* = 0.03 μM and EC<sub>90</sub> = 0.6 μM. The activities of these compounds were marginally better than the 17-membered compound <b>29</b>. However, the 14-membered compound <b>34</b> (<i>K</i><sub>i</sub>* = 0.210 μM) demonstrated much diminished binding activity in comparison to the larger ring sized systems. It was therefore concluded that a minimum of a 15-membered ring was required for the compound to exhibit desirable potency. We therefore decided to evaluate SAR with a 16-membered macrocycle and subsequently to extend important findings to 15- and 17-membered rings as well.</div><div class="NLM_p">Since we had observed from previous SARs (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compounds <b>31</b> and <b>32</b>) that modification of P<sub>3</sub> capping improved both enzyme binding potency and replicon cellular activity, we decided to extend the studies further. We embarked on incorporating these residues to evaluate their effect on the activity of <b>36</b>. A summary of these modifications is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>.</div><div class="NLM_table-wrap" id="tbl4">Table 4<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0013.gif" alt="" id="_i10" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0014.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div></div><div class="NLM_p">The introduction of P<sub>3</sub> caps had a profound effect in improving enzyme binding and replicon cellular activity. Thus, incorporation of cyclopropyl derived ketone moiety resulted in compounds <b>37</b> (<i>K</i><sub>i</sub>* = 0.011 μM and EC<sub>90</sub> = 0.1 μM) and <b>38</b> (<i>K</i><sub>i</sub>* = 0.011 μM and EC<sub>90</sub> = 0.18 μM), a 5-fold improvement in enzyme binding and 5- to 10-fold enhancement in cellular activity compared to <i>tert</i>-butylurea compound <b>29</b>. Similarly, introduction of a <i>tert</i>-butylglycineurea P<sub>3</sub> cap that was further modified with methylsulfonamide and thiophenesulfonamide resulted in compounds <b>39</b> (<i>K</i><sub>i</sub>* = 0.003 μM and EC<sub>90</sub> = 0.25 μM) and <b>40</b> (<i>K</i><sub>i</sub>* = 0.002 μM and EC<sub>90</sub> = 0.07 μM), respectively. It is noted that the thiophenesulfonamide derived compound <b>40</b> had <i>K</i><sub>i</sub>* = 0.002 μM, a 25-fold improvement in potency compared to the Boc compound <b>29</b>, and a cellular potency of EC<sub>90</sub> = 0.07 μM, a 15-fold improvement in activity over <b>29</b>. This was the first time in this series that we achieved a compound with EC<sub>90</sub> ≤ 0.1 μM. Having established that compounds with excellent cellular activities could be achieved, we evaluated the PK properties of compound <b>40</b>. Analysis of <b>40</b> in rapid rat assay indicated plasma levels of <b>40</b> were low (AUC = 0.07 μM·h), presumably because of poor absorption. Our previous experience in the acyclic series had clearly demonstrated that the replacement of P<sub>1</sub>′ primary amide with secondary amides greatly improved PK profiles of the inhibitors. However, in most cases this change was accompanied with loss in activity. In an effort to improve the potency and PK of these molecules, we studied the structure−activity relationship at the P<sub>1</sub>′ region. Small aliphatic isocyanides were synthesized and incorporated using methods outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Compounds resulting from these modifications are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 5. <a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0015.gif" alt="" id="gr12" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0016.gif" alt="" id="_i12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">(∗) EC<sub>50</sub> was used for comparison, since EC<sub>90</sub> could not be determined for all compounds.</p></div></div></div><div class="NLM_p">Introduction of small aliphatic groups at P<sub>1</sub>′ was well tolerated. Thus, incorporation of ethyl- and propylamide moieties at P<sub>1</sub>′ resulted in compounds <b>41</b> (<i>K</i><sub>i</sub>* = 0.010 μM and EC<sub>50</sub> = 0.030 μM) and <b>42</b> (<i>K</i><sub>i</sub>* = 0.014 μM and EC<sub>50</sub> = 0.080 μM), respectively. These compounds were slightly less potent than the corresponding primary amide derivative <b>40</b> (<i>K</i><sub>i</sub>* = 0.002 μM and EC<sub>50</sub> = 0.020 μM). Similarly, introduction of cycopropylmethylamide as the P<sub>1</sub>′ group resulted in compound <b>43</b> (<i>K</i><sub>i</sub>* = 0.021 μM and EC<sub>50</sub> = 0.050 μM), which was less active than the corresponding primary amide analogue <b>40</b>. However, the introduction of allyl amide at P<sub>1</sub>′ was well tolerated resulting in compound <b>44</b> (<i>K</i><sub>i</sub>* = 0.005 μM and EC<sub>50</sub> = 0.020 μM). The allylamide derivative <b>44</b> was equipotent to the corresponding primary amide compound <b>40</b> and demonstrated good oral plasma levels in rats (AUC = 1.26 μM·h). Since the P<sub>1</sub>′ allylamide group provided the combination with the best activity and acceptable PK, we further investigated the modification of P<sub>3</sub> capping residues in this series. The improved activity of compound <b>44</b> compared to <b>42</b> may result from the π-character of the double bond in the allyl group.</div><div class="NLM_p">A wide range of P<sub>3</sub> caps were selected and incorporated in these inhibitors to evaluate their activities. These results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. Many of the P<sub>1</sub>′ allyl amide derivatives demonstrated excellent enzyme binding (<i>K</i><sub>i</sub>*) and replicon cellular potency combined with good PK in rats. The allylamide derivatives <b>45</b> and <b>46</b> demonstrated <i>K</i><sub>i</sub>* = 0.020 and 0.006 μM and EC<sub>90</sub> = 0.48 and 0.28 μM, respectively. The cellular activities of these compounds were slightly worse than the corresponding primary amide analogues <b>37</b> and <b>38</b>. However, the introduction of allylamide in inhibitors that contained other modified P<sub>3</sub> caps demonstrated improved <i>K</i><sub>i</sub>* as well as EC<sub>90</sub>. Thus, the methylsulfonamide compound <b>47</b> had a binding <i>K</i><sub>i</sub>* = 0.003 μM and EC<sub>90</sub> = 0.055 μM and the 2-pyridylsulfonamide derived inhibitor <b>48</b> had an enzyme activity of <i>K</i><sub>i</sub>* = 0.007 μM and EC<sub>90</sub> = 0.090 μM. Synthesis of the cyclic sulfonamide derivative of inhibitor <b>40</b> resulted in compound <b>49</b> (<i>K</i><sub>i</sub>* = 0.007 μM and EC<sub>90</sub> = 0.15 μM), which was less potent than acyclic analogue <b>40</b>. Introduction of dimethylsulfonylurea derived P<sub>3</sub> capping resulted in compound <b>50</b> with <i>K</i><sub>i</sub>* = 0.014 μM and EC<sub>90</sub> = 0.06 μM. It was encouraging to note that the dimethylsulfonylurea compound <b>50</b> demonstrate reasonable PK with AUC = 1.04 μM·h in rats when dosed orally at 5 mg/kg.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last">Table 6. <a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></p></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0017.gif" alt="" id="gr13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0018.gif" alt="" id="_i13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">(†) The po dosing was at 10 mg/kg in 0.4% hpmc, and AUC was measured from 0 to 6 h. (∗) The po dosing was 5 mg/kg in 0.4% hpmc.</p></div></div></div><div class="NLM_p">The introduction of imide derived P<sub>3</sub> caps had a profound effect on the cellular activity of the P<sub>1</sub>−P<sub>3</sub> macrocyclic inhibitors. Thus, incorporation of pthalimide derived cap resulted in compound <b>51</b> with <i>K</i><sub>i</sub>* = 0.016 μM and EC<sub>90</sub> = 0.1 μM, which was less potent than <b>50</b>. However introduction of dimethylglutarimide derived P<sub>3</sub> capping resulted in compound <b>52</b> (<i>K</i><sub>i</sub>* = 0.001 μM and EC<sub>90</sub> = 0.020 μM). This resulted in a marked improvement in replicon cellular potency compared to the primary amide analogue <b>40</b>. It also demonstrated good plasma levels in rats with AUC = 1.1 μM·h. Similarly, introduction of a bicyclic derived imide cap resulted in compound <b>54</b>, which once again demonstrated excellent binding (<i>K</i><sub>i</sub>* = 0.003 μM) and improved replicon cellular activity (EC<sub>90</sub> = 0.015 μM). The modification of the dimethylglutarimide moiety to the corresponding dimethyl lactam derivative resulted in inhibitor <b>55</b> (<i>K</i><sub>i</sub>* = 0.002 μM and EC<sub>90</sub> = 0.020 μM), which had similar activity to <b>52</b> and also demonstrated good plasma levels in rats with AUC = 1.5 μM·h.</div><div class="NLM_p">The X-ray structure of inhibitor <b>52</b> bound to HCV NS3 protease was solved and is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. From the structure, it was clear that the aliphatic chain linking the P<sub>1</sub> and P<sub>3</sub> made excellent contact in the lypophilic region connecting the S<sub>1</sub> and S<sub>3</sub> pockets. The P<sub>2</sub> (1<i>R</i>,5<i>S</i>)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane ring adopted a bent conformation that allowed maximum overlap of the methylenes of proline and cyclopropyl ring to Ala-156. The conformation adopted by cyclopropyl group allowed the methyl group proximal to the carbonyl to interact with His-57 and the methyl group distal to carbonyl to interact with Ala-156 and Arg-155. The <i>tert-</i>butyl group of P<sub>3</sub> imide capping occupied the S<sub>4</sub> region of space, making excellent van der Walls contact with the protein, and the carbonyl of the imides group formed a hydrogen bond with Csy-159. The electrophilic ketoamide group reversibly trapped Ser-139 to form a covalent bond with the enzyme, and the hydrogen of the P<sub>1</sub>′ allylamide donated a hydrogen bond to the peptidic backbone of the protein, locking the inhibitor to the surface.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0019.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of inhibitor <b>52</b> bound to NS3 protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to van der Waals contacts, inhibitor <b>52</b> formed a series of specific hydrogen bonds with the protein surface. When the various hydrogen bonding interactions that existed between inhibitor <b>52</b> and NS3 protease were mapped out, it was evident that the P<sub>1</sub>′ allylamide donated a hydrogen bond to the protein, and the carbonyl oxygen in turn made two hydrogen bonds with the nitrogens of Ser-139 and Gly-137. The urea nitrogens donated two hydrogen bonds to Ala-157, thus improving potency and HCV specificity. Additionally, the nitrogen of the P<sub>1</sub> residue donated a hydrogen bond to Arg-155 and the oxygen of P<sub>3</sub> carbonyl group accepted a hydrogen bond from Ala-157. In combination with hydrophobic interaction the array of hydrogen bonds also contributed greatly to the binding potency and selectivity of compound <b>52</b>.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analysis of the X-ray structure of the acyclic series of inhibitors bound to NS3 protease clearly revealed the proximity of S<sub>1</sub> and S<sub>3</sub> sites. This prompted the syntheses of P<sub>1</sub>−P<sub>3</sub> macrocyclic series of inhibitors that could potentially bind to the enzyme in a preorganized binding conformation. Guided by modeling, a 17-membered ring was initially determined to be the optimal size. Macrocyclic inhibitors spanning from P<sub>3</sub>−P<sub>2</sub>′ were synthesized using Grubbs olefin metathesis reaction. These inhibitors bound to protein with excellent enzyme binding and displayed moderate cellular activity in the replicon based cellular assay (EC<sub>90</sub> ≈ 0.5−1.0 μM). In an attempt to improve cellular activity, P<sub>1</sub>′ primary amide compounds similar to <b>1</b> were synthesized. These inhibitors were active and had further improved cellular activity to our first generation clinical candidate (i.e., EC<sub>90</sub> ≈ 0.35 μM). SAR studies in the primary amide series of inhibitors clearly demonstrated a 16-membered ring as the optimal ring size.</div><div class="NLM_p last">SAR in the 16-membered macrocycle demonstrated that the introduction of novel P<sub>3</sub> caps further improved cellular activity. Introduction of these P<sub>3</sub> caps allowed identification of inhibitors that had greatly improved cellular activity compared to our first generation clinical candidate, boceprevir. However, these compounds had poor PK in rats. In an attempt to obtain compounds with better plasma exposure, secondary amides were explored. Structure−activity relationship at the P<sub>1</sub>′ site identified allylamide as an optimal P<sub>1</sub>′ residue that was well tolerated. Reinvestigation of P<sub>3</sub> capping in the allylamide series identified compounds with enzyme binding and cellular activity (EC<sub>90</sub> ≈ 0.05−0.06 μM) improved over <b>1</b>. The introduction of imide derived P<sub>3</sub> caps provided compounds with improved cellular activity by an additional 3-fold, leading to compound <b>52</b> with EC<sub>90</sub> = 0.02 μM, ∼20 times more potent than our first generation compound <b>1</b>. These compounds not only had greatly improved cellular activity but also had good plasma level when evaluated for PK in rats and are being further evaluated for PK in higher species. We thus clearly demonstrated that P<sub>1</sub>−P<sub>3</sub> macrocyclic inhibitors that incorporated a ketoamide warhead demonstrated excellent binding and cellular activity, which was optimized to generate compounds that were more potent than <b>1</b>. X-ray structure of inhibitor <b>52</b> bound to enzyme also revealed a crucial hydrogen bonding of the imide oxygens to Cys-159 that contributed to improved potency and improved cellular activity.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">Dry solvents were purchased from Aldrich or Acros and used without further purification. Other solvents or reagents were used as obtained except when otherwise noted. Analytical thin layer chromatography (TLC) was performed on precoated silica gel plates available from Analtech. Column chromatography were performed using Merck silica gel 60 (particle size 0.040−0.055 mm, 230−400 mesh) or using Biotage or Isco chromatographic systems. All compounds were synthesized as a single diastereomer at P<sub>1</sub>, and most compounds were further purified using Varian normal phase HPLC with YMC-diol column with solvent system solvent A (hexanes) and solvent B (a mixture of isopropanol, CH<sub>2</sub>Cl<sub>2</sub>, and acetonitrile). Visualization was accomplished with UV light or by staining with basic KMnO<sub>4</sub> solution, methanolic H<sub>2</sub>SO<sub>4</sub>, or Vaughn’s reagent. NMR spectra were recorded in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> unless otherwise noted at 300, 400, or 500 MHz (<sup>1</sup>H NMR), or 75, 100, or 125 MHz (<sup>13</sup>C NMR). Mass spectra were obtained using electron spray or FAB ionization methods.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 1,1-Dimethylethyl-[(17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-3(<i>S</i>)-[2-[[2-[[2-(dimethylamino)-2-oxo-1(<i>S</i>)-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxoethyl]-1,2,3,4,5,6,7,10,11,12,13,14,15,17,17a,18,18a,18b-octadecahydro-18,18-dimethyl-1,15-dioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecin-14(<i>S</i>)-yl]carbamate [<b>24</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.78−8.76 (m, 1 H), 8.60−8.29 (m, 2 H), 7.36−7.31 (m, 5 H), 5.83 (d, 1 H, <i>J</i> =7.9 Hz), 5.26−5.13 (m, 2 H), 4.40−3.66 (m, 8 H), 2.93 (s, 3 H), 2.85 (s, 3 H), 2.02−0.85 (bm, 18 H), 1.35 (s, 9 H), 0.99 (s, 3 H), 0.88 (s, 3 H). MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 773 [(M + 1)<sup>+</sup>, 70], 751 [(M + 1)<sup>+</sup>, 60], 651 (100).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 1,1-Dimethylethyl-[(17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-3(<i>S</i>)-[2-[[2-[[2-(dimethylamino)-2-oxo-1(<i>S</i>)-phenylethyl]amino]-2-oxoethyl]amino]-1,2-dioxoethyl]eicosahydro-18,18-dimethyl-1,15-dioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecin-14(<i>S</i>)-yl]carbamate [<b>25</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.77 (t, 1H, <i>J =</i> 5.9 Hz), 8.55 (d, 1 H, <i>J =</i> 7.3 Hz), 8.32 (d, 1 H, <i>J =</i> 8.8 Hz), 7.35−7.28 (m, 5 H), 7.05 (d, 1 H, <i>J =</i> 6.1 Hz), 5.80 (d, 1 H, <i>J =</i> 8.1 Hz), 5.27 (bt, 1 H, <i>J =</i> 8.8 Hz), 4.32 (s, 1 H), 4.10−3.96 (m, 2 H), 3.81−3.70 (m, 3 H), 2.91 (s, 3 H), 2.83 (s, 3 H), 1.84−0.84 (m, 22 H), 1.33 (s, 9 H), 0.99 (s, 3 H), 0.89 (s, 3 H). MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 775 [(M + 1)<sup>+</sup>, 70], 753 [(M + 1)<sup>+</sup>, 60], 653 (100), 277 (80), 232 (60), 148 (80), 117 (95).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1,1-Dimethylethyl-[(17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-3(<i>S</i>)-[2-[(1,1-dimethylethyl)amino]-1,2-dioxoethyl]eicosahydro-18,18-dimethyl-1,15-dioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecin-14(<i>S</i>)-yl]carbamate [<b>28</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.30 (d, 1 H, <i>J =</i> 9.1 Hz), 7.97 (s, 1 H), 7.05 (d, 1 H, <i>J</i> = 7.9 Hz), 5.23 (t, 1 H, <i>J</i> =9.5 Hz), 4.34 (s, 1 H), 4.10 (bs, 1 H), 4.01 (d, 1 H, <i>J</i> = 10.1 Hz), 3.75 (dd, 1 H, <i>J</i> = 5.7 and 4.8 Hz), 1.79−1.15 (m, 22 H), 1.35 (s, 9 H), 1.31 (s, 9 H), 0.99 (s, 3 H), 0.91 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 171.9, 171.0, 162.3, 155.9, 78.7, 60.4, 52.4, 52.3, 51.7, 47.7, 32.1, 31.9, 31.2, 27.9, 27.6, 27.4, 26.9, 26.9, 26.3, 24.8, 23.2, 19.6, 13.5, MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 591 [(M + 1)<sup>+</sup>, 70], 491 (100).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1,1-Dimethylethyl-[(17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-3(<i>S</i>)-(2-amino-1,2-dioxoethyl)-eicosahydro-18,18-dimethyl-1,15-dioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecin-14(<i>S</i>)-yl]carbamate [<b>29</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.29 (d, 1 H, <i>J =</i> 8.8 Hz), 8.03 (s, 1 H), 7.77 (s, 1 H), 7.04 (d, 1 H, <i>J =</i> 7.7 Hz), 5.24 (t, 1 H, <i>J =</i> 10.4 Hz), 4.32 (s, 1 H), 4.08 (bt, 1 H), 3.98 (d, 1 H, <i>J =</i> 9.3 Hz), 3.72 (dd, 1 H, <i>J =</i> 4.4 and 5.5 Hz), 1.77−1.11 (m, 22 H), 1.32 (s, 9 H), 0.98 (s, 3 H), 0.89 (s, 3 H). MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 557 [(M + Na)<sup>+</sup>, 10]<sup>+</sup>, 535 (10), 435 (80), 390 (100).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-14(<i>S</i>)-[[[(1,1-Dimethylethyl)amino]carbonyl]amino]eicosahydro-18,18-dimethyl-α,1,15-trioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecine-3(<i>S</i>)-acetamide [<b>30</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.32 (d, 1 H, <i>J =</i> 9.0 Hz), 8.06 (s, 1 H), 7.80 (s, 1 H), 5.90 (d, 1 H, <i>J</i> = 9.5 Hz), 5.76 (s, 1 H), 5.27−5.23 (m, 1 H), 5.35 (s, 1 H), 4.30−4.23 (m, 1 H), 3.99 (bd, 1 H, <i>J =</i> 10.0 Hz), 3.75 (dd, 1 H, <i>J =</i> 3.0 and 4.0 Hz), 1.18 (s, 9 H), 1.48−0.89 (m, 22 H), 1.00 (s, 3 H), 0.89 (s, 3 H). MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 556 [(M + Na)<sup>+</sup>, 15]<sup>+</sup>, 534 (35), 450 (85), 435 (100), 126 (70)</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (17a<i>S</i>,18a<i>R</i>,18b<i>S</i>)-Eicosahydro-18,18-dimethyl-14(<i>S</i>)-[[[(1-methylcyclohexyl)amino]carbonyl]amino]-α,1,15-trioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacycloheptadecine-3(<i>S</i>)-acetamide [<b>31</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.32 (d, 1 H, <i>J =</i> 9.1 Hz), 8.05 (s, 1 H), 7.80 (s, 1 H), 6.09−6.01 (m, 1 H), 5.57 (s, 1 H), 5.24 (bt, 1 H, <i>J =</i> 10.4), 4.35 (s, 1 H), 4.30−4.25 (m, 1 H), 3.99 (bd, 1 H, <i>J =</i> 11.0 Hz), 3.75−3.72 (m, 1 H), 1.89−1.15 (m, 35 H), 1.00 (s, 3 H), 0.88 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 199.0, 171.9, 157.3, 60.2, 52.4, 51.7, 50.9, 47.6, 37.7, 37.2, 32.8, 31.8, 31.1, 30.4, 29.0, 28.3, 27.9, 27.6, 27.0, 26.9, 26.4, 26.1, 24.9, 23.4, 22.2, 19.5, 13.6. MS (ESI, <i>m</i>/<i>z</i>, relative intensity), 574 [(M + 1)<sup>+</sup>, 40], 435 (100).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1,1-Dimethylethyl-[(15a<i>S</i>,16a<i>R</i>,16b<i>S</i>)-3(<i>S</i>)-(2-amino-1,2-dioxoethyl)octadecahydro-16,16-dimethyl-1,13-dioxocyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclopentadecin-12(<i>S</i>)-yl]carbamate [<b>35</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.34 (d, 1 H, <i>J =</i> 9.1 Hz), 8.05 (s, 1 H), 7.79 (s, 1 H), 6.93 (d, 1 H, <i>J</i> =7.6 Hz), 5.28 (dt, 1 H, <i>J =</i> 2.8 and 11.4 Hz), 4.40 (s, 1 H), 4.11 (bt, 1 H, <i>J =</i> 8.1 Hz), 3.98 (d, 1 H, <i>J =</i> 9.8 Hz), 3.79 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 1.88−1.72 (m, 2 H), 1.48−1.06 (m, 16 Hz), 1.35 (s, 9 H), 1.01 (s, 3 H), 0.90 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.9, 171.7, 171.2, 164.3, 155.8, 78.8, 60.3, 52.6, 52.4, 47.7, 31.2, 30.7, 30.5, 29.0, 28.9, 28.3, 28.1, 27.0, 26.7, 26.1, 25.7, 24.5, 24.0, 19.5, 13.5. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 507 [(M + 1)<sup>+</sup>, 65], 450 (25), 407 (100).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1,1-Dimethylethyl[(13<i>S</i>,16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-3-(2-amino-1,2-dioxoethyl)octadecahydro-17,17-dimethyl-1,14-dioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecin-13-yl]carbamate [<b>36</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.34 (d, 1 H, <i>J =</i> 9.5 Hz), 8.06 (s, 1 H), 7.80 (s, 1 H), 7.09 (d, 1 H, <i>J</i> = 7.6 Hz), 5.31 (t, 1 H, <i>J =</i> 11.0 Hz), 4.36 (s, 1 H), 4.11−4.05 (m, 1 H)), 3.99 (d, 1 H, <i>J =</i> 10.4 Hz), 3.76 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 1.88−1.19 (m, 20 H), 1.34 (s, 9 H), 1.01 (s, 3 H), 0.92 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.8, 172.0, 171.2, 164.2, 155.9, 78.7, 60.7, 52.5, 52.4, 47.7, 42.9, 36.5, 31.8, 31.6, 31.2, 31.3, 28.9, 28.6, 28.1, 27.9, 27.4, 26.9, 26.5, 26.4, 24.2, 22.9, 22.2, 19.6, 14.8, 13.5. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 521 [(M + 1)<sup>+</sup>, 100], 421 (40).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-(cyclopropylcarbonyl)-2-methylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>37</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.32 (d, 1 H, <i>J =</i> 9.4 Hz), 8.04 (s, 1 H), 7.78 (s, 1 H), 6.38 (d, 1 H, <i>J =</i> 8.2 Hz), 6.23 (d, 1 H, <i>J =</i> 8.5 Hz), 5.30 (t, 1 H, <i>J =</i> 9.5 Hz, 4.36 (s, 1 H), 4.33 (dd, 1 H, <i>J =</i> 4.7 and 4.1 Hz), 4.29−4.24 (m, 1 H), 3.89 (d, 1 H, <i>J</i> = 10.4 Hz), 3.77 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 2.24−2.13 (m, 2 H), 1.72−0.71(m, 30 H), 1.00 (s, 3 H), 0.86 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 210.8, 198.7, 172.0, 171.4, 164.2, 157.9, 64.5, 60.5, 52.6, 51.4, 47.6, 32.2, 31.5, 31.3, 30.1, 28.3, 27.8, 28.0, 27.3, 26.9, 26.6, 26.2, 24.4, 22.4, 20.4, 19.4, 18.8, 17.8, 13.6, 11.6, 11.2. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 588 [(M + 1)<sup>+</sup>, 100], 421(40).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-Cyclohexyl-2-cyclopropyl-2-oxoethyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>38</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.34 (d, 1 H, <i>J =</i> 9.1 Hz), 8.05 (s, 1 H), 7.79 (s, 1 H), 6.36 (d, 1 H, <i>J =</i> 8.8 Hz), 6.26 (d, 1 H, <i>J =</i> 8.8 Hz), 5.30 (t, 1 H, <i>J =</i> 9.0 Hz), 4.36 (s, 1 H), 4.36 (dd, 1 H, <i>J =</i> 5.0 and 4.7 Hz), 4.29−4.25 (m, 1 H), 3.89 (dd, 1 H, <i>J =</i> 10.4 Hz), 3.77 (q, 1 H, <i>J =</i> 5.4 Hz), 2.18−2.13 (m, 2 H), 1.80−0.76 (m, 34 H), 1.00 (s, 3 H), 0.88 (s, 3 H). MS (ESI, <i>m</i>/<i>z</i> relative intensity) 628 [(M + 1)<sup>+</sup>, 20], 421 (10), 130 (100).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[[methyl(methylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>39</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz), δ, 8.32 (d, 1 H, <i>J =</i> 9.0 Hz), 8.03 (s, 1 H), 7.77 (s, 1 H), 6.21 (d, 1 H, <i>J =</i> 8.8 Hz), 5.87 (s, 1 H), 5.28 (t, 1 H, <i>J</i> =10.1 Hz), 4.34 (s, 1 H), 4.26−4.22 (m, 1 H), 3.85 (d, 1 H, <i>J =</i> 10.1 Hz), 3.75 (dd, 1 H, <i>J</i> =10.1 and 5.4 Hz), 3.59 (d, 1 H, <i>J =</i> 13.6 Hz), 3.41 (d, 1 H, <i>J =</i> 13.9 Hz), 3.31 (s, 6 H), 2.21−2.11 (m, 2 H), 1.67−1.06 (m, 18 H), 1.24 (s, 9 H), 0.99 (s, 3 H), 0.87 (s, 3 H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 125 MHz), δ 209.2, 182.5, 181.8, 174.7, 167.7, 70.9, 70.6, 64.8, 63.1, 61.7, 61.5, 58.0, 45.8, 45.6, 42.8, 42.0, 41.8, 38.7, 38.5, 38.4, 37.7, 37.5, 37.5, 37.4, 37.2, 37.0, 36.6, 36.3, 35.0, 33.8, 32.9, 32.0, 32.0, 29.9, 24.1. MS (ESI, <i>m</i>/<i>z</i> relative intensity) 693 [(M + K)<sup>+</sup>, 15], 677 [(M + Na)<sup>+</sup>, 25], 655 [(M + 1)<sup>+</sup>, 100]. HRMS calcd for C<sub>31</sub>H<sub>54</sub>N<sub>6</sub>NaO<sub>7</sub>S [M + 1]<sup>+</sup>: 677.3672. Found: 677.3685.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[[methyl(2-thienylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]-<i>N</i>-ethyloctadecahydro-17,17-dimethyl-α,1,14-trioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>41</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.71 (t, 1 H, <i>J =</i> 5.7 Hz), 8.35 (d, 1 H, <i>J =</i> 8.8 Hz), 8.00 (dd, 1 H, <i>J =</i> 1.3 and 5.0 Hz), 7.65 (d, 1 H, <i>J =</i> 3.8 Hz), 7.26 (dd, 1 H, <i>J =</i> 3.8 and 1.0 Hz), 6.15 (d, 1 H, <i>J =</i> 8.8 Hz), 5.89 (d, 1 H, <i>J =</i> 9.7 Hz), 5.31 (t, 1 H, <i>J =</i> 10.7 Hz), 4.35 (s, 1 H), 4.29 (bt, 1 H, <i>J =</i> 9.1 Hz), 3.93 (d, 1 H, <i>J =</i> 9.8 Hz), 3.77 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 3.64 (dt, 1 H, <i>J =</i> 3.2 and 8.8 Hz), 3.20−3.11 (m, 2 H), 2.96−2.87 (m, 2 H), 2.68 (s, 3 H), 1.75−1.59 (m, 2 H), 1.47−0.83 (m, 21 H), 0.99 (s, 3 H), 0.85 (s, 3 H), 0.81 (s, 9 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.4, 172.0, 171.7, 161.8, 158.2, 137.8, 133.8, 133.0, 128.9, 60.4, 55.7, 52.7, 51.6, 51.4, 47.6, 36.0, 35.0, 34.3, 32.2, 31.6, 31.3, 28.4, 28.0, 27.8, 27.4, 27.0, 26.9, 26.6, 26.3, 24.4, 22.3, 19.4, 15.1, 13.6. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 773 [(M + Na)<sup>+</sup>, 100], 751 [(M + 1)<sup>+</sup>, 60].</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[[methyl(2-thienylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-propyl-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>42</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.71 (t, 1 H, <i>J =</i> 6.0 Hz), 8.36 (d, 1 H, <i>J =</i> 9.1 Hz), 8.00 (dd, 1 H, <i>J</i> = 1.3 and 3.8 Hz), 7.65 (dd, 1 H, <i>J =</i> 1.3 and 2.5 Hz), 7.26 (dd, 1 H, <i>J =</i> 3.8 and 1.3 Hz), 6.15 (d, 1H, <i>J =</i> 9.1 Hz), 5.88 (d, 1 H, <i>J =</i> 10.1 Hz), 5.31 (t, 1H, <i>J =</i> 9.1 Hz), 4.34 (s, 1 H), 4.30 (t, 1 H, <i>J</i> = 8.2 Hz), 3.93 (d, 1 H, <i>J =</i> 10.4 Hz), 3.77 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 3.64 (dt, 1 H, <i>J =</i> 4.4 and 9.8 Hz), 3.13−3.04 (m, 2 H), 2.95−2.87 (m, 2 H), 2.67 (s, 3 H), 1.73−1.63 (m, 2 H), 1.50−1.07 (m, 20 H), 0.99 (s, 3 H), 0.84 (s, 3 H), 0.81 (s, 9 H), 0.85−0.81 (m, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ,198.5, 172.0, 171.7, 162.1, 158.2, 137.7, 133.9, 133.0, 129.0, 60.4, 55.7, 55.7, 52.7, 51.6, 51.4, 47.6, 41.1, 36.0, 35.0, 32.2, 31.6, 31.2, 28.4, 28.0, 27.8, 27.4, 27.0, 26.9, 26.6, 26.3, 24.4, 22.8, 22.3, 19.4, 13.6, 12.1. MS (ES, <i>m</i>/<i>z</i> relative intensity) 788 [(M + Na)<sup>+</sup>, 40], 766 [(M + 1)<sup>+</sup>, 100].</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-<i>N</i>-(Cyclopropylmethyl)-13(<i>S</i>)-[[[[2,2-dimethyl-1(<i>S</i>)-[[methyl(2-thienylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>43</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.80 (d, 1 H, <i>J =</i> 9.1 Hz), 8.00 (dd, 1 H, <i>J =</i> 1.3 and 3.8 Hz), 7.65 (dd, 1 H, <i>J =</i> 9.1 Hz), 8.00 (dd, 1 H, <i>J =</i> 1.3 and 3.8 Hz), 7.65 (dd, 1 H, <i>J =</i> 1.3 and 3.8 Hz), 7.26 (dd, 1 H, <i>J =</i> 3.8 and 1.3 Hz), 6.15 (d, 1 H, <i>J =</i> 8.5 Hz), 5.89 (d, 1H, <i>J =</i> 10.1 Hz), 5.32 (t, 1 H, <i>J =</i> 9.5 Hz), 4.35 (s, 1H), 4.29 (t, 1 H, <i>J =</i> 7.6 Hz), 3.93 (d, 1 H, <i>J =</i> 10.4 Hz), 3.77 (dd, 1 H, <i>J =</i> 5.4 and 4.7 Hz), 3.64 (dt, 1 H, <i>J =</i> 4.4 and 9.7 Hz), 3.07−2.87 (m, 4 H), 2.67 (s, 3 H), 1.70−1.62 (m, 2 H), 1.45−0.87 (m, 18 H), 0.99 (s, 3 H), 0.85 (s, 3 H), 0.81 (s, 9 H), 0.42−0.39 (m, 2 H), 0.21−0.18 (m, 2 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.5, 172.0, 171.7, 162.0, 158.2, 133.8, 133.0, 128.9, 137.7, 60.4, 55.7, 52.7, 51.4, 47.6, 43.7, 36.0, 35.0, 32.2, 31.6, 31.3, 28.4, 27.8, 28.0, 27.4, 27.1, 27.0, 26.9, 26.6, 26.3, 24.4, 22.3, 19.4, 13.6, 11.4, 4.1, 4.0. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 799 [(M + Na)<sup>+</sup>, 60], 777 [(M + 1)<sup>+</sup>, 100].</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[[methyl(2-thienylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>44</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.06 (bs, 1 H), 7.62 (dd, 1 H, <i>J =</i> 1.3 and 3.8 Hz), 7.57 (dd, 1 H, <i>J</i> = 1.3 and 2.5 Hz), 7.49 (b, 1H), 7.16 (dd, 1 H, <i>J =</i> 3.8 and 1.3 Hz), 5.93−5.67 (m, 2 H), 5.69 (bt, 1 H, <i>J =</i> 8.2 Hz), 5.27−5.19 (m, 2 H), 4.72 (m, 1 H), 4.63 (s, 1 H), 4.31 (d, 1 H, <i>J =</i> 10.4 Hz), 4.06−3.90 (m, 5 H), 2.93−2.77 (m, 2 H), 2.85 (s, 3 H), 1.92−1.31 (m, 20 H), 1.04 (s, 3 H), 0.93 (s, 3 H), 0.91 (s, 9 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.5, 173.7, 171.7, 159.3, 158.2, 138.7, 133.3, 132.2, 131.9, 127.9, 117.6, 60.7, 54.9, 53.7, 51.7, 51.0, 48.4, 42.2, 35.2, 34.5, 33.4, 32.5, 31.0, 27.9, 27.3, 27.1, 27.3, 26.9, 26.4, 25.8, 25.0, 23.3, 26.7, 19.3, 13.5. MS (ESI, <i>m</i>/<i>z</i> relative intensity) 817 [(M + Na + CH<sub>3</sub>OH)<sup>+</sup>, 60], 795 [(M + Na)<sup>+</sup>, 65], 763 [(M + 1)<sup>+</sup>, 100]. HRMS calcd for C<sub>37</sub>H<sub>58</sub>NaN<sub>6</sub>O<sub>7</sub>S<sub>2</sub> [M + Na]<sup>+</sup>: 785.3706. Found: 785.3706.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-(Cyclopropylcarbonyl)-2-methylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>45</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.89 (t, 1 H, <i>J =</i> 5.7 Hz), 8.37 (d, 1 H, <i>J =</i> 9.1 Hz), 6.39 (d, 1 H, <i>J =</i> 8.8 Hz), 6.23 (d, 1 H, <i>J =</i> 8.8 Hz), 5.85−5.36 (m, 1H), 5.30 (t, 1 H, <i>J =</i> 9.7 Hz), 5.14−5.06 (m, 2 H), 4.35 (s, 1 H), 4.26 (dt, 1 H, <i>J =</i> 1.9 and 10.1 Hz), 3.91−3.71 (m, 4 H), 2.21−2.15 (m, 2 H), 1.73−1.64 (m, 2 H), 1.52−0.72 (m, 23 H), 1.00 (s, 3 H), 0.87 (s, 3 H), 0.70 (d, 6 H, <i>J =</i> 6.6 Hz). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 210.8, 198.2, 172.0, 171.4, 162.1, 157.9, 135.0, 116.4, 64.5, 60.5, 52.8, 51.4, 47.6, 41.7, 32.1, 31.5, 31.2, 30.1, 28.3, 28.0, 27.8, 27.3, 26.9, 26.6, 26.2, 24.4, 22.4, 20.4, 19.4, 18.8, 17.8, 13.6, 11.7, 11.2, 8.5. MS (ESI, <i>m</i>/<i>z</i> relative intensity), 628 [(M + 1)<sup>+</sup>, 100], 461 (20), 450 (10).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[[methyl(2-pyridinylsulfonyl)amino]methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>48</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.89 (t, 1 H, <i>J</i> = 5.9 Hz), 8.72 (d, 1H, <i>J</i> = 5.1 Hz), 8.37 (d, 1 H, <i>J</i> = 8.8 Hz), 8.07 (t, 1 H, <i>J</i> = 7.3 Hz), 7.88 (d, 1 H, <i>J</i> = 7.3 Hz), 7.66 (dd, 1 H, <i>J</i> = 5.1 and 2.9 Hz), 6.13 (d, 1 H, <i>J</i> = 8.8 Hz), 5.84−5.73 (m, 2 H), 5.28 (t, 1 H, <i>J</i> = 9.5 Hz), 5.06 (dd, 2 H, <i>J</i> = 18.0 and 3.0 Hz), 4.30 (s, 1 H), 4.25 (t, 1 H, <i>J</i> = 8.8 Hz), 3.92 (d, 1 H, <i>J</i> = 10.3 Hz), 3.77−3.60 (m, 4 H), 3.20 (d, 1 H, <i>J</i> = 10.2 Hz), 3.05 (t, 1 H, <i>J</i> = 10.2 Hz), 2.75 (s, 3 H), 1.63 (m, 1 H), 1.45−0.83 (m, 19 H), 0.97 (s, 3 H), 0.83 (s, 3 H), 0.77 (s, 9 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 198.3, 172.1, 171.7, 162.1, 162.0, 158.3, 157.1, 151.1, 139.6, 135.0, 128.0, 123.3, 116.5, 60.5, 55.8, 52.8, 52.3, 51.5, 47.6, 41.7, 36.4, 35.0, 32.2, 31.8, 31.6, 28.5, 28.0, 27.9, 27.4, 27.2, 27.1, 26.9, 26.6, 26.3, 22.3, 19.5, 15.0, 13.7. MS (ESI, <i>m</i>/<i>z</i> relative intensity) 780 [(M + Na)<sup>+</sup>, 50], 758 [(M + H)<sup>+</sup>, 100].</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-[[[(Dimethylamino)sulfonyl]methylamino]methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>50</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.89 (t, 1 H, <i>J =</i> 6.0 Hz), 8.37 (d, 1 H, <i>J =</i> 9.1 Hz), 6.15 (d, 1 H, <i>J =</i> 9.1 Hz), 5.83−5.76 (m, 2 H), 5.29 (t, 1 H, <i>J =</i> 10.1 Hz), 5.14−5.06 (m, 2 H), 4.33 (s, 1 H), 4.30 (t, 1 H, <i>J =</i> 9.1 Hz), 3.92 (d, 1 H, <i>J =</i> 10.4 Hz), 3.81−3.71 (m, 3 H), 3.61 (dt, 1 H, <i>J =</i> 2.5 and 10.4 Hz), 3.17 (dd, 1 H, <i>J =</i> 2.8 and 10.7 Hz), 2.94 (dd, 1 H, <i>J =</i> 11.0 and 2.5 Hz), 2.71 (s, 3 H), 2.69 (s, 6 H), 1.71−1.63 (m, 2 H), 1.46−1.17 (m, 18 H), 0.99 (s, 3 H), 0.84 (s, 3 H), 0.81 (s, 9 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 198.2, 172.0, 171.6, 162.0, 158.1, 135.0, 116.4, 60.4, 55.8, 52.8, 51.6, 51.3, 47.6, 41.7, 38.5, 36.0, 34.9, 32.3, 31.6, 31.2, 28.4, 27.9, 27.3, 27.1, 27.0, 26.9, 26.6, 26.2, 24.4, 22.3, 19.4, 13.6. MS (ESI, <i>m</i>/<i>z</i> relative intensity) 724 [(M + 1)<sup>+</sup>, 100], 461 (10).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-[(1,3-Dihydro-1,3-dioxo-2<i>H</i>-isoindol-2-yl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>51</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.87 (t, 1 H, <i>J =</i> 6.0 Hz), 8.32 (d, 1 H, <i>J =</i> 9.1 Hz), 7.83 (bs, 4 H), 5.99 (d, 1 H, <i>J =</i> 8.8 Hz), 5.84 (d, 1 H, <i>J =</i> 10.4 Hz), 5.82−5.75 (m, 1 H), 5.24 (bt, 1 H, <i>J =</i> 10.4 Hz), 5.13−5.05 (m, 2 H), 4.27 (s, 1 H), 3.88 (dt, 1 H, <i>J =</i> 4.1 and 9.4 Hz), 3.79−3.49 (m, 7 H), 1.66−1.63 (m, 1 H), 1.39−0.92 (m, 19 H), 0.96 (s, 3 H), 0.93 (s, 9 H), 0.77 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.1, 171.9, 171.0, 168.6, 162.1, 158.0, 135.0, 135.0, 132.5, 123.6, 116.4, 60.4, 56.2, 52.9, 51.3, 47.4, 41.6, 39.5, 34.3, 31.9, 31.4, 31.2, 28.2, 27.8, 27.8, 27.1, 27.0, 26.8, 26.5, 26.0, 24.5, 22.2, 19.3, 13.5. MS (ESI, <i>m</i>/<i>z</i> relative intensity) 755 [(M + Na)<sup>+</sup>, 40], 733 [(M + 1)<sup>+</sup>, 100].</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-[(4,4-Dimethyl-2,6-dioxo-1-piperidinyl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>52</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 8.10 (t, 1 H, <i>J =</i> 5.7 Hz), 8.37 (d, 1 H, <i>J =</i> 8.8 Hz), 6.19 (d, 1H, <i>J =</i> 8.5 Hz), 5.83−5.75 (m, 1 H), 5.58 (d, 1 H, <i>J =</i> 10.4 Hz), 5.27 (bt, 1 H, <i>J =</i> 9.1 Hz), 5.13−5.05 (m, 2 H), 4.31 (s, 1 H), 4.18 (t, 1 H, <i>J =</i> 8.8 Hz), 3.83− 3.65 (m, 6 H), 3.58 (d, 1 H, <i>J =</i> 12.6 Hz), 2.43 (dd, 4 H, <i>J =</i> 17.0 and 11.0 Hz), 1.66−1.62 (m, 2 H), 1.44−1.11 (m, 18 H), 0.98 (s, 3 H), 0.96 (s, 6 H), 0.84 (s, 9 H), 0.82 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), δ, 198.2, 172.8, 172.0, 171.3, 162.1, 158.1, 135.0, 116.4, 60.4, 55.4, 52.8, 51.3, 47.5, 46.3, 41.7, 39.5, 35.0, 32.4, 31.5, 31.2, 29.2, 28.3, 27.9, 27.9, 27.3, 27.0, 26.9, 26.5, 26.1, 24.5, 22.4, 19.4, 13.6. MS (ES, <i>m</i>/<i>z</i> relative intensity) 749 [(M + Na)<sup>+</sup>, 20], 727 [(M + 1)<sup>+</sup>, 100].</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[2,2-Dimethyl-1(<i>S</i>)-[(4-methyl-2,6-dioxo-1-piperazinyl)methyl]propyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>53</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ, 8.00 (1H, d, <i>J =</i> 7.88 Hz), 7.61 (1H, broad s), 5.95 (1H, broad s), 5.85 (1H, ddt, <i>J =</i> 5.67, 10.40, 17.02 Hz), 5.63 (1H, t, <i>J =</i> 8.51 Hz), 5.21 (1H, ddt, <i>J =</i> 1.26, 1.57, 17.02 Hz), 5.19 (1H, broad s), 5.18 (1H, dd, <i>J =</i> 1.26, 10.40 Hz), 4.60 (1H, ddd, <i>J =</i> 3.46, 9.45, 10.40 Hz), 4.54 (1H, s), 4.11 (1H, d, <i>J =</i> 10.08 Hz), 3.79−4.02 (6H, m), 3.42 (2H, d, <i>J =</i> 16.07 Hz), 3.33 (2H, d, <i>J =</i> 16.07 Hz), 2.37 (3H, s), 1.84 (4H, m), 1.68 (1H, m), 1.43−1.52 (4H, m), 1.15−1.42 (10H, m), 1.05 (1H, m), 0.96 (3H, s), 0.91 (9H, s), 0.81 (3H, s). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>), δ, 198.2, 172.9, 171.3, 170.1, 158.8, 157.5, 132.9, 117.2, 60.2, 58.0, 55.9, 53.1, 51.1, 48.1, 43.7, 41.8, 39.4, 34.2, 33.5, 32.3, 30.8, 29.2, 27.3, 26.9, 26.87, 26.84, 26.4, 26.3, 26.0, 25.4, 24.5, 22.8, 18.9, 13.0 ppm. HRMS (ESI) calcd for C<sub>37</sub>H<sub>60</sub>N<sub>7</sub>O<sub>7</sub> [M + H]<sup>+</sup>: 714.4554. Found: 714.4556.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (16a<i>S</i>,17a<i>R</i>,17b<i>S</i>)-13(<i>S</i>)-[[[[1(<i>S</i>)-[(2,4-Dioxo-3-azabicyclo[3.2.1]oct-3-yl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]octadecahydro-17,17-dimethyl-α,1,14-trioxo-<i>N</i>-(2-propenyl)-2<i>H</i>-cyclopropa[3,4]pyrrolo[1,2-<i>a</i>][1,4]diazacyclohexadecine-3(<i>S</i>)-acetamide [<b>54</b>]</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ, 8.03 (1H, d, <i>J =</i> 6.6 Hz), 7.69 (1H, broad s), 6.04 (1H, broad s), 5.85 (1H, ddt, <i>J =</i> 5.67, 10.08, 17.0 Hz), 5.64 (1H, broad s), 5.22 (1H, ddt, <i>J =</i> 1.2, 1.5, 17.0 Hz), 5.21 (1H, broad s), 5.17 (1H, ddt, <i>J =</i> 1.2, 1.2, 10.0 Hz), 4.64 (1H, d, <i>J =</i> 8.8 Hz), 4.56 (1H, broad s), 4.16 (1H, d, <i>J =</i> 10.0 Hz), 3.89−4.02 (3H, m), 3.84 (1H, dt, <i>J =</i> 4.72, 10.0 Hz), 3.73 (1H, s), 3.71 (1H, d, <i>J =</i> 6.3 Hz), 3.13 (1H, broad s), 3.08 (1H, broad s), 2.16 (1H, d, <i>J =</i> 11. Hz), 2.02 (3H, m), 1.86 (2H, m), 1.70 (5H, m), 1.58 (1H, dt, <i>J =</i> 4.0, 12.0 Hz), 1.48 (4H, m), 1.14−1.43 (9H, m), 1.05 (1H, m), 0.96 (3H, s), 0.89 (9H, s), 0.81 (3H, s). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): δ 198.4, 173.0, 171.3, 158.8, 157.6, 132.9, 117.2, 60.1, 56.0, 53.1, 51.0, 48.1, 44.9, 44.7, 41.8, 38.8, 34.2, 33.6, 32.5, 32.3, 31.5, 30.8, 29.2, 27.3, 27.2, 26.9, 26.87, 26.83, 26.46, 26.42, 26.0, 25.5, 24.6, 22.9, 22.6, 18.9, 13.0 ppm. HRMS (ESI) calcd for C<sub>39</sub>H<sub>61</sub>N<sub>6</sub>O<sub>7</sub> [M + H]<sup>+</sup>: 725.4602. Found: 725.4581.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srikanth Venkatraman</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0457766d6f656a706c2a52616a6f6570766569656a447774676b76742a676b69"><span class="__cf_email__" data-cfemail="792a0b101218170d11572f1c1712180d0b18141817390a091a160b09571a1614">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Velazquez</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wanli Wu</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Blackman</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin X. Chen</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephane Bogen</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Latha Nair</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao Tong</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Chase</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Hart</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sony Agrawal</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Pichardo</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Prongay</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Chi Cheng</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Viyyoor Girijavallabhan</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Piwinski</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neng-Yang Shih</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. George Njoroge</span> - <span class="hlFld-Affiliation affiliation">Schering Plough Research Institute, K-15, MS-3545, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm800940u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span>Fact Sheet Number 164; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, October<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fact+Sheet+Number+164%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+October+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DWorld%2520Health%2520Organization%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of hepatitis C: geographic differences and temporal trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+hepatitis+C%3A+geographic+differences+and+temporal+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2ebQ54K0WF54Trntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520hepatitis%2520C%253A%2520geographic%2520differences%2520and%2520temporal%2520trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglio, P. J.</span><span> </span><span class="NLM_article-title">Scope of worldwide hepatitis C problem</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_elocation-id">S10−S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&author=R.+S.+Brownauthor=P.+J.+Gaglio&title=Scope+of+worldwide+hepatitis+C+problem"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DGaglio%26aufirst%3DP.%2BJ.%26atitle%3DScope%2520of%2520worldwide%2520hepatitis%2520C%2520problem%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM199811193392101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9819446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1485-1492&author=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=E.+R.+Schiffauthor=M.+L.+Shiffmanauthor=W.+M.+Leeauthor=V.+K.+Rustgiauthor=Z.+D.+Goodmanauthor=M.-H.+Lingauthor=S.+Cortauthor=J.+K.+Albrecht&title=Interferon+alpha-2b+alone+or+in+combination+with+ribavirin+as+initial+treatment+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span></div><div class="casAuthors">Mchutchison, John G.; Gordon, Stuart C.; Schiff, Eugene R.; Shiffman, Mitchell L.; Lee, William M.; Rustgi, Vinod K.; Goodman, Zachary D.; Ling, Mei-Hsiu; Cort, Susannah; Albrecht, Janice K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1485-1492</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virol. response to interferon therapy.  We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of patients with chronic hepatitis C.  We randomly assigned 912 patients with chronic hepatitis C to receive std.-dose interferon alfa-2b alone or in combination with ribavirin (1000 or 1200 mg orally per day, depending on body wt.) for 24 or 48 wk.  Efficacy was assessed by measurements of serum hepatitis C virus (HCV) RNA and serum aminotransferases and by liver biopsy.  The rate of sustained virol. response (defined as an undetectable serum HCV RNA level 24 wk after treatment was completed) was higher among patients who received combination therapy for either 24 wk (70 of 228 patients, 31 percent) or 48 wk (87 of 228 patients, 38 percent) than among patients who received interferon alone for either 24 wk (13 of 231 patients, 6 percent) or 48 wk (29 of 225 patients, 13 percent) (P<0.001 for the comparison of interferon alone with both 24 wk and 48 wk of combination treatment).  Among patients with HCV genotype 1 infection, the best response occurred in those who were treated for 48 wk with interferon and ribavirin.  Histol. improvement was more common in patients who were treated with combination therapy for either 24 wk (57 percent) or 48 wk (61 percent) than in those who were treated with interferon alone for either 24 wk (44 percent) or 48 wk (41 percent).  The drug doses had to be reduced and treatment discontinued more often in patients who were treated with combination therapy.  In patients with chronic hepatitis C, initial therapy with interferon and ribavirin was more effective than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9oxTyHQud7LVg90H21EOLACvtfcHk0li9Qkq1kTjXAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D&md5=41f8d301b8b7eddddda610cb71755cb2</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392101%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DLing%26aufirst%3DM.-H.%26aulast%3DCort%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DInterferon%2520alpha-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520as%2520initial%2520treatment%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1485%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban-Mur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoefs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span> </span><span class="NLM_article-title">Interferon alpha-2b alone or in combination with ribavirin for treatment of relapse of chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM199811193392102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9819447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1493-1499&author=G.+L.+Davisauthor=R.+Esteban-Murauthor=V.+Rustgiauthor=J.+Hoefsauthor=S.+C.+Gordonauthor=C.+Trepoauthor=M.+L.+Shiffmanauthor=S.+Zeuzemauthor=A.+Craxiauthor=M.-H.+Lingauthor=J.+Albrecht&title=Interferon+alpha-2b+alone+or+in+combination+with+ribavirin+for+treatment+of+relapse+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C</span></div><div class="casAuthors">Davis, Gary L.; Esteban-Mur, Rafael; Rustgi, Vinod; Hoefs, John; Gordon, Stuart C.; Trepo, Christian; Shiffman, Mitchell L.; Zeuzem, Stefan; Craxi, Antonio; Ling, Mei-Hsiu; Albrecht, Janice</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1493-1499</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Interferon alfa is the only effective treatment for patients with chronic hepatitis C.  Forty percent of patients have an initial response to this therapy, but most subsequently relapse.  We compared the effect of interferon alone with that of interferon plus oral ribavirin for relapses of chronic hepatitis C.  We studied 345 patients with chronic hepatitis C who relapsed after interferon treatment.  A total of 173 patients were randomly assigned to receive std.-dose recombinant interferon alfa-2b concurrently with ribavirin (1000 to 1200 mg orally per day, depending on body wt.) for six months, and 172 patients were assigned to receive interferon and placebo.  At the completion of treatment, serum levels of hepatitis C virus (HCV) RNA were undetectable in 141 of the 173 patients who were treated with interferon and ribavirin and in 80 of the 172 patients who were treated with interferon alone (82 percent vs. 47 percent, P<0.001).  Serum HCV RNA levels remained undetectable 24 wk after the end of treatment in 84 patients (49 percent) in the combination-therapy group, but in only 8 patients (5 percent) in the interferon group (P<0.001).  Sustained normalization of serum alanine aminotransferase concns. and histol. improvement were highly correlated with virol. response.  Base-line serum HCV RNA levels of 2×106 copies per mL or less were assocd. with higher rates of response in both treatment groups.  Viral genotypes other than type 1 were assocd. with sustained responses only in the combination-therapy group.  Combined therapy caused a predictable fall in Hb concns. but otherwise had a safety profile similar to that of interferon alone.  In patients with chronic hepatitis C who relapse after treatment with interferon, therapy with interferon and oral ribavirin results in higher rates of sustained virol., biochem., and histol. response than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV6gdE4nx7UbVg90H21EOLACvtfcHk0li9MaJft2WS9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbg%253D&md5=88488c15f794c27ee52e7364ded6bc4a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392102%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DG.%2BL.%26aulast%3DEsteban-Mur%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DHoefs%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLing%26aufirst%3DM.-H.%26aulast%3DAlbrecht%26aufirst%3DJ.%26atitle%3DInterferon%2520alpha-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520for%2520treatment%2520of%2520relapse%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1493%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinman, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasenack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Grady, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunda, M. J.</span><span> </span><span class="NLM_article-title">Peginterferon alpha-2a in patients with chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM200012073432301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11106715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1666-1172&author=S.+Zeuzemauthor=S.+V.+Feinmanauthor=J.+Rasenackauthor=E.+J.+Heathcoteauthor=M.-Y.+Laiauthor=E.+Ganeauthor=J.+O%E2%80%99Gradyauthor=J.+Reichenauthor=M.+Diagoauthor=A.+Linauthor=J.+Hoffmanauthor=M.+J.+Brunda&title=Peginterferon+alpha-2a+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a in patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem, Stefan; Feinman, S. Victor; Rasenack, Jens; Heathcote, E. Jenny; Lai, Ming-Yang; Gane, Edward; O'Grady, John; Reichen, Jurg; Diago, Moises; Lin, Amy; Hoffman, Joseph; Brunda, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1666-1672</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Covalent attachment of a 40-kd branched-chain polyethylene glycol moiety to interferon alfa-2a results in a compd. (peginterferon alfa-2a) that has sustained absorption, a slower rate of clearance, and a longer half-life than unmodified interferon alfa-2a.  We compared the clin. effects of a regimen of peginterferon alfa-2a with those of a regimen of interferon alfa-2a in the initial treatment of patients with chronic hepatitis C.  We randomly assigned 531 patients with chronic hepatitis C to receive either 180 μg of peginterferon alfa-2a s.c. once per wk for 48 wk (267 patients) or 6 million units of interferon alfa-2a s.c. three times per wk for 12 wk, followed by 3 million units three times per wk for 36 wk (264 patients).  All the patients were assessed at week 72 for a sustained virol. response, defined as an undetectable level of hepatitis C virus RNA (<100 copies per mL).  In the peginterferon group, 223 of the 267 patients completed treatment and 206 completed follow-up.  In the interferon group, 161 of the 264 patients completed treatment and 154 completed follow-up.  In an intention-to-treat anal. in which patients who missed the examn. at the end of treatment or follow-up were considered not to have had a response at that point, peginterferon alfa-2a was assocd. with a higher rate of virol. response than was interferon alfa-2a at week 48 (69 percent vs. 28 percent, P=0.001) and at week 72 (39 percent vs. 19 percent, P=0.001).  Sustained normalization of serum alanine aminotransferase concns. at week 72 was also more common in the peginterferon group than in the interferon group (45 percent vs. 25 percent, P=0.001).  The two groups were similar with respect to the frequency and severity of adverse events, which were typical of those assocd. with interferon alfa.  Conclusions In patients with chronic hepatitis C, a regimen of peginterferon alfa-2a given once weekly is more effective than a regimen of interferon alfa-2a given three times weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhZ1-de6JVzLVg90H21EOLACvtfcHk0li9MaJft2WS9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhurY%253D&md5=ca6830366b388db15f1df0a230dd1040</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432301%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DFeinman%26aufirst%3DS.%2BV.%26aulast%3DRasenack%26aufirst%3DJ.%26aulast%3DHeathcote%26aufirst%3DE.%2BJ.%26aulast%3DLai%26aufirst%3DM.-Y.%26aulast%3DGane%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DJ.%26aulast%3DReichen%26aufirst%3DJ.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DBrunda%26aufirst%3DM.%2BJ.%26atitle%3DPeginterferon%2520alpha-2a%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1666%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Heathcote, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooksley, W. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pamphilis, J.</span><span> </span><span class="NLM_article-title">Peginterferon alpha-2a in patients with chronic hepatitis C and cirrhosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM200012073432302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11106716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1673-1680&author=E.+J.+Heathcoteauthor=M.+L.+Shiffmanauthor=W.+G.+E.+Cooksleyauthor=G.+M.+Dusheikoauthor=S.+S.+Leeauthor=L.+Balartauthor=R.+Reindollarauthor=R.+K.+Reddyauthor=T.+L.+Wrightauthor=A.+Linauthor=J.+Hoffmanauthor=J.+De+Pamphilis&title=Peginterferon+alpha-2a+in+patients+with+chronic+hepatitis+C+and+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis</span></div><div class="casAuthors">Heathcote, E. Jenny; Shiffman, Mitchell L.; Cooksley, W. Graham E.; Dusheiko, Geoffrey M.; Lee, Samuel S.; Balart, Luis; Reindollar, Robert; Reddy, Rajender K.; Wright, Teresa L.; Lin, Amy; Hoffman, Joseph; De Pamphilis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1673-1680</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Chronic hepatitis C virus (HCV) infection in patients with cirrhosis is difficult to treat.  In patients with chronic hepatitis C but without cirrhosis, once-weekly administration of interferon modified by the attachment of a 40-kd branched-chain polyethylene glycol moiety (peginterferon alfa-2a) is more efficacious than a regimen of unmodified interferon.  We examd. the efficacy and safety of peginterferon alfa-2a in patients with HCV-related cirrhosis or bridging fibrosis.  We randomly assigned 271 patients with cirrhosis or bridging fibrosis to receive s.c. treatment with 3 million units of interferon alfa-2a three times weekly (88 patients), 90 μg of peginterferon alfa-2a once weekly (96), or 180 μg of peginterferon alfa-2a once weekly (87).  Treatment lasted 48 wk and was followed by a 24-wk follow-up period.  We assessed efficacy by measuring HCV RNA and alanine aminotransferase and by evaluating liver-biopsy specimens.  A histol. response was defined as a decrease of at least 2 points on the 22-point Histol. Activity Index.  In an intention-to-treat anal., HCV RNA was undetectable at week 72 in 8 percent, 15 percent, and 30 percent of the patients treated with interferon alfa-2a and with 90 μg and 180 μg of peginterferon alfa-2a, resp. (P=0.001 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  At week 72, alanine aminotransferase concns. had normalized in 15 percent, 20 percent, and 34 percent of patients, resp. (P=0.004 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  In the subgroup of 184 patients with paired liver-biopsy specimens, the rates of histol. response at week 72 were 31 percent, 44 percent, and 54 percent, resp. (P=0.02 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  All three treatments were similarly tolerated.  In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 μg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 million units of std. interferon alfa-2a administered three times weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTlFTBA3F_s7Vg90H21EOLACvtfcHk0li9MaJft2WS9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhurc%253D&md5=d4132ca895c14f9b32b703d19fd94fc8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432302%26sid%3Dliteratum%253Aachs%26aulast%3DHeathcote%26aufirst%3DE.%2BJ.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DCooksley%26aufirst%3DW.%2BG.%2BE.%26aulast%3DDusheiko%26aufirst%3DG.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BS.%26aulast%3DBalart%26aufirst%3DL.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DWright%26aufirst%3DT.%2BL.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DDe%2BPamphilis%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alpha-2a%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520and%2520cirrhosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1673%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Manns, M. P.; McHutchison, J. G.; Gordon, S. C.; Rustgi, V. K.; Shiffman, M.; Reindollar, R.; Goodman, Z. D.; Koury, K.; Ling, M.-H.; Albrecht, J. K.</span> (and International Hepatitis Interventional Therapy Group).  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span>− <span class="NLM_lpage">965</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manns%2C+M.+P.%3B+McHutchison%2C+J.+G.%3B+Gordon%2C+S.+C.%3B+Rustgi%2C+V.+K.%3B+Shiffman%2C+M.%3B+Reindollar%2C+R.%3B+Goodman%2C+Z.+D.%3B+Koury%2C+K.%3B+Ling%2C+M.-H.%3B+Albrecht%2C+J.+K.+%28and+International+Hepatitis+Interventional+Therapy+Group%29.+Lancet+2001%2C+358%2C+958%E2%88%92965."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D958%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schairer, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1939-1942&author=R.+B.+Perniauthor=L.+J.+Farmerauthor=K.+M.+Cottrellauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=J.+L.+Kimauthor=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=J.+P.+Maxwellauthor=M.+A.+Murckoauthor=J.+Pitlikauthor=B.+G.+Raoauthor=W.+C.+Schairerauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=K.+Wilsonauthor=J.+A.+Thomson&title=Inhibitors+of+hepatitis+C+virus+NS3%C2%B74A+protease.+Part+3%3A+P2+proline+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DSchairer%26aufirst%3DW.%2BC.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%25C2%25B74A%2520protease.%2520Part%25203%253A%2520P2%2520proline%2520variants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1939%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Novel P4 truncated tripeptidyl ά-ketoamides as HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=263-266&author=J.+Lamarauthor=F.+Victorauthor=N.+Snyderauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=Novel+P4+truncated+tripeptidyl+%CE%AC-ketoamides+as+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DNovel%2520P4%2520truncated%2520tripeptidyl%2520%25CE%25AC-ketoamides%2520as%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D263%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2151-2154&author=E.+Niziauthor=U.+Kochauthor=J.+M.+Ontoriaauthor=A.+Marchettiauthor=F.+Narjesauthor=S.+Malanconaauthor=V.+G.+Matassaauthor=C.+Gardelli&title=Capped+dipeptide+phenethylamide+inhibitors+of+the+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCapped%2520dipeptide%2520phenethylamide%2520inhibitors%2520of%2520the%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavimi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">P1 phenethyl peptide boronic acid inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3199-3202&author=E.+S.+Priestleyauthor=I.+De+Luccaauthor=B.+Ghavimiauthor=S.+Erickson-Viitanenauthor=C.+P.+Decicco&title=P1+phenethyl+peptide+boronic+acid+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DDe%2BLucca%26aufirst%3DI.%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3DP1%2520phenethyl%2520peptide%2520boronic%2520acid%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3199%26epage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=711-713&author=W.+Hanauthor=Z.+Huauthor=X.+Jiangauthor=C.+P.+Decicco&title=%CE%B1-Ketoamides%2C+%CE%B1-ketoesters+and+%CE%B1-diketones+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3D%25CE%25B1-Ketoamides%252C%2520%25CE%25B1-ketoesters%2520and%2520%25CE%25B1-diketones%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D711%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1005-1008&author=R.+Zhangauthor=J.+P.+Durkinauthor=W.+T.+Windsor&title=Azapeptides+as+inhibitors+of+the+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDurkin%26aufirst%3DJ.%2BP.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DAzapeptides%2520as%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2−P1 cyclopropyl alanine combination for improved potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4515-4519&author=S.+Bogenauthor=A.+K.+Saksenaauthor=A.+Arasappanauthor=H.+Guauthor=F.+G.+Njorogeauthor=V.+Girijavallabhanauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madison&title=Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+use+of+a+P2%E2%88%92P1+cyclopropyl+alanine+combination+for+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520use%2520of%2520a%2520P2%25E2%2588%2592P1%2520cyclopropyl%2520alanine%2520combination%2520for%2520improved%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4515%26epage%3D4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=257-261&author=F.+Victorauthor=J.+Lamarauthor=N.+Snyderauthor=Y.+Yipauthor=D.+Guoauthor=N.+Yumibeauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=P1+and+P3+optimization+of+novel+bicycloproline+P2+bearing+tetrapeptidyl+%CE%B1-ketoamide+based+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DYip%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DP1%2520and%2520P3%2520optimization%2520of%2520novel%2520bicycloproline%2520P2%2520bearing%2520tetrapeptidyl%2520%25CE%25B1-ketoamide%2520based%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kaito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watnabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukiyama-Kohara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus particle detected by immunoelectron microscopic study</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1099%2F0022-1317-75-7-1755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=7517432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK2cXkslyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=1755-1760&author=M.+Kaitoauthor=S.+Watnabeauthor=K.+Tsukiyama-Koharaauthor=K.+Yamaguchiauthor=Y.+Kobayashiauthor=M.+Konishiauthor=M.+Yokoiauthor=S.+Ishidaauthor=S.+Suzukiauthor=M.+Kohara&title=Hepatitis+C+virus+particle+detected+by+immunoelectron+microscopic+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus particle detected by immunoelectron microscopic study</span></div><div class="casAuthors">Kaito, Masahiko; Watanabe, Shozo; Tsukiyama-Kohara, Kyoko; Yamaguchi, Kenjiro; Kobayashi, Yoshinao; Konishi, Masayoshi; Yokoi, Masato; Ishida, Satoshi; Suzuki, Shiro; Kohara, Michinori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1755-60</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    </div><div class="casAbstract">To clarify the morphol. of hepatitis C virus (HCV), an indirect immunogold electron microscope study was carried out on two plasma samples with high HCV RNA titers using polyclonal and monoclonal antibodies specific to the putative HCV envelope protein.  Spherical virus-like particles 55 to 65 nm in diam. with spike-like projections, were found in 1.14 to 1.6 g/mL fractions after sucrose d. gradient centrifugation.  These particles were found only in HCV-infected blood donors and had morphol. features similar to those of flaviviruses.  Moreover, these particles specifically reacted with the polyclonal and monoclonal antibodies to the putative HCV envelope protein.  This is the first known report in which the morphol. of the HCV particle is clearly shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyf5RO3vEW_rVg90H21EOLACvtfcHk0ljsURoj70aBWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslyitL4%253D&md5=16939581cdc38b383fa760e50cb48cce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-75-7-1755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-75-7-1755%26sid%3Dliteratum%253Aachs%26aulast%3DKaito%26aufirst%3DM.%26aulast%3DWatnabe%26aufirst%3DS.%26aulast%3DTsukiyama-Kohara%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DYokoi%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DKohara%26aufirst%3DM.%26atitle%3DHepatitis%2520C%2520virus%2520particle%2520detected%2520by%2520immunoelectron%2520microscopic%2520study%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D1994%26volume%3D75%26spage%3D1755%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1046%2Fj.1365-2893.1999.00152.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10607229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FnsFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=165-181&author=R.+Bartenschlager&title=The+NS3%2F4A+proteinase+of+the+hepatitis+C+virus%3A+unravelling+structure+and+function+of+an+unusual+enzyme+and+a+prime+target+for+antiviral+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy</span></div><div class="casAuthors">Bartenschlager R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-81</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) is a major causative agent of transfusion-acquired and sporadic non-A, non-B hepatitis worldwide.  Infections most often persist and lead, in approximately 50% of all patients, to chronic liver disease.  As is characteristic for a member of the family Flaviviridae, HCV has a plus-strand RNA genome encoding a polyprotein, which is cleaved co- and post-translationally into at least 10 different products.  These cleavages are mediated, among others, by a virally encoded chymotrypsin-like serine proteinase located in the N-terminal domain of non-structural protein 3 (NS3).  Activity of this enzyme requires NS4A, a 54-residue polyprotein cleavage product, to form a stable complex with the NS3 domain.  This review will describe the biochemical properties of the NS3/4A proteinase, its X-ray crystal structure and current attempts towards development of efficient inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLDJ-rg9mQkKx48Rj5GnGofW6udTcc2ebjJ2Abzfzl77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FnsFajtQ%253D%253D&md5=2e321bb0e2bbcdfd3b8b2bc7c1d803bd</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2893.1999.00152.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2893.1999.00152.x%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520NS3%252F4A%2520proteinase%2520of%2520the%2520hepatitis%2520C%2520virus%253A%2520unravelling%2520structure%2520and%2520function%2520of%2520an%2520unusual%2520enzyme%2520and%2520a%2520prime%2520target%2520for%2520antiviral%2520therapy%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D1999%26volume%3D6%26spage%3D165%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlborn-Laake, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span> </span><span class="NLM_article-title">Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3835</span><span class="NLM_x">–</span> <span class="NLM_lpage">3844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=8389908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK3sXltlGhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=3835-3844&author=R.+Bartenschlagerauthor=L.+Ahlborn-Laakeauthor=J.+Mousauthor=H.+Jacobsen&title=Nonstructural+protein+3+of+the+hepatitis+C+virus+encodes+a+serine-type+proteinase+required+for+cleavage+at+the+NS3%2F4+and+NS4%2F5+junctions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions</span></div><div class="casAuthors">Bartenschlager, Ralf; Ahlborn-Laake, Ludwina; Mous, Jan; Jacobsen, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3835-44</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Processing of the nonstructural (NS) polyprotein of the hepatitis C virus was studied.  A series of cDNAs corresponding to predicted NS2/3/4 or NS3/4 regions were constructed, and processing of the polyproteins was studied in an in vitro transcription-translation system.  A catalytically active serine-type proteinase is encoded by the NS3 region.  Substitution of the serine residue of the putative catalytic triad (H, D, and S) by alanine blocked cleavage at the NS3/4 junction, whereas processing between NS2 and NS3 was not affected.  Thus, cleavage at the NS2/3 junction is mediated either by cellular enzymes or by an NS2 inherent proteinase activity.  Deletion anal. of an NS3/4 cDNA construct mapped the N-terminus of the enzymically active proteinase between amino acids 1049 and 1065 of the polyprotein.  As internal deletions of variable segments of the presumed helicase domain prevented processing at the NS3/4 junction, a continuous NS3 region appears to be required for processing at this site.  To analyze hepatitis C virus polyprotein cleavage in vivo, recombinant vaccinia viruses expressing NS2/3/4 or NS3/4/5 proteins were generated.  In agreement with the in vitro data, cleavage between NS2 and NS3 was independent of a catalytically active NS3 proteinase, whereas substitution of the active-site serine residue by the amino acid alanine completely blocked processing at the NS3/4 and NS4/5 junctions.  These results demonstrate that NS3 encodes the viral proteinase essential for generating the N-termini of NS4 and NS5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZMJUo7Cry47Vg90H21EOLACvtfcHk0lhedbHVPvXhaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlGhtbs%253D&md5=5bc3945b52e5f59edef857f0ce2196f8</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DAhlborn-Laake%26aufirst%3DL.%26aulast%3DMous%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DH.%26atitle%3DNonstructural%2520protein%25203%2520of%2520the%2520hepatitis%2520C%2520virus%2520encodes%2520a%2520serine-type%2520proteinase%2520required%2520for%2520cleavage%2520at%2520the%2520NS3%252F4%2520and%2520NS4%252F5%2520junctions%26jtitle%3DJ.%2520Virol.%26date%3D1993%26volume%3D67%26spage%3D3835%26epage%3D3844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Reed, K. E.; Rice, C. M.</span><span> </span><span class="NLM_article-title">Molecular Characterization of Hepatitis C Virus</span>. In  <span class="citation_source-book">Hepatitis C Virus</span>; <span class="NLM_contrib-group">Reesink, H. W.</span>, Ed.; <span class="NLM_publisher-name">Karger</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">37</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1159%2F000060472" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=1-37&author=K.+E.+Reed&author=C.+M.+Riceauthor=H.+W.+Reesink&title=Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1159%2F000060472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1159%252F000060472%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DK.%2BE.%26atitle%3DMolecular%2520Characterization%2520of%2520Hepatitis%2520C%2520Virus%26btitle%3DHepatitis%2520C%2520Virus%26aulast%3DReesink%26aufirst%3DH.%2BW.%26pub%3DKarger%26date%3D1998%26spage%3D1%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0lhedbHVPvXhaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=6-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=T.+S.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DT.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D18%26spage%3D6%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barket, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakulchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarreal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebbe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munroe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Discovery of a novel bicycloproline P<sub>2</sub> bearing peptidyl [alpha]-ketoamide LY514962 as HCV protease inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=251-256&author=Y.+Yipauthor=F.+Victorauthor=J.+Lamarauthor=R.+Johnsonauthor=Q.+M.+Wangauthor=D.+Barketauthor=J.+Glassauthor=L.+Jinauthor=L.+Liuauthor=D.+Venableauthor=M.+Wakulchikauthor=C.+Xieauthor=B.+Heinzauthor=E.+Villarrealauthor=J.+Colacinoauthor=N.+Yumibeauthor=M.+Tebbeauthor=J.+Munroeauthor=S.-H.+Chen&title=Discovery+of+a+novel+bicycloproline+P2+bearing+peptidyl+%5Balpha%5D-ketoamide+LY514962+as+HCV+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DY.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DBarket%26aufirst%3DD.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenable%26aufirst%3DD.%26aulast%3DWakulchik%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DHeinz%26aufirst%3DB.%26aulast%3DVillarreal%26aufirst%3DE.%26aulast%3DColacino%26aufirst%3DJ.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DTebbe%26aufirst%3DM.%26aulast%3DMunroe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520bicycloproline%2520P2%2520bearing%2520peptidyl%2520%255Balpha%255D-ketoamide%2520LY514962%2520as%2520HCV%2520protease%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D251%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Emerging therapies for hepatitis C infection</span> <span class="citation_source-journal">Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1517%2F14728214.6.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=15989494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=13-42&author=B.+W.+Dymock&title=Emerging+therapies+for+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for hepatitis C virus infection</span></div><div class="casAuthors">Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-42</span>CODEN:
                <span class="NLM_cas:coden">EMDRFV</span>;
        ISSN:<span class="NLM_cas:issn">1361-9195</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 172 refs.  Hepatitis C virus (HCV) has infected millions of people worldwide and has emerged as a global health crisis.  The currently available therapy is interferon (IFN) either alone or in combination with ribavirin.  However, the disappointing efficacy of IFN has led to the considerable need for improved treatments and a no. of new therapies are under evaluation in clin. trials.  These include pegylated IFNs, which have altered physiochem. characteristics allowing once-weekly dosing.  Combination of pegylated IFN with ribavirin should further improve sustained response rates.  However, not all patients are successfully treated with IFNs, particularly those infected with genotype 1 of the virus, and it is likely that potent, specific drugs will be required.  The majority of new approaches currently trying to combat this viral disease are aimed at inhibition of viral targets.  Most effort has been directed towards inhibition of the NS3 serine protease, and potent inhibitors have now been described.  However, a clin. candidate is yet to emerge against this difficult target.  Considerable work by leading researchers has provided crystal structures of the key replicative enzymes, NS3 protease, NS3 helicase, NS5B polymerase and full-length NS3 protease-helicase, and there is much hope that such structural information will bear fruit.  More recently, inhibition of host targets, particularly inosine monophosphate dehydrogenase (IMPDH), has become of interest and there are on-going clin. trials with such inhibitors.  Research aimed at novel treatments for HCV disease is gathering pace and very recent developments in cell-based assay systems can only hasten the discovery of improved therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjm4y0XuTNLVg90H21EOLACvtfcHk0lh4BvEZyNsSJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D&md5=3f96a719833a9cf89bc565376fc7324e</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1517%2F14728214.6.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.6.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DEmerging%2520therapies%2520for%2520hepatitis%2520C%2520infection%26jtitle%3DEmerging%2520Drugs%26date%3D2001%26volume%3D6%26spage%3D13%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Francesco%2C+R.%3B+Migliaccio%2C+G.Nature+2005%2C+436%2C+953%E2%80%93960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Robison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Robisonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobison%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Brazil, M.</span><span> </span><span class="NLM_article-title">Antiviral drugs: macrocyclic inhibitor for hepatitis C</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2003&pages=945&author=M.+Brazil&title=Antiviral+drugs%3A+macrocyclic+inhibitor+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrazil%26aufirst%3DM.%26atitle%3DAntiviral%2520drugs%253A%2520macrocyclic%2520inhibitor%2520for%2520hepatitis%2520C%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D212%26spage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youwei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjeev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinod, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaele, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhongguo, C.</span><span> </span><span class="NLM_article-title">Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 Å resolution structure in a hexagonal crystal form</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9568891" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=837-847&author=Y.+Youweiauthor=L.+Yingauthor=M.+Sanjeevauthor=S.+Vinodauthor=L.+C.+Jamesauthor=M.+Mohinderauthor=S.+Christianauthor=T.+Liciaauthor=D.+Raffaeleauthor=K.+C.+Lawrenceauthor=C.+Zhongguo&title=Complex+of+NS3+protease+and+NS4A+peptide+of+BK+strain+hepatitis+C+virus%3A+a+2.2+%C3%85+resolution+structure+in+a+hexagonal+crystal+form"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYouwei%26aufirst%3DY.%26aulast%3DYing%26aufirst%3DL.%26aulast%3DSanjeev%26aufirst%3DM.%26aulast%3DVinod%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DMohinder%26aufirst%3DM.%26aulast%3DChristian%26aufirst%3DS.%26aulast%3DLicia%26aufirst%3DT.%26aulast%3DRaffaele%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DK.%2BC.%26aulast%3DZhongguo%26aufirst%3DC.%26atitle%3DComplex%2520of%2520NS3%2520protease%2520and%2520NS4A%2520peptide%2520of%2520BK%2520strain%2520hepatitis%2520C%2520virus%253A%2520a%25202.2%2520%25C3%2585%2520resolution%2520structure%2520in%2520a%2520hexagonal%2520crystal%2520form%26jtitle%3DProtein%2520Sci.%26date%3D1998%26volume%3D7%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Love, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichersham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomska, Z.</span><span> </span><span class="NLM_article-title">The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=331-342&author=R.+A.+Loveauthor=H.+E.+Pargeauthor=J.+A.+Wichershamauthor=Z.+Hostomskyauthor=N.+Habukaauthor=E.+W.+Moomawauthor=T.+Adachiauthor=Z.+Hostomska&title=The+crystal+structure+of+hepatitis+C+virus+NS3+proteinase+reveals+a+trypsin-like+fold+and+a+structural+zinc+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DParge%26aufirst%3DH.%2BE.%26aulast%3DWichersham%26aufirst%3DJ.%2BA.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DHostomska%26aufirst%3DZ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520proteinase%2520reveals%2520a%2520trypsin-like%2520fold%2520and%2520a%2520structural%2520zinc%2520binding%2520site%26jtitle%3DCell%26date%3D1996%26volume%3D87%26spage%3D331%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dweyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1016%2FS0969-2126%2898%2900010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9493270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=89-100&author=J.+L.+Kimauthor=K.+A.+Morgensternauthor=J.+P.+Griffithauthor=M.+D.+Dweyerauthor=J.+A.+Thomsonauthor=M.+A.+Murckoauthor=C.+Linauthor=P.+R.+Caron&title=Hepatitis+C+virus+NS3+RNA+helicase+domain+with+a+bound+oligonucleotide%3A+the+crystal+structure+provides+insights+into+the+mode+of+unwinding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding</span></div><div class="casAuthors">Kim, Joseph L.; Morgenstern, Kurt A.; Griffith, James P.; Dwyer, Maureen D.; Thomson, John A.; Murcko, Mark A.; Lin, Chao; Caron, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) represents a major health concern as it is responsible for a significant no. of hepatitis cases worldwide.  Much research has focused on the replicative enzymes of HCV as possible targets for more effective therapeutic agents.  THe HCV NS3 helicase domain may provide one such suitable target.  Helicases are enzymes which can unwind double-stranded regions of DNA or RNA in an ATP-dependent reaction.  The structures of several helicases have been published but the structural details as to how ATP binding and hydrolysis are coupled to DNA unwinding are unknown.  Here, the structure of the HCV NS3 RNA helicase domain complexed with a single-stranded DNA oligonucleotide was solved to 2.2 Å resoln.  The protein consisted of 3 structural domains with the oligonucleotide lying in a groove between the 1st 2 domains and the 3rd.  The 1st 2 domains had an adenylate kinase-like fold, including a phosphate-binding loop in the 1st domain.  HCV NS3 helicase is a member of a superfamily of helicases, termed superfamily II.  Residues of NS3 helicase which are conserved among superfamily II helicases line an interdomain cleft between the 1st 2 domains.  The oligonucleotide bound in an orthogonal binding site and contacted relatively few conserved residues.  There were no strong sequence-specific interactions with the oligonucleotide bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJtlmpwoM4bbVg90H21EOLACvtfcHk0ljxkPfeu0BqIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVGltLg%253D&md5=9cacf02ee275d0d0922b72099a32de2d</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900010-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DDweyer%26aufirst%3DM.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26atitle%3DHepatitis%2520C%2520virus%2520NS3%2520RNA%2520helicase%2520domain%2520with%2520a%2520bound%2520oligonucleotide%253A%2520the%2520crystal%2520structure%2520provides%2520insights%2520into%2520the%2520mode%2520of%2520unwinding%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipovsek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S. A.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1998&pages=1-18&author=A.+D.+Kwongauthor=J.+L.+Kimauthor=G.+Raoauthor=D.+Lipovsekauthor=S.+A.+Raybuck&title=Hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DRao%26aufirst%3DG.%26aulast%3DLipovsek%26aufirst%3DD.%26aulast%3DRaybuck%26aufirst%3DS.%2BA.%26atitle%3DHepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntiviral%2520Res.%26date%3D1998%26volume%3D40%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madision, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amio]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatits C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=B.+L.+Madisionauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2-3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damio%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatits+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadision%26aufirst%3DB.%2BL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2-3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damio%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatits%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span> </span><span class="NLM_article-title">A continuous spectrophotometric assay for the hepatitis C virus serine protease</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1999&pages=268-275&author=R.+Zhangauthor=B.+M.+Beyerauthor=J.+Durkinauthor=R.+Ingramauthor=F.+G.+Njorogeauthor=W.+T.+Windsorauthor=B.+A.+Malcolm&title=A+continuous+spectrophotometric+assay+for+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26atitle%3DA%2520continuous%2520spectrophotometric%2520assay%2520for%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D270%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">The behavior and significance of slow binding enzyme inhibitors</span> <span class="citation_source-journal">Adv. Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+behavior+and+significance+of+slow+binding+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0lgULKqVGtLjoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520behavior%2520and%2520significance%2520of%2520slow%2520binding%2520enzyme%2520inhibitors%26jtitle%3DAdv.%2520Enzymol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lgULKqVGtLjoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span> </span><span class="NLM_article-title">Synthesis of two novel cyclic biphenyl ether analogs of an inhibitor of HCV NS3 protease</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1000-1002&author=A.+Marchettiauthor=J.+M.+Ontoriaauthor=V.+G.+Matassa&title=Synthesis+of+two+novel+cyclic+biphenyl+ether+analogs+of+an+inhibitor+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26atitle%3DSynthesis%2520of%2520two%2520novel%2520cyclic%2520biphenyl%2520ether%2520analogs%2520of%2520an%2520inhibitor%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DSynlett%26date%3D1999%26spage%3D1000%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tyndall, J. D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Macrocyclic mimic the extended peptide conformation recognized by aspartic, serine, cysteine, and metallo proteases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.2174%2F0929867013372715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11375757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=893-907&author=J.+D.+A.+Tyndallauthor=D.+P.+Fairlie&title=Macrocyclic+mimic+the+extended+peptide+conformation+recognized+by+aspartic%2C+serine%2C+cysteine%2C+and+metallo+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span></div><div class="casAuthors">Tyndall, Joel D. A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with refs.  It has been previously demonstrated that aspartic, serine, metallo and cysteine proteases bind to their inhibitors and substrate analogs in a single conformation, the saw-tooth or extended beta-strand.  Consequently a generic approach to the development of protease inhibitors is the use of constraints that conformationally restrict putative inhibitor mols. to an extended form.  In this way the inhibitor is pre-organized for binding to a protease and does not need to rearrange its structure.  One constraining device that has proven to be effective for such pre-organization is macrocyclization.  This article illustrates the general principle that macrocycles, esp. those composed of 3-4 amino acids and usually 13-17 ring atoms, can effectively mimic the extended conformation of short peptide sequences.  Such structure-stabilizing macrocycles are stable to degrdn. by proteases, valuable components of potent protease inhibitors, and in many cases they are also bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuoMyDlMrlbVg90H21EOLACvtfcHk0lgULKqVGtLjoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D&md5=2525f64466090d8f371452ed9f0d676c</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.2174%2F0929867013372715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372715%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DMacrocyclic%2520mimic%2520the%2520extended%2520peptide%2520conformation%2520recognized%2520by%2520aspartic%252C%2520serine%252C%2520cysteine%252C%2520and%2520metallo%2520proteases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D893%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of HCV NS3 protease; design and strucure activity relationship</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.2174%2F156802607781212202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=17627558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1290-1301&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+Inhibitors+of+HCV+NS3+protease%3B+design+and+strucure+activity+relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3-4A protease: design and structure activity relationship</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HCV NS3, a serine protease, that when bound to NS-4A cofactor facilitates development of mature virons by catalyzing cleavage of a single polyprotein to form functional and structural proteins of HCV.  X-ray structure of the enzyme reveal a very shallow binding pocket at the catalytic site which makes development of inhibitors a daunting task.  Various novel approaches have been used to design, preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 residues and P1-P3 groups.  The design and structure activity relationship of these macrocyclic inhibitors are reviewed in the following article.  X-ray structure of inhibitor bound to the active site of the enzyme is also discussed.  Macrocyclization proved to be an effective tool for depeptidization of peptidic inhibitors, imparting enhanced metabolic stability and improved pharmacokinetic properties in the resultant mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhDndFaOnLrVg90H21EOLACvtfcHk0ljYyD59UQxhZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP&md5=da704c17e2ed4f3780d550c1b81348fa</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F156802607781212202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212202%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520HCV%2520NS3%2520protease%253B%2520design%2520and%2520strucure%2520activity%2520relationship%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1290%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=546-574&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+acid-based+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520acid-based%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D546%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis c NS3-4A protease using structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">5091</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0489556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5088-5091&author=S.+Venkatramanauthor=F.+G.+Njorogeauthor=V.+M.+Girijavallabhanauthor=V.+S.+Madisonauthor=N+H.+Yaoauthor=A.+J.+Prongayauthor=N.+Butkiewiczauthor=J.+Pichardo&title=Design+and+synthesis+of+depeptidized+macrocyclic+inhibitors+of+hepatitis+c+NS3-4A+protease+using+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm0489556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0489556%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%2BM.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DYao%26aufirst%3DN%2BH.%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520depeptidized%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520c%2520NS3-4A%2520protease%2520using%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5088%26epage%3D5091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim-Wilby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of SCH 446211(SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication NS3 serine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2750</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060077j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2750-2757&author=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=S.+Venkatramanauthor=W.+Panauthor=T.+Parekhauthor=R.+E.+Pikeauthor=S.+Ruanauthor=R.+Liuauthor=B.+Baroudyauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=A.+Prongayauthor=J.-M.+Brissonauthor=T.+Y.+Hsiehauthor=K.-C.+Chengauthor=S.+J.+Kempauthor=O.+E.+Levyauthor=M.+Lim-Wilbyauthor=S.+Y.+Tamuraauthor=A.+K.+Saksenaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+SCH+446211%28SCH6%29%3A+a+new+ketoamide+inhibitor+of+the+HCV+NS3+serine+protease+and+HCV+subgenomic+RNA+replication+NS3+serine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060077j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060077j%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPike%26aufirst%3DR.%2BE.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26aulast%3DLevy%26aufirst%3DO.%2BE.%26aulast%3DLim-Wilby%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DS.%2BY.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520SCH%2520446211%2528SCH6%2529%253A%2520a%2520new%2520ketoamide%2520inhibitor%2520of%2520the%2520HCV%2520NS3%2520serine%2520protease%2520and%2520HCV%2520subgenomic%2520RNA%2520replication%2520NS3%2520serine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2750%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Velázquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Application of ring-closing metathesis for the synthesis of macrocyclic peptidomimetics as inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0711265" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3061-3064&author=F.+Vel%C3%A1zquezauthor=S.+Venkatramanauthor=W.+Wuauthor=M.+Blackmanauthor=A.+Prongayauthor=V.+Girijavallabhanauthor=N.-Y.+Shihauthor=F.+G.+Njoroge&title=Application+of+ring-closing+metathesis+for+the+synthesis+of+macrocyclic+peptidomimetics+as+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fol0711265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0711265%26sid%3Dliteratum%253Aachs%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DApplication%2520of%2520ring-closing%2520metathesis%2520for%2520the%2520synthesis%2520of%2520macrocyclic%2520peptidomimetics%2520as%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3061%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schwab, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziller, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">A Series of Well-Defined Metathesis Catalysts-Synthesis of [RuCl<sub>2</sub>(CHR)(PR<sub>3</sub>)<sub>2</sub>] and its reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2039</span><span class="NLM_x">–</span> <span class="NLM_lpage">2041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=2039-2041&author=P.+Schwabauthor=M.+B.+Franceauthor=J.+W.+Zillerauthor=R.+H.+Grubbs&title=A+Series+of+Well-Defined+Metathesis+Catalysts-Synthesis+of+%5BRuCl2%28CHR%29%28PR3%292%5D+and+its+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DP.%26aulast%3DFrance%26aufirst%3DM.%2BB.%26aulast%3DZiller%26aufirst%3DJ.%2BW.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DA%2520Series%2520of%2520Well-Defined%2520Metathesis%2520Catalysts-Synthesis%2520of%2520%255BRuCl2%2528CHR%2529%2528PR3%25292%255D%2520and%2520its%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D2039%26epage%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trnka, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">The Development of L2X2Ru=CHR Olefin Metathesis Catalysts: An Organometallic Success Story</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar000114f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslCqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2001&pages=18-29&author=T.+M.+Trnkaauthor=R.+H.+Grubbs&title=The+Development+of+L2X2Ru%3DCHR+Olefin+Metathesis+Catalysts%3A+An+Organometallic+Success+Story"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of L2X2Ru:CHR Olefin Metathesis Catalysts: An Organometallic Success Story</span></div><div class="casAuthors">Trnka, Tina M.; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with over 85 refs.  In recent years, the olefin metathesis reaction has attracted widespread attention as a versatile C-C bond-forming method.  Many new applications have become possible because of major advances in catalyst design.  State-of-the-art Ru catalysts are not only highly active but also compatible with most functional groups and easy to use.  This Account traces the ideas and discoveries that were instrumental in the development of these catalysts, with particular emphasis on (PCy3)2Cl2Ru:CHPh and its derivs.  The discussion includes an anal. of trends in catalyst activity, a description of catalysts coordinated with N-heterocyclic carbene ligands, and an overview of ongoing work to improve the activity, stability, and selectivity of this family of L2X2Ru:CHR complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAgjOFFNgww7Vg90H21EOLACvtfcHk0litdiV5QLR1-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslCqsb4%253D&md5=66a09fb9213ecdd4b7c22831c1c38ddb</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Far000114f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far000114f%26sid%3Dliteratum%253Aachs%26aulast%3DTrnka%26aufirst%3DT.%2BM.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DThe%2520Development%2520of%2520L2X2Ru%253DCHR%2520Olefin%2520Metathesis%2520Catalysts%253A%2520An%2520Organometallic%2520Success%2520Story%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2001%26volume%3D34%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burk, M. J.</span><span> </span><span class="NLM_article-title">C2-symmetric bis(phospholanes) and their use in highly enantioselective hydrogenation reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">8518</span><span class="NLM_x">–</span> <span class="NLM_lpage">8519</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00022a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=8518-8519&author=M.+J.+Burk&title=C2-symmetric+bis%28phospholanes%29+and+their+use+in+highly+enantioselective+hydrogenation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fja00022a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00022a047%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26atitle%3DC2-symmetric%2520bis%2528phospholanes%2529%2520and%2520their%2520use%2520in%2520highly%2520enantioselective%2520hydrogenation%2520reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D8518%26epage%3D8519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burk, M. J.</span><span> </span><span class="NLM_article-title">Modular phospholane ligands in asymmetric catalysis</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar990085c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsl2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=363-372&author=M.+J.+Burk&title=Modular+phospholane+ligands+in+asymmetric+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Modular Phospholane Ligands in Asymmetric Catalysis</span></div><div class="casAuthors">Burk, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-372</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review contg. 51 refs. outlines the prepn. and application of a class of phosphine ligands based upon the trans-2,5-disubstituted phospholane moiety.  The modular nature of these ligands has allowed facile variation of both phospholane substituent and backbone structure, thus providing access to ligands.  Bidentate bis(phospholane) ligands are very useful in asym. catalytic hydrogenation reactions.  In particular, the authors highlight the versatility of highly efficient bis(phospholane)rhodium catalysts that allow enantioselective hydrogenation to produce a diverse range of compds. contg. C-N, C-O, and C-C stereogenic centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvHWVq09cZe7Vg90H21EOLACvtfcHk0litdiV5QLR1-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsl2hu7s%253D&md5=b592ee7c317233753e93254fceb58d55</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Far990085c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far990085c%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26atitle%3DModular%2520phospholane%2520ligands%2520in%2520asymmetric%2520catalysis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26spage%3D363%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mamai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madalengoitia, J. S.</span><span> </span><span class="NLM_article-title">Poly-<span class="smallcaps smallerCapital">l</span>-proline type-II peptide mimics based on the 3-azabicyclo[3.1.0]hexane system</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo001201o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=455-460&author=A.+Mamaiauthor=R.+Zhangauthor=A.+Natarajanauthor=J.+S.+Madalengoitia&title=Poly-l-proline+type-II+peptide+mimics+based+on+the+3-azabicyclo%5B3.1.0%5Dhexane+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo001201o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001201o%26sid%3Dliteratum%253Aachs%26aulast%3DMamai%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DMadalengoitia%26aufirst%3DJ.%2BS.%26atitle%3DPoly-l-proline%2520type-II%2520peptide%2520mimics%2520based%2520on%2520the%25203-azabicyclo%255B3.1.0%255Dhexane%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D455%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madalengoitia, J. S.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of poly-<span class="smallcaps smallerCapital">l</span>-proline type-II peptide mimics based on the 3-azabicyclo[3.1.0]hexane system</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981814p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=330-331&author=R.+Zhangauthor=J.+S.+Madalengoitia&title=Design%2C+synthesis+and+evaluation+of+poly-l-proline+type-II+peptide+mimics+based+on+the+3-azabicyclo%5B3.1.0%5Dhexane+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjo981814p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981814p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMadalengoitia%26aufirst%3DJ.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520poly-l-proline%2520type-II%2520peptide%2520mimics%2520based%2520on%2520the%25203-azabicyclo%255B3.1.0%255Dhexane%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D330%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span> </span><span class="NLM_article-title">HATU = <i>O</i>-(7-azabenzotriazoll-yl-l,l,3,3-tetramethyluronium hexafluorophosphate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">4397</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00063a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=4397&author=L.+A.+Carpino&title=HATU+%3D+O-%287-azabenzotriazoll-yl-l%2Cl%2C3%2C3-tetramethyluronium+hexafluorophosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja00063a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00063a082%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26atitle%3DHATU%2520%253D%2520O-%25287-azabenzotriazoll-yl-l%252Cl%252C3%252C3-tetramethyluronium%2520hexafluorophosphate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D4397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">A useful 12-I-5 triacetoxyperiodinane (the Dess−Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 species</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">7277</span><span class="NLM_x">–</span> <span class="NLM_lpage">7287</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00019a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=7277-7287&author=D.+B.+Dessauthor=J.+C.+Martin&title=A+useful+12-I-5+triacetoxyperiodinane+%28the+Dess%E2%88%92Martin+periodinane%29+for+the+selective+oxidation+of+primary+or+secondary+alcohols+and+a+variety+of+related+12-I-5+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00019a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00019a027%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DA%2520useful%252012-I-5%2520triacetoxyperiodinane%2520%2528the%2520Dess%25E2%2588%2592Martin%2520periodinane%2529%2520for%2520the%2520selective%2520oxidation%2520of%2520primary%2520or%2520secondary%2520alcohols%2520and%2520a%2520variety%2520of%2520related%252012-I-5%2520species%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D7277%26epage%3D7287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">Rats were orally administered with 10 mg of compound in 0.4% HPMC. Blood was withdrawn periodically and pooled. AUC was calculated over a 0−6 h period.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rats+were+orally+administered+with+10+mg+of+compound+in+0.4%25+HPMC.+Blood+was+withdrawn+periodically+and+pooled.+AUC+was+calculated+over+a+0%E2%88%926+h+period."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e','cit3f','cit3g','cit3h','cit3i'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maxwell D. Cummings, <span class="NLM_string-name hlFld-ContribAuthor">Sivakumar Sekharan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6843-6853. <a href="https://doi.org/10.1021/acs.jmedchem.8b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BMacrocycle%252BDesign%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%252Band%252BSimple%252BMetrics%252BTo%252BIdentify%252BOpportunities%252Bfor%252BMacrocyclization%252Bof%252BSmall-Molecule%252BLigands%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18122018%26date%3D22032019%26date%3D12032019%26volume%3D62%26issue%3D15%26spage%3D6843%26epage%3D6853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dinesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Sandeep R.  Vemula</span>, and <span class="hlFld-ContribAuthor ">Gregory R.  Cook</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Catalytic Synthesis of α-Ketoamides. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2016,</strong> <em>6 </em>
                                    (8)
                                     , 4920-4945. <a href="https://doi.org/10.1021/acscatal.6b01116" title="DOI URL">https://doi.org/10.1021/acscatal.6b01116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.6b01116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.6b01116%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BCatalytic%252BSynthesis%252Bof%252B%2525CE%2525B1-Ketoamides%26aulast%3DKumar%26aufirst%3DDinesh%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19042016%26date%3D14062016%26date%3D28062016%26date%3D05082016%26date%3D17062016%26volume%3D6%26issue%3D8%26spage%3D4920%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span> and <span class="hlFld-ContribAuthor ">Margherita  Brindisi</span>  . </span><span class="cited-content_cbyCitation_article-title">Organic Carbamates in Drug Design and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 2895-2940. <a href="https://doi.org/10.1021/jm501371s" title="DOI URL">https://doi.org/10.1021/jm501371s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501371s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501371s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOrganic%252BCarbamates%252Bin%252BDrug%252BDesign%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04092014%26date%3D07012015%26date%3D09042015%26volume%3D58%26issue%3D7%26spage%3D2895%26epage%3D2940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dora  Toledo Warshaviak</span>, <span class="hlFld-ContribAuthor ">Gali  Golan</span>, <span class="hlFld-ContribAuthor ">Kenneth W.  Borrelli</span>, <span class="hlFld-ContribAuthor ">Kai  Zhu</span>, and <span class="hlFld-ContribAuthor ">Ori  Kalid</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (7)
                                     , 1941-1950. <a href="https://doi.org/10.1021/ci500175r" title="DOI URL">https://doi.org/10.1021/ci500175r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500175r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500175r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DStructure-Based%252BVirtual%252BScreening%252BApproach%252Bfor%252BDiscovery%252Bof%252BCovalently%252BBound%252BLigands%26aulast%3DToledo%2BWarshaviak%26aufirst%3DDora%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18032014%26date%3D26062014%26date%3D28072014%26date%3D16062014%26volume%3D54%26issue%3D7%26spage%3D1941%26epage%3D1950" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Dömling</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, and <span class="hlFld-ContribAuthor ">Kan  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemistry and Biology Of Multicomponent Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2012,</strong> <em>112 </em>
                                    (6)
                                     , 3083-3135. <a href="https://doi.org/10.1021/cr100233r" title="DOI URL">https://doi.org/10.1021/cr100233r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr100233r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr100233r%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChemistry%252Band%252BBiology%252BOf%252BMulticomponent%252BReactions%26aulast%3DD%25C3%25B6mling%26aufirst%3DAlexander%26date%3D2012%26date%3D2012%26date%3D2010%26date%3D23072010%26date%3D22032012%26date%3D13062012%26volume%3D112%26issue%3D6%26spage%3D3083%26epage%3D3135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriko  Okamoto</span>, <span class="hlFld-ContribAuthor ">Kei  Takeda</span>, and <span class="hlFld-ContribAuthor ">Reiko  Yanada</span>  . </span><span class="cited-content_cbyCitation_article-title">Platinum-Catalyzed, One-Pot Tandem Synthesis of Indoles and Isoquinolines via Sequential Rearrangement of Amides and Aminocyclization. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2010,</strong> <em>75 </em>
                                    (22)
                                     , 7615-7625. <a href="https://doi.org/10.1021/jo101347f" title="DOI URL">https://doi.org/10.1021/jo101347f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo101347f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo101347f%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPlatinum-Catalyzed%25252C%252BOne-Pot%252BTandem%252BSynthesis%252Bof%252BIndoles%252Band%252BIsoquinolines%252Bvia%252BSequential%252BRearrangement%252Bof%252BAmides%252Band%252BAminocyclization%26aulast%3DOkamoto%26aufirst%3DNoriko%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D28072010%26date%3D21102010%26date%3D19112010%26volume%3D75%26issue%3D22%26spage%3D7615%26epage%3D7625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Benedetta  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Marco  Pompei</span>, <span class="hlFld-ContribAuthor ">Maria Cecilia  Palumbi</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Monica  Donghi</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Fiore</span>, <span class="hlFld-ContribAuthor ">Uwe  Koch</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>, <span class="hlFld-ContribAuthor ">Silvia  Pesci</span>, <span class="hlFld-ContribAuthor ">Alessia  Petrocchi</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span> and <span class="hlFld-ContribAuthor ">Cristina  Gardelli</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Hepatitis C Virus NS3 Protease with Basic Amine Functionality at the P3-Amino Acid N-Terminus: Discovery and Optimization of a New Series of P2−P4 Macrocycles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (15)
                                     , 4820-4837. <a href="https://doi.org/10.1021/jm900372w" title="DOI URL">https://doi.org/10.1021/jm900372w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900372w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900372w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252Bwith%252BBasic%252BAmine%252BFunctionality%252Bat%252Bthe%252BP3-Amino%252BAcid%252BN-Terminus%25253A%252BDiscovery%252Band%252BOptimization%252Bof%252Ba%252BNew%252BSeries%252Bof%252BP2%2525E2%252588%252592P4%252BMacrocycles%26aulast%3DHarper%26aufirst%3DSteven%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D24032009%26date%3D22072009%26date%3D13082009%26volume%3D52%26issue%3D15%26spage%3D4820%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Huang</span>, <span class="hlFld-ContribAuthor ">Baihui  Liang</span>, <span class="hlFld-ContribAuthor ">Xiuwen  Chen</span>, <span class="hlFld-ContribAuthor ">Yifu  Liu</span>, <span class="hlFld-ContribAuthor ">Yawen  Li</span>, <span class="hlFld-ContribAuthor ">Jingwen  Liang</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Tang</span>, <span class="hlFld-ContribAuthor ">Yibiao  Li</span>, <span class="hlFld-ContribAuthor ">Zhongzhi  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid assembly of α-ketoamides through a decarboxylative strategy of isocyanates with α-oxocarboxylic acids under mild conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (21)
                                     , 4783-4787. <a href="https://doi.org/10.1039/D1OB00562F" title="DOI URL">https://doi.org/10.1039/D1OB00562F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00562F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00562F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRapid%252Bassembly%252Bof%252B%2525CE%2525B1-ketoamides%252Bthrough%252Ba%252Bdecarboxylative%252Bstrategy%252Bof%252Bisocyanates%252Bwith%252B%2525CE%2525B1-oxocarboxylic%252Bacids%252Bunder%252Bmild%252Bconditions%26aulast%3DHuang%26aufirst%3DJunjie%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D21%26spage%3D4783%26epage%3D4787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debarati  Das</span>, <span class="hlFld-ContribAuthor ">Bhalchandra M.  Bhanage</span>. </span><span class="cited-content_cbyCitation_article-title">Double Carbonylation Reactions: Overview and Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (15)
                                     , 3022-3058. <a href="https://doi.org/10.1002/adsc.202000245" title="DOI URL">https://doi.org/10.1002/adsc.202000245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000245%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDouble%252BCarbonylation%252BReactions%25253A%252BOverview%252Band%252BRecent%252BAdvances%26aulast%3DDas%26aufirst%3DDebarati%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D15%26spage%3D3022%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yadavalli Subba  Rao</span>, <span class="hlFld-ContribAuthor ">Dandugula Sneha  Latha</span>, <span class="hlFld-ContribAuthor ">Nagaraju  Devunuri</span>, <span class="hlFld-ContribAuthor ">Abdulrahman I.  Almansour</span>, <span class="hlFld-ContribAuthor ">Natarajan  Arumugam</span>, <span class="hlFld-ContribAuthor ">Srinivasarao  Yaragorla</span>. </span><span class="cited-content_cbyCitation_article-title">Alkylation of α‐Oxo‐Compounds through C(sp
              3
              )‐H Functionalization of 2‐Methyl Quinolines Under Catalyst‐ and Solvent‐Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (27)
                                     , 4134-4145. <a href="https://doi.org/10.1002/ejoc.202000511" title="DOI URL">https://doi.org/10.1002/ejoc.202000511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000511%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAlkylation%252Bof%252B%2525CE%2525B1%2525E2%252580%252590Oxo%2525E2%252580%252590Compounds%252Bthrough%252BC%252528sp%252B3%252B%252529%2525E2%252580%252590H%252BFunctionalization%252Bof%252B2%2525E2%252580%252590Methyl%252BQuinolines%252BUnder%252BCatalyst%2525E2%252580%252590%252Band%252BSolvent%2525E2%252580%252590Free%252BConditions%26aulast%3DRao%26aufirst%3DYadavalli%2BSubba%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D27%26spage%3D4134%26epage%3D4145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eman M. M.  Abdelraheem</span>, <span class="hlFld-ContribAuthor ">Imogen  Goodwin</span>, <span class="hlFld-ContribAuthor ">Shabnam  Shaabani</span>, <span class="hlFld-ContribAuthor ">Michel P.  de Haan</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Kurpiewska</span>, <span class="hlFld-ContribAuthor ">Justyna  Kalinowska-Tłuścik</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">‘Atypical Ugi’ tetrazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (12)
                                     , 1799-1802. <a href="https://doi.org/10.1039/C9CC09194G" title="DOI URL">https://doi.org/10.1039/C9CC09194G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC09194G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC09194G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3D%2525E2%252580%252598Atypical%252BUgi%2525E2%252580%252599%252Btetrazoles%26aulast%3DAbdelraheem%26aufirst%3DEman%2BM.%2BM.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D12%26spage%3D1799%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pietro  Capurro</span>, <span class="hlFld-ContribAuthor ">Andrea  Basso</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical reactions for building small molecules. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 35-82. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00002-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00002-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00002-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00002-9%26sid%3Dliteratum%253Aachs%26atitle%3DChemical%252Breactions%252Bfor%252Bbuilding%252Bsmall%252Bmolecules%26aulast%3DCapurro%26aufirst%3DPietro%26date%3D2020%26spage%3D35%26epage%3D82%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pritha  Das</span>, <span class="hlFld-ContribAuthor ">Hasina Mamataj  Begam</span>, <span class="hlFld-ContribAuthor ">Samir Kumar  Bhunia</span>, <span class="hlFld-ContribAuthor ">Ranjan  Jana</span>. </span><span class="cited-content_cbyCitation_article-title">Photoredox‐Catalyzed Tandem Demethylation of
              N
              ,
              N
              ‐Dimethyl Anilines Followed by Amidation with α‐Keto or Alkynyl Carboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (17)
                                     , 4048-4054. <a href="https://doi.org/10.1002/adsc.201900525" title="DOI URL">https://doi.org/10.1002/adsc.201900525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900525%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DPhotoredox%2525E2%252580%252590Catalyzed%252BTandem%252BDemethylation%252Bof%252BN%252B%25252C%252BN%252B%2525E2%252580%252590Dimethyl%252BAnilines%252BFollowed%252Bby%252BAmidation%252Bwith%252B%2525CE%2525B1%2525E2%252580%252590Keto%252Bor%252BAlkynyl%252BCarboxylic%252BAcids%26aulast%3DDas%26aufirst%3DPritha%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D17%26spage%3D4048%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edeildo Ferreira  da Silva-Júnior</span>, <span class="hlFld-ContribAuthor ">João Xavier  de Araújo-Júnior</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (18)
                                     , 3963-3978. <a href="https://doi.org/10.1016/j.bmc.2019.07.038" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPeptide%252Bderivatives%252Bas%252Binhibitors%252Bof%252BNS2B-NS3%252Bprotease%252Bfrom%252BDengue%25252C%252BWest%252BNile%25252C%252Band%252BZika%252Bflaviviruses%26aulast%3Dda%2BSilva-J%25C3%25BAnior%26aufirst%3DEdeildo%2BFerreira%26date%3D2019%26volume%3D27%26issue%3D18%26spage%3D3963%26epage%3D3978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narasimha Swamy  Thirukovela</span>, <span class="hlFld-ContribAuthor ">Ramesh  Balaboina</span>, <span class="hlFld-ContribAuthor ">Ravinder  Vadde</span>, <span class="hlFld-ContribAuthor ">Chandra  Sekhar Vasam</span>. </span><span class="cited-content_cbyCitation_article-title">Water dispersed gold nanoparticles catalyzed aerobic oxidative cross-dehydrogenative coupling: An efficient synthesis of α-ketoamides in water. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (42)
                                     , 3749-3752. <a href="https://doi.org/10.1016/j.tetlet.2018.08.042" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.08.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.08.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DWater%252Bdispersed%252Bgold%252Bnanoparticles%252Bcatalyzed%252Baerobic%252Boxidative%252Bcross-dehydrogenative%252Bcoupling%25253A%252BAn%252Befficient%252Bsynthesis%252Bof%252B%2525CE%2525B1-ketoamides%252Bin%252Bwater%26aulast%3DThirukovela%26aufirst%3DNarasimha%2BSwamy%26date%3D2018%26volume%3D59%26issue%3D42%26spage%3D3749%26epage%3D3752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Wint Wint  Phoo</span>, <span class="hlFld-ContribAuthor ">Ying Ru  Loh</span>, <span class="hlFld-ContribAuthor ">Weiling  Wang</span>, <span class="hlFld-ContribAuthor ">Shuang  Liu</span>, <span class="hlFld-ContribAuthor ">Ming Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Alvin W.  Hung</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Keller</span>, <span class="hlFld-ContribAuthor ">Dahai  Luo</span>, <span class="hlFld-ContribAuthor ">CongBao  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2017,</strong> <em>25 </em>
                                    (8)
                                     , 1242-1250.e3. <a href="https://doi.org/10.1016/j.str.2017.06.006" title="DOI URL">https://doi.org/10.1016/j.str.2017.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2017.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DStructural%252BDynamics%252Bof%252BZika%252BVirus%252BNS2B-NS3%252BProtease%252BBinding%252Bto%252BDipeptide%252BInhibitors%26aulast%3DLi%26aufirst%3DYan%26date%3D2017%26volume%3D25%26issue%3D8%26spage%3D1242%26epage%3D1250.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Venkatraman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: Ketoamide-Derived HCV NS3 Serine Protease Inhibitors for the Treatment of Chronic Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 583-608. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12452-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12452-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12452-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12452-7%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BKetoamide-Derived%252BHCV%252BNS3%252BSerine%252BProtease%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%26aulast%3DVenkatraman%26aufirst%3DS.%26date%3D2017%26spage%3D583%26epage%3D608%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Debin  Zeng</span>, <span class="hlFld-ContribAuthor ">Yuying  Ma</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Quandeng  Nie</span>, <span class="hlFld-ContribAuthor ">Zhengjie  Cui</span>, <span class="hlFld-ContribAuthor ">Yaxin  Wang</span>, <span class="hlFld-ContribAuthor ">Luqing  Shang</span>, <span class="hlFld-ContribAuthor ">Zheng  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 1762-1766. <a href="https://doi.org/10.1016/j.bmcl.2016.02.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252B%2525CE%2525B1-keto%252Bamides%252Bas%252Benterovirus%252B71%252B3C%252Bprotease%252Binhibitors%26aulast%3DZeng%26aufirst%3DDebin%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D1762%26epage%3D1766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Hulme</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ayaz</span>, <span class="hlFld-ContribAuthor ">Guillermo  Martinez-Ariza</span>, <span class="hlFld-ContribAuthor ">Federico  Medda</span>, <span class="hlFld-ContribAuthor ">Arthur  Shaw</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Multicomponent Reaction Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 145-187. <a href="https://doi.org/10.1002/9781118771723.ch6" title="DOI URL">https://doi.org/10.1002/9781118771723.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118771723.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118771723.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BMulticomponent%252BReaction%252BChemistry%26aulast%3DHulme%26aufirst%3DChristopher%26date%3D2015%26date%3D2015%26spage%3D145%26epage%3D187%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DSmall%252BMolecule%252BMedicinal%252BChemistry%26aulast%3DCzechtizky%26aufirst%3DWerngard%26date%3D2015%26volume%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Shi</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5539-5545. <a href="https://doi.org/10.1016/j.bmc.2015.07.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bcompounds%252Bwith%252Bmoderate%252Banti-hepatitis%252BC%252Bvirus%252BNS3%252Bprotease%252Bactivity%252Bin%252Bvitro%26aulast%3DShi%26aufirst%3DFangyuan%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5539%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Sandra  Gemma</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Serine Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 67-112. <a href="https://doi.org/10.1002/9783527665211.ch3" title="DOI URL">https://doi.org/10.1002/9783527665211.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527665211.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527665211.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BSerine%252BProtease%252BInhibitors%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2015%26date%3D2015%26spage%3D67%26epage%3D112%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DStructure-Based%252BDesign%252Bof%252BDrugs%252Band%252BOther%252BBioactive%252BMolecules%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and development of boceprevir. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (11)
                                     , 1439-1447. <a href="https://doi.org/10.1517/17460441.2013.843525" title="DOI URL">https://doi.org/10.1517/17460441.2013.843525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.843525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.843525%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bboceprevir%26aulast%3DRotella%26aufirst%3DDavid%2BP%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D11%26spage%3D1439%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xian  Liu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Nannan  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Small Molecules as Inhibitors of  Hepatitis C Virus by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2013,</strong> <em>14 </em>
                                    (11)
                                     , 22845-22856. <a href="https://doi.org/10.3390/ijms141122845" title="DOI URL">https://doi.org/10.3390/ijms141122845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms141122845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms141122845%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIdentification%252Bof%252BNovel%252BSmall%252BMolecules%252Bas%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DLi%26aufirst%3DJing%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D11%26spage%3D22845%26epage%3D22856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daria J.  Hazuda</span>, <span class="hlFld-ContribAuthor ">Margaret  Burroughs</span>, <span class="hlFld-ContribAuthor ">Anita Y.M.  Howe</span>, <span class="hlFld-ContribAuthor ">Janice  Wahl</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>. </span><span class="cited-content_cbyCitation_article-title">Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection. </span><span class="cited-content_cbyCitation_journal-name">Annals of the New York Academy of Sciences</span><span> <strong>2013,</strong> <em>1291 </em>
                                    (1)
                                     , 69-76. <a href="https://doi.org/10.1111/nyas.12218" title="DOI URL">https://doi.org/10.1111/nyas.12218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nyas.12218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnyas.12218%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520the%2520New%2520York%2520Academy%2520of%2520Sciences%26atitle%3DDevelopment%252Bof%252Bboceprevir%25253A%252Ba%252Bfirst-in-class%252Bdirect%252Bantiviral%252Btreatment%252Bfor%252Bchronic%252Bhepatitis%252BC%252Binfection%26aulast%3DHazuda%26aufirst%3DDaria%2BJ.%26date%3D2013%26date%3D2013%26volume%3D1291%26issue%3D1%26spage%3D69%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Andrew  Prongay</span>, <span class="hlFld-ContribAuthor ">George F.  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 343-363. <a href="https://doi.org/10.1002/9783527651085.ch14" title="DOI URL">https://doi.org/10.1002/9783527651085.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527651085.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527651085.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BA%252BCase%252BStudy%252Bfor%252BRole%252Bof%252BStructure-Based%252BDrug%252BDesign%26aulast%3DVenkatraman%26aufirst%3DSrikanth%26date%3D2012%26date%3D2012%26spage%3D343%26epage%3D363%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DAnalogue-Based%252BDrug%252BDiscovery%252BIII%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2012%26volume%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: The First and Second Generation of HCV NS3 Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 296-335. <a href="https://doi.org/10.1002/9781118219683.ch12" title="DOI URL">https://doi.org/10.1002/9781118219683.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118219683.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118219683.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BThe%252BFirst%252Band%252BSecond%252BGeneration%252Bof%252BHCV%252BNS3%252BProtease%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26spage%3D296%26epage%3D335%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCase%252BStudies%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26volume%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver R.  Thiel</span>. </span><span class="cited-content_cbyCitation_article-title">Metathesis Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 215-255. <a href="https://doi.org/10.1002/9781118309872.ch5" title="DOI URL">https://doi.org/10.1002/9781118309872.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118309872.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118309872.ch5%26sid%3Dliteratum%253Aachs%26atitle%3DMetathesis%252BReactions%26aulast%3DThiel%26aufirst%3DOliver%2BR.%26date%3D2012%26date%3D2012%26spage%3D215%26epage%3D255%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DApplications%252Bof%252BTransition%252BMetal%252BCatalysis%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCrawley%26aufirst%3DMatthew%2BL.%26date%3D2012%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Jesús  Pérez de Vega</span>, <span class="hlFld-ContribAuthor ">María Isabel  García-Aranda</span>, <span class="hlFld-ContribAuthor ">Rosario  González-Muñiz</span>. </span><span class="cited-content_cbyCitation_article-title">A role for ring-closing metathesis in medicinal chemistry: Mimicking secondary architectures in bioactive peptides. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2011,</strong> <em>31 </em>
                                    (5)
                                     , 677-715. <a href="https://doi.org/10.1002/med.20199" title="DOI URL">https://doi.org/10.1002/med.20199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20199%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DA%252Brole%252Bfor%252Bring-closing%252Bmetathesis%252Bin%252Bmedicinal%252Bchemistry%25253A%252BMimicking%252Bsecondary%252Barchitectures%252Bin%252Bbioactive%252Bpeptides%26aulast%3DP%25C3%25A9rez%2Bde%2BVega%26aufirst%3DMar%25C3%25ADa%2BJes%25C3%25BAs%26date%3D2011%26date%3D2010%26volume%3D31%26issue%3D5%26spage%3D677%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva A.  Operskalski</span>, <span class="hlFld-ContribAuthor ">Andrea  Kovacs</span>. </span><span class="cited-content_cbyCitation_article-title">HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies. </span><span class="cited-content_cbyCitation_journal-name">Current HIV/AIDS Reports</span><span> <strong>2011,</strong> <em>8 </em>
                                    (1)
                                     , 12-22. <a href="https://doi.org/10.1007/s11904-010-0071-3" title="DOI URL">https://doi.org/10.1007/s11904-010-0071-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11904-010-0071-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11904-010-0071-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520HIV%252FAIDS%2520Reports%26atitle%3DHIV%25252FHCV%252BCo-infection%25253A%252BPathogenesis%25252C%252BClinical%252BComplications%25252C%252BTreatment%25252C%252Band%252BNew%252BTherapeutic%252BTechnologies%26aulast%3DOperskalski%26aufirst%3DEva%2BA.%26date%3D2011%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. P.  Romano</span>, <span class="hlFld-ContribAuthor ">A.  Ali</span>, <span class="hlFld-ContribAuthor ">W. E.  Royer</span>, <span class="hlFld-ContribAuthor ">C. A.  Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2010,</strong> <em>107 </em>
                                    (49)
                                     , 20986-20991. <a href="https://doi.org/10.1073/pnas.1006370107" title="DOI URL">https://doi.org/10.1073/pnas.1006370107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1006370107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1006370107%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DDrug%252Bresistance%252Bagainst%252BHCV%252BNS3%25252F4A%252Binhibitors%252Bis%252Bdefined%252Bby%252Bthe%252Bbalance%252Bof%252Bsubstrate%252Brecognition%252Bversus%252Binhibitor%252Bbinding%26aulast%3DRomano%26aufirst%3DK.%2BP.%26date%3D2010%26date%3D2010%26volume%3D107%26issue%3D49%26spage%3D20986%26epage%3D20991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Latha G.  Nair</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Kevin  Chen</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Weing  Yang</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>, <span class="hlFld-ContribAuthor ">N.-Y.  Shih</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel fluoro amino acids: synthons for potent macrocyclic HCV NS3 protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (23)
                                     , 3057-3061. <a href="https://doi.org/10.1016/j.tetlet.2010.04.010" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bfluoro%252Bamino%252Bacids%25253A%252Bsynthons%252Bfor%252Bpotent%252Bmacrocyclic%252BHCV%252BNS3%252Bprotease%252Binhibitors%26aulast%3DNair%26aufirst%3DLatha%2BG.%26date%3D2010%26volume%3D51%26issue%3D23%26spage%3D3057%26epage%3D3061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">The Journey to the Discovery of Boceprevir: An NS3–NS4 HCV Protease Inhibitor for the Treatment of Chronic Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 1-36. <a href="https://doi.org/10.1016/S0079-6468(10)49001-3" title="DOI URL">https://doi.org/10.1016/S0079-6468(10)49001-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0079-6468(10)49001-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0079-6468%2810%2949001-3%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BJourney%252Bto%252Bthe%252BDiscovery%252Bof%252BBoceprevir%25253A%252BAn%252BNS3%2525E2%252580%252593NS4%252BHCV%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2010%26spage%3D1%26epage%3D36%26pub%3DElsevier%26date%3D2010%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriko  Okamoto</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Miwa</span>, <span class="hlFld-ContribAuthor ">Hideki  Minami</span>, <span class="hlFld-ContribAuthor ">Kei  Takeda</span>, <span class="hlFld-ContribAuthor ">Reiko  Yanada</span>. </span><span class="cited-content_cbyCitation_article-title">Concise One-Pot Tandem Synthesis of Indoles and Isoquinolines from Amides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2009,</strong> <em>121 </em>
                                    (51)
                                     , 9873-9876. <a href="https://doi.org/10.1002/ange.200904960" title="DOI URL">https://doi.org/10.1002/ange.200904960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.200904960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.200904960%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DConcise%252BOne-Pot%252BTandem%252BSynthesis%252Bof%252BIndoles%252Band%252BIsoquinolines%252Bfrom%252BAmides%26aulast%3DOkamoto%26aufirst%3DNoriko%26date%3D2009%26date%3D2009%26volume%3D121%26issue%3D51%26spage%3D9873%26epage%3D9876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noriko  Okamoto</span>, <span class="hlFld-ContribAuthor ">Yoshihisa  Miwa</span>, <span class="hlFld-ContribAuthor ">Hideki  Minami</span>, <span class="hlFld-ContribAuthor ">Kei  Takeda</span>, <span class="hlFld-ContribAuthor ">Reiko  Yanada</span>. </span><span class="cited-content_cbyCitation_article-title">Concise One-Pot Tandem Synthesis of Indoles and Isoquinolines from Amides. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2009,</strong> <em>48 </em>
                                    (51)
                                     , 9693-9696. <a href="https://doi.org/10.1002/anie.200904960" title="DOI URL">https://doi.org/10.1002/anie.200904960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.200904960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.200904960%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DConcise%252BOne-Pot%252BTandem%252BSynthesis%252Bof%252BIndoles%252Band%252BIsoquinolines%252Bfrom%252BAmides%26aulast%3DOkamoto%26aufirst%3DNoriko%26date%3D2009%26date%3D2009%26volume%3D48%26issue%3D51%26spage%3D9693%26epage%3D9696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amogh  Boloor</span>, <span class="hlFld-ContribAuthor ">Denise  Hanway</span>, <span class="hlFld-ContribAuthor ">Maria  Joshi</span>, <span class="hlFld-ContribAuthor ">David T.  Winn</span>, <span class="hlFld-ContribAuthor ">Gabriel  Mendez</span>, <span class="hlFld-ContribAuthor ">Marlena  Walls</span>, <span class="hlFld-ContribAuthor ">Ping  Wei</span>, <span class="hlFld-ContribAuthor ">Fuxin  Qian</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuliang  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael E.  Hepperle</span>, <span class="hlFld-ContribAuthor ">Xinqiang  Li</span>, <span class="hlFld-ContribAuthor ">David A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Juan M.  Betancort</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (19)
                                     , 5708-5711. <a href="https://doi.org/10.1016/j.bmcl.2009.08.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.08.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.08.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantiviral%252Bactivity%252Bof%252BHCV%252BNS3%25252F4A%252Bpeptidomimetic%252Bboronic%252Bacid%252Binhibitors%26aulast%3DBoloor%26aufirst%3DAmogh%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5708%26epage%3D5711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">John F.  Kadow</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 20 Progress towards the Discovery and Development of Specifically Targeted Inhibitors of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 397-440. <a href="https://doi.org/10.1016/S0065-7743(09)04420-0" title="DOI URL">https://doi.org/10.1016/S0065-7743(09)04420-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0065-7743(09)04420-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0065-7743%2809%2904420-0%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B20%252BProgress%252Btowards%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BSpecifically%252BTargeted%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2009%26spage%3D397%26epage%3D440%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B44%26date%3D2009%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of acyclic inhibitors of type <b>1</b> bound to NS3 protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) AcHNCH(COOH)COOC<sub>2</sub>H<sub>5</sub>, Ac<sub>2</sub>O, pyridine, room temp, 24 h; (b) H<sub>2</sub>, Rh(Et-Duphos]OTf, ethanol, room temp, 0.5 h; (c) Boc<sub>2</sub>O, DMAP, THF, reflux; (d) aq LiOH, room temp; (e) PCC, CH<sub>2</sub>Cl<sub>2</sub>, room temp, 12 h; (f) (i) Boc<sub>2</sub>O, DMAP, THF reflux; (ii) N<sub>2</sub>H<sub>4</sub>, ethanol, room temp; (g) 4 M HCl in dioxane, room temp, 1 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0004.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF, NMM; (b) (i) aq LiOH, THF, room temp; (ii) <b>13</b>, HATU, CH<sub>2</sub>Cl<sub>2</sub>/DMF, NMM; (c) (Cy<sub>3</sub>P)<sub>2</sub>RuCl<sub>2</sub>CHC<sub>6</sub>H<sub>5</sub>, toluene, 60 °C; (d) (i) H<sub>2</sub>, Pd/C, EtOAc; (ii) LiBH<sub>4</sub>, THF, room temp; (e) Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, room temp; (f) RNC, AcOH, room temp; (g) aq LiOH, THF, room temp; (h) when R = H, DMSO, EDCI·HCl, Cl<sub>2</sub>CHCOOH, toluene; (i) when R ≠ H, Dess−Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, room temp; (j) (i) 4 M HCl dioxane; (ii) R<sup>1</sup>NCO, NMM, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0010.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/medium/jm-2008-00940u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0019.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of inhibitor <b>52</b> bound to NS3 protease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800940u/production/images/large/jm-2008-00940u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800940u&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span>Fact Sheet Number 164; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva, Switzerland</span>, October<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fact+Sheet+Number+164%3B+World+Health+Organization%3A+Geneva%2C+Switzerland%2C+October+2000."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DWorld%2520Health%2520Organization%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wasley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Epidemiology of hepatitis C: geographic differences and temporal trends</span> <span class="citation_source-journal">Semin. Liver Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1055%2Fs-2000-9506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10895428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1-16&author=A.+Wasleyauthor=M.+J.+Alter&title=Epidemiology+of+hepatitis+C%3A+geographic+differences+and+temporal+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of hepatitis C: geographic differences and temporal trends</span></div><div class="casAuthors">Wasley A; Alter M J</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in liver disease</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0272-8087</span>.
    </div><div class="casAbstract">Hepatitis C Virus (HCV) infection appears to be endemic in most parts of the world, with an estimated overall prevalence of 3%.  However, there is considerable geographic and temporal variation in the incidence and prevalence of HCV infection.  Using age-specific prevalence data, at least three distinct transmission patterns can be identified.  In countries with the first pattern (e.g., United States, Australia), most infections are found among persons 30-49 years old, indicating that the risk for HCV infection was greatest in the relatively recent past (10-30 years ago) and primarily affected young adults.  In countries with the second pattern (e.g., Japan, Italy), most infections are found among older persons, consistent with the risk for HCV infection having been greatest in the distant past.  In countries with the third pattern (e.g., Egypt), high rates of infection are observed in all age groups, indicating an ongoing high risk for acquiring HCV infection.  In countries with the first pattern, injection drug use has been the predominant risk factor for HCV infection, whereas in those with the second or third patterns, unsafe injections and contaminated equipment used in healthcare-related procedures appear to have played a predominant role in transmission.  Much of the variability between regions can be explained by the frequency and extent to which different risk factors have contributed to the transmission of HCV.  Because different strategies are required to interrupt different patterns of HCV transmission, determining the epidemiology of HCV infection in areas where that information has not yet been assessed is critical for developing appropriate prevention programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSp2wQyhQIHd7HHuJhbyicZfW6udTcc2eZdnjdrPq-g9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252Fit12ltg%253D%253D&md5=7c7736c5229d0104950eace9fa66a3fe</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1055%2Fs-2000-9506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2000-9506%26sid%3Dliteratum%253Aachs%26aulast%3DWasley%26aufirst%3DA.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DEpidemiology%2520of%2520hepatitis%2520C%253A%2520geographic%2520differences%2520and%2520temporal%2520trends%26jtitle%3DSemin.%2520Liver%2520Dis.%26date%3D2000%26volume%3D20%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brown, R. S.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaglio, P. J.</span><span> </span><span class="NLM_article-title">Scope of worldwide hepatitis C problem</span> <span class="citation_source-journal">Liver Transplant.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_elocation-id">S10−S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&author=R.+S.+Brownauthor=P.+J.+Gaglio&title=Scope+of+worldwide+hepatitis+C+problem"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26aulast%3DGaglio%26aufirst%3DP.%2BJ.%26atitle%3DScope%2520of%2520worldwide%2520hepatitis%2520C%2520problem%26jtitle%3DLiver%2520Transplant.%26date%3D2003%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM199811193392101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9819446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1485-1492&author=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=E.+R.+Schiffauthor=M.+L.+Shiffmanauthor=W.+M.+Leeauthor=V.+K.+Rustgiauthor=Z.+D.+Goodmanauthor=M.-H.+Lingauthor=S.+Cortauthor=J.+K.+Albrecht&title=Interferon+alpha-2b+alone+or+in+combination+with+ribavirin+as+initial+treatment+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span></div><div class="casAuthors">Mchutchison, John G.; Gordon, Stuart C.; Schiff, Eugene R.; Shiffman, Mitchell L.; Lee, William M.; Rustgi, Vinod K.; Goodman, Zachary D.; Ling, Mei-Hsiu; Cort, Susannah; Albrecht, Janice K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1485-1492</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virol. response to interferon therapy.  We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of patients with chronic hepatitis C.  We randomly assigned 912 patients with chronic hepatitis C to receive std.-dose interferon alfa-2b alone or in combination with ribavirin (1000 or 1200 mg orally per day, depending on body wt.) for 24 or 48 wk.  Efficacy was assessed by measurements of serum hepatitis C virus (HCV) RNA and serum aminotransferases and by liver biopsy.  The rate of sustained virol. response (defined as an undetectable serum HCV RNA level 24 wk after treatment was completed) was higher among patients who received combination therapy for either 24 wk (70 of 228 patients, 31 percent) or 48 wk (87 of 228 patients, 38 percent) than among patients who received interferon alone for either 24 wk (13 of 231 patients, 6 percent) or 48 wk (29 of 225 patients, 13 percent) (P<0.001 for the comparison of interferon alone with both 24 wk and 48 wk of combination treatment).  Among patients with HCV genotype 1 infection, the best response occurred in those who were treated for 48 wk with interferon and ribavirin.  Histol. improvement was more common in patients who were treated with combination therapy for either 24 wk (57 percent) or 48 wk (61 percent) than in those who were treated with interferon alone for either 24 wk (44 percent) or 48 wk (41 percent).  The drug doses had to be reduced and treatment discontinued more often in patients who were treated with combination therapy.  In patients with chronic hepatitis C, initial therapy with interferon and ribavirin was more effective than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9oxTyHQud7LVg90H21EOLACvtfcHk0liqAWoppCfKbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D&md5=41f8d301b8b7eddddda610cb71755cb2</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392101%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DLing%26aufirst%3DM.-H.%26aulast%3DCort%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DInterferon%2520alpha-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520as%2520initial%2520treatment%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1485%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Davis, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban-Mur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoefs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J.</span><span> </span><span class="NLM_article-title">Interferon alpha-2b alone or in combination with ribavirin for treatment of relapse of chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM199811193392102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9819447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1493-1499&author=G.+L.+Davisauthor=R.+Esteban-Murauthor=V.+Rustgiauthor=J.+Hoefsauthor=S.+C.+Gordonauthor=C.+Trepoauthor=M.+L.+Shiffmanauthor=S.+Zeuzemauthor=A.+Craxiauthor=M.-H.+Lingauthor=J.+Albrecht&title=Interferon+alpha-2b+alone+or+in+combination+with+ribavirin+for+treatment+of+relapse+of+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C</span></div><div class="casAuthors">Davis, Gary L.; Esteban-Mur, Rafael; Rustgi, Vinod; Hoefs, John; Gordon, Stuart C.; Trepo, Christian; Shiffman, Mitchell L.; Zeuzem, Stefan; Craxi, Antonio; Ling, Mei-Hsiu; Albrecht, Janice</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1493-1499</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Interferon alfa is the only effective treatment for patients with chronic hepatitis C.  Forty percent of patients have an initial response to this therapy, but most subsequently relapse.  We compared the effect of interferon alone with that of interferon plus oral ribavirin for relapses of chronic hepatitis C.  We studied 345 patients with chronic hepatitis C who relapsed after interferon treatment.  A total of 173 patients were randomly assigned to receive std.-dose recombinant interferon alfa-2b concurrently with ribavirin (1000 to 1200 mg orally per day, depending on body wt.) for six months, and 172 patients were assigned to receive interferon and placebo.  At the completion of treatment, serum levels of hepatitis C virus (HCV) RNA were undetectable in 141 of the 173 patients who were treated with interferon and ribavirin and in 80 of the 172 patients who were treated with interferon alone (82 percent vs. 47 percent, P<0.001).  Serum HCV RNA levels remained undetectable 24 wk after the end of treatment in 84 patients (49 percent) in the combination-therapy group, but in only 8 patients (5 percent) in the interferon group (P<0.001).  Sustained normalization of serum alanine aminotransferase concns. and histol. improvement were highly correlated with virol. response.  Base-line serum HCV RNA levels of 2×106 copies per mL or less were assocd. with higher rates of response in both treatment groups.  Viral genotypes other than type 1 were assocd. with sustained responses only in the combination-therapy group.  Combined therapy caused a predictable fall in Hb concns. but otherwise had a safety profile similar to that of interferon alone.  In patients with chronic hepatitis C who relapse after treatment with interferon, therapy with interferon and oral ribavirin results in higher rates of sustained virol., biochem., and histol. response than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV6gdE4nx7UbVg90H21EOLACvtfcHk0ljTPLvWirMq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbg%253D&md5=88488c15f794c27ee52e7364ded6bc4a</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392102%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DG.%2BL.%26aulast%3DEsteban-Mur%26aufirst%3DR.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DHoefs%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLing%26aufirst%3DM.-H.%26aulast%3DAlbrecht%26aufirst%3DJ.%26atitle%3DInterferon%2520alpha-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520for%2520treatment%2520of%2520relapse%2520of%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1493%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinman, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasenack, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcote, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gane, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Grady, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunda, M. J.</span><span> </span><span class="NLM_article-title">Peginterferon alpha-2a in patients with chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1666</span><span class="NLM_x">–</span> <span class="NLM_lpage">1172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM200012073432301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11106715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1666-1172&author=S.+Zeuzemauthor=S.+V.+Feinmanauthor=J.+Rasenackauthor=E.+J.+Heathcoteauthor=M.-Y.+Laiauthor=E.+Ganeauthor=J.+O%E2%80%99Gradyauthor=J.+Reichenauthor=M.+Diagoauthor=A.+Linauthor=J.+Hoffmanauthor=M.+J.+Brunda&title=Peginterferon+alpha-2a+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a in patients with chronic hepatitis C</span></div><div class="casAuthors">Zeuzem, Stefan; Feinman, S. Victor; Rasenack, Jens; Heathcote, E. Jenny; Lai, Ming-Yang; Gane, Edward; O'Grady, John; Reichen, Jurg; Diago, Moises; Lin, Amy; Hoffman, Joseph; Brunda, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1666-1672</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Covalent attachment of a 40-kd branched-chain polyethylene glycol moiety to interferon alfa-2a results in a compd. (peginterferon alfa-2a) that has sustained absorption, a slower rate of clearance, and a longer half-life than unmodified interferon alfa-2a.  We compared the clin. effects of a regimen of peginterferon alfa-2a with those of a regimen of interferon alfa-2a in the initial treatment of patients with chronic hepatitis C.  We randomly assigned 531 patients with chronic hepatitis C to receive either 180 μg of peginterferon alfa-2a s.c. once per wk for 48 wk (267 patients) or 6 million units of interferon alfa-2a s.c. three times per wk for 12 wk, followed by 3 million units three times per wk for 36 wk (264 patients).  All the patients were assessed at week 72 for a sustained virol. response, defined as an undetectable level of hepatitis C virus RNA (<100 copies per mL).  In the peginterferon group, 223 of the 267 patients completed treatment and 206 completed follow-up.  In the interferon group, 161 of the 264 patients completed treatment and 154 completed follow-up.  In an intention-to-treat anal. in which patients who missed the examn. at the end of treatment or follow-up were considered not to have had a response at that point, peginterferon alfa-2a was assocd. with a higher rate of virol. response than was interferon alfa-2a at week 48 (69 percent vs. 28 percent, P=0.001) and at week 72 (39 percent vs. 19 percent, P=0.001).  Sustained normalization of serum alanine aminotransferase concns. at week 72 was also more common in the peginterferon group than in the interferon group (45 percent vs. 25 percent, P=0.001).  The two groups were similar with respect to the frequency and severity of adverse events, which were typical of those assocd. with interferon alfa.  Conclusions In patients with chronic hepatitis C, a regimen of peginterferon alfa-2a given once weekly is more effective than a regimen of interferon alfa-2a given three times weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhZ1-de6JVzLVg90H21EOLACvtfcHk0ljTPLvWirMq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhurY%253D&md5=ca6830366b388db15f1df0a230dd1040</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432301%26sid%3Dliteratum%253Aachs%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DFeinman%26aufirst%3DS.%2BV.%26aulast%3DRasenack%26aufirst%3DJ.%26aulast%3DHeathcote%26aufirst%3DE.%2BJ.%26aulast%3DLai%26aufirst%3DM.-Y.%26aulast%3DGane%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DJ.%26aulast%3DReichen%26aufirst%3DJ.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DBrunda%26aufirst%3DM.%2BJ.%26atitle%3DPeginterferon%2520alpha-2a%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1666%26epage%3D1172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Heathcote, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooksley, W. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusheiko, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balart, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pamphilis, J.</span><span> </span><span class="NLM_article-title">Peginterferon alpha-2a in patients with chronic hepatitis C and cirrhosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1673</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1056%2FNEJM200012073432302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11106716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2d&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovVGhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1673-1680&author=E.+J.+Heathcoteauthor=M.+L.+Shiffmanauthor=W.+G.+E.+Cooksleyauthor=G.+M.+Dusheikoauthor=S.+S.+Leeauthor=L.+Balartauthor=R.+Reindollarauthor=R.+K.+Reddyauthor=T.+L.+Wrightauthor=A.+Linauthor=J.+Hoffmanauthor=J.+De+Pamphilis&title=Peginterferon+alpha-2a+in+patients+with+chronic+hepatitis+C+and+cirrhosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2dR"><div class="casContent"><span class="casTitleNuber">2d</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis</span></div><div class="casAuthors">Heathcote, E. Jenny; Shiffman, Mitchell L.; Cooksley, W. Graham E.; Dusheiko, Geoffrey M.; Lee, Samuel S.; Balart, Luis; Reindollar, Robert; Reddy, Rajender K.; Wright, Teresa L.; Lin, Amy; Hoffman, Joseph; De Pamphilis, Jean</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1673-1680</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Chronic hepatitis C virus (HCV) infection in patients with cirrhosis is difficult to treat.  In patients with chronic hepatitis C but without cirrhosis, once-weekly administration of interferon modified by the attachment of a 40-kd branched-chain polyethylene glycol moiety (peginterferon alfa-2a) is more efficacious than a regimen of unmodified interferon.  We examd. the efficacy and safety of peginterferon alfa-2a in patients with HCV-related cirrhosis or bridging fibrosis.  We randomly assigned 271 patients with cirrhosis or bridging fibrosis to receive s.c. treatment with 3 million units of interferon alfa-2a three times weekly (88 patients), 90 μg of peginterferon alfa-2a once weekly (96), or 180 μg of peginterferon alfa-2a once weekly (87).  Treatment lasted 48 wk and was followed by a 24-wk follow-up period.  We assessed efficacy by measuring HCV RNA and alanine aminotransferase and by evaluating liver-biopsy specimens.  A histol. response was defined as a decrease of at least 2 points on the 22-point Histol. Activity Index.  In an intention-to-treat anal., HCV RNA was undetectable at week 72 in 8 percent, 15 percent, and 30 percent of the patients treated with interferon alfa-2a and with 90 μg and 180 μg of peginterferon alfa-2a, resp. (P=0.001 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  At week 72, alanine aminotransferase concns. had normalized in 15 percent, 20 percent, and 34 percent of patients, resp. (P=0.004 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  In the subgroup of 184 patients with paired liver-biopsy specimens, the rates of histol. response at week 72 were 31 percent, 44 percent, and 54 percent, resp. (P=0.02 for the comparison between 180 μg of peginterferon alfa-2a and interferon alfa-2a).  All three treatments were similarly tolerated.  In patients with chronic hepatitis C and cirrhosis or bridging fibrosis, 180 μg of peginterferon alfa-2a administered once weekly is significantly more effective than 3 million units of std. interferon alfa-2a administered three times weekly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTlFTBA3F_s7Vg90H21EOLACvtfcHk0ljTPLvWirMq1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovVGhurc%253D&md5=d4132ca895c14f9b32b703d19fd94fc8</span></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=10.1056%2FNEJM200012073432302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200012073432302%26sid%3Dliteratum%253Aachs%26aulast%3DHeathcote%26aufirst%3DE.%2BJ.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DCooksley%26aufirst%3DW.%2BG.%2BE.%26aulast%3DDusheiko%26aufirst%3DG.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BS.%26aulast%3DBalart%26aufirst%3DL.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DWright%26aufirst%3DT.%2BL.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DDe%2BPamphilis%26aufirst%3DJ.%26atitle%3DPeginterferon%2520alpha-2a%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%2520and%2520cirrhosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1673%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Manns, M. P.; McHutchison, J. G.; Gordon, S. C.; Rustgi, V. K.; Shiffman, M.; Reindollar, R.; Goodman, Z. D.; Koury, K.; Ling, M.-H.; Albrecht, J. K.</span> (and International Hepatitis Interventional Therapy Group).  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span>− <span class="NLM_lpage">965</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manns%2C+M.+P.%3B+McHutchison%2C+J.+G.%3B+Gordon%2C+S.+C.%3B+Rustgi%2C+V.+K.%3B+Shiffman%2C+M.%3B+Reindollar%2C+R.%3B+Goodman%2C+Z.+D.%3B+Koury%2C+K.%3B+Ling%2C+M.-H.%3B+Albrecht%2C+J.+K.+%28and+International+Hepatitis+Interventional+Therapy+Group%29.+Lancet+2001%2C+358%2C+958%E2%88%92965."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D958%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottrell, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitlik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schairer, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Drie, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span> </span><span class="NLM_article-title">Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1939</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1939-1942&author=R.+B.+Perniauthor=L.+J.+Farmerauthor=K.+M.+Cottrellauthor=J.+J.+Courtauthor=L.+F.+Courtneyauthor=D.+D.+Deiningerauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=J.+L.+Kimauthor=C.+Linauthor=K.+Linauthor=Y.-P.+Luongauthor=J.+P.+Maxwellauthor=M.+A.+Murckoauthor=J.+Pitlikauthor=B.+G.+Raoauthor=W.+C.+Schairerauthor=R.+D.+Tungauthor=J.+H.+Van+Drieauthor=K.+Wilsonauthor=J.+A.+Thomson&title=Inhibitors+of+hepatitis+C+virus+NS3%C2%B74A+protease.+Part+3%3A+P2+proline+variants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DCottrell%26aufirst%3DK.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BJ.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDeininger%26aufirst%3DD.%2BD.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DMaxwell%26aufirst%3DJ.%2BP.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DPitlik%26aufirst%3DJ.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DSchairer%26aufirst%3DW.%2BC.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DVan%2BDrie%26aufirst%3DJ.%2BH.%26aulast%3DWilson%26aufirst%3DK.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26atitle%3DInhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%25C2%25B74A%2520protease.%2520Part%25203%253A%2520P2%2520proline%2520variants%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1939%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Novel P4 truncated tripeptidyl ά-ketoamides as HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=263-266&author=J.+Lamarauthor=F.+Victorauthor=N.+Snyderauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=Novel+P4+truncated+tripeptidyl+%CE%AC-ketoamides+as+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DNovel%2520P4%2520truncated%2520tripeptidyl%2520%25CE%25AC-ketoamides%2520as%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D263%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malancona, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2151-2154&author=E.+Niziauthor=U.+Kochauthor=J.+M.+Ontoriaauthor=A.+Marchettiauthor=F.+Narjesauthor=S.+Malanconaauthor=V.+G.+Matassaauthor=C.+Gardelli&title=Capped+dipeptide+phenethylamide+inhibitors+of+the+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DMalancona%26aufirst%3DS.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCapped%2520dipeptide%2520phenethylamide%2520inhibitors%2520of%2520the%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Priestley, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucca, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghavimi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson-Viitanen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">P1 phenethyl peptide boronic acid inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3199</span><span class="NLM_x">–</span> <span class="NLM_lpage">3202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3199-3202&author=E.+S.+Priestleyauthor=I.+De+Luccaauthor=B.+Ghavimiauthor=S.+Erickson-Viitanenauthor=C.+P.+Decicco&title=P1+phenethyl+peptide+boronic+acid+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DDe%2BLucca%26aufirst%3DI.%26aulast%3DGhavimi%26aufirst%3DB.%26aulast%3DErickson-Viitanen%26aufirst%3DS.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3DP1%2520phenethyl%2520peptide%2520boronic%2520acid%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3199%26epage%3D3202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decicco, C. P.</span><span> </span><span class="NLM_article-title">α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=711-713&author=W.+Hanauthor=Z.+Huauthor=X.+Jiangauthor=C.+P.+Decicco&title=%CE%B1-Ketoamides%2C+%CE%B1-ketoesters+and+%CE%B1-diketones+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26atitle%3D%25CE%25B1-Ketoamides%252C%2520%25CE%25B1-ketoesters%2520and%2520%25CE%25B1-diketones%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D711%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span> </span><span class="NLM_article-title">Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1005-1008&author=R.+Zhangauthor=J.+P.+Durkinauthor=W.+T.+Windsor&title=Azapeptides+as+inhibitors+of+the+hepatitis+C+virus+NS3+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDurkin%26aufirst%3DJ.%2BP.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26atitle%3DAzapeptides%2520as%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1005%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Bogen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2−P1 cyclopropyl alanine combination for improved potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4515-4519&author=S.+Bogenauthor=A.+K.+Saksenaauthor=A.+Arasappanauthor=H.+Guauthor=F.+G.+Njorogeauthor=V.+Girijavallabhanauthor=J.+Pichardoauthor=N.+Butkiewiczauthor=A.+Prongayauthor=V.+Madison&title=Hepatitis+C+virus+NS3-4A+serine+protease+inhibitors%3A+use+of+a+P2%E2%88%92P1+cyclopropyl+alanine+combination+for+improved+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%2520inhibitors%253A%2520use%2520of%2520a%2520P2%25E2%2588%2592P1%2520cyclopropyl%2520alanine%2520combination%2520for%2520improved%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4515%26epage%3D4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=257-261&author=F.+Victorauthor=J.+Lamarauthor=N.+Snyderauthor=Y.+Yipauthor=D.+Guoauthor=N.+Yumibeauthor=R.+B.+Johnsonauthor=Q.+M.+Wangauthor=J.+I.+Glassauthor=S.-H.+Chen&title=P1+and+P3+optimization+of+novel+bicycloproline+P2+bearing+tetrapeptidyl+%CE%B1-ketoamide+based+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DSnyder%26aufirst%3DN.%26aulast%3DYip%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DR.%2BB.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DGlass%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DP1%2520and%2520P3%2520optimization%2520of%2520novel%2520bicycloproline%2520P2%2520bearing%2520tetrapeptidyl%2520%25CE%25B1-ketoamide%2520based%2520HCV%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D257%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kaito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watnabe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukiyama-Kohara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus particle detected by immunoelectron microscopic study</span> <span class="citation_source-journal">J. Gen. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1755</span><span class="NLM_x">–</span> <span class="NLM_lpage">1760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1099%2F0022-1317-75-7-1755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=7517432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK2cXkslyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1994&pages=1755-1760&author=M.+Kaitoauthor=S.+Watnabeauthor=K.+Tsukiyama-Koharaauthor=K.+Yamaguchiauthor=Y.+Kobayashiauthor=M.+Konishiauthor=M.+Yokoiauthor=S.+Ishidaauthor=S.+Suzukiauthor=M.+Kohara&title=Hepatitis+C+virus+particle+detected+by+immunoelectron+microscopic+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus particle detected by immunoelectron microscopic study</span></div><div class="casAuthors">Kaito, Masahiko; Watanabe, Shozo; Tsukiyama-Kohara, Kyoko; Yamaguchi, Kenjiro; Kobayashi, Yoshinao; Konishi, Masayoshi; Yokoi, Masato; Ishida, Satoshi; Suzuki, Shiro; Kohara, Michinori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1755-60</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    </div><div class="casAbstract">To clarify the morphol. of hepatitis C virus (HCV), an indirect immunogold electron microscope study was carried out on two plasma samples with high HCV RNA titers using polyclonal and monoclonal antibodies specific to the putative HCV envelope protein.  Spherical virus-like particles 55 to 65 nm in diam. with spike-like projections, were found in 1.14 to 1.6 g/mL fractions after sucrose d. gradient centrifugation.  These particles were found only in HCV-infected blood donors and had morphol. features similar to those of flaviviruses.  Moreover, these particles specifically reacted with the polyclonal and monoclonal antibodies to the putative HCV envelope protein.  This is the first known report in which the morphol. of the HCV particle is clearly shown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyf5RO3vEW_rVg90H21EOLACvtfcHk0lgP1uQTs726SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslyitL4%253D&md5=16939581cdc38b383fa760e50cb48cce</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1099%2F0022-1317-75-7-1755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252F0022-1317-75-7-1755%26sid%3Dliteratum%253Aachs%26aulast%3DKaito%26aufirst%3DM.%26aulast%3DWatnabe%26aufirst%3DS.%26aulast%3DTsukiyama-Kohara%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DY.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DYokoi%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DKohara%26aufirst%3DM.%26atitle%3DHepatitis%2520C%2520virus%2520particle%2520detected%2520by%2520immunoelectron%2520microscopic%2520study%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D1994%26volume%3D75%26spage%3D1755%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy</span> <span class="citation_source-journal">J. Viral Hepatitis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1046%2Fj.1365-2893.1999.00152.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10607229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252FnsFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=165-181&author=R.+Bartenschlager&title=The+NS3%2F4A+proteinase+of+the+hepatitis+C+virus%3A+unravelling+structure+and+function+of+an+unusual+enzyme+and+a+prime+target+for+antiviral+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy</span></div><div class="casAuthors">Bartenschlager R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of viral hepatitis</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-81</span>
        ISSN:<span class="NLM_cas:issn">1352-0504</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV) is a major causative agent of transfusion-acquired and sporadic non-A, non-B hepatitis worldwide.  Infections most often persist and lead, in approximately 50% of all patients, to chronic liver disease.  As is characteristic for a member of the family Flaviviridae, HCV has a plus-strand RNA genome encoding a polyprotein, which is cleaved co- and post-translationally into at least 10 different products.  These cleavages are mediated, among others, by a virally encoded chymotrypsin-like serine proteinase located in the N-terminal domain of non-structural protein 3 (NS3).  Activity of this enzyme requires NS4A, a 54-residue polyprotein cleavage product, to form a stable complex with the NS3 domain.  This review will describe the biochemical properties of the NS3/4A proteinase, its X-ray crystal structure and current attempts towards development of efficient inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLDJ-rg9mQkKx48Rj5GnGofW6udTcc2eZUyzfAO5tdALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252FnsFajtQ%253D%253D&md5=2e321bb0e2bbcdfd3b8b2bc7c1d803bd</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2893.1999.00152.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2893.1999.00152.x%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DThe%2520NS3%252F4A%2520proteinase%2520of%2520the%2520hepatitis%2520C%2520virus%253A%2520unravelling%2520structure%2520and%2520function%2520of%2520an%2520unusual%2520enzyme%2520and%2520a%2520prime%2520target%2520for%2520antiviral%2520therapy%26jtitle%3DJ.%2520Viral%2520Hepatitis%26date%3D1999%26volume%3D6%26spage%3D165%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlborn-Laake, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mous, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span> </span><span class="NLM_article-title">Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">3835</span><span class="NLM_x">–</span> <span class="NLM_lpage">3844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=8389908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK3sXltlGhtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=3835-3844&author=R.+Bartenschlagerauthor=L.+Ahlborn-Laakeauthor=J.+Mousauthor=H.+Jacobsen&title=Nonstructural+protein+3+of+the+hepatitis+C+virus+encodes+a+serine-type+proteinase+required+for+cleavage+at+the+NS3%2F4+and+NS4%2F5+junctions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions</span></div><div class="casAuthors">Bartenschlager, Ralf; Ahlborn-Laake, Ludwina; Mous, Jan; Jacobsen, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3835-44</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    </div><div class="casAbstract">Processing of the nonstructural (NS) polyprotein of the hepatitis C virus was studied.  A series of cDNAs corresponding to predicted NS2/3/4 or NS3/4 regions were constructed, and processing of the polyproteins was studied in an in vitro transcription-translation system.  A catalytically active serine-type proteinase is encoded by the NS3 region.  Substitution of the serine residue of the putative catalytic triad (H, D, and S) by alanine blocked cleavage at the NS3/4 junction, whereas processing between NS2 and NS3 was not affected.  Thus, cleavage at the NS2/3 junction is mediated either by cellular enzymes or by an NS2 inherent proteinase activity.  Deletion anal. of an NS3/4 cDNA construct mapped the N-terminus of the enzymically active proteinase between amino acids 1049 and 1065 of the polyprotein.  As internal deletions of variable segments of the presumed helicase domain prevented processing at the NS3/4 junction, a continuous NS3 region appears to be required for processing at this site.  To analyze hepatitis C virus polyprotein cleavage in vivo, recombinant vaccinia viruses expressing NS2/3/4 or NS3/4/5 proteins were generated.  In agreement with the in vitro data, cleavage between NS2 and NS3 was independent of a catalytically active NS3 proteinase, whereas substitution of the active-site serine residue by the amino acid alanine completely blocked processing at the NS3/4 and NS4/5 junctions.  These results demonstrate that NS3 encodes the viral proteinase essential for generating the N-termini of NS4 and NS5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZMJUo7Cry47Vg90H21EOLACvtfcHk0lhH31PzkmH5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltlGhtbs%253D&md5=5bc3945b52e5f59edef857f0ce2196f8</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DAhlborn-Laake%26aufirst%3DL.%26aulast%3DMous%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DH.%26atitle%3DNonstructural%2520protein%25203%2520of%2520the%2520hepatitis%2520C%2520virus%2520encodes%2520a%2520serine-type%2520proteinase%2520required%2520for%2520cleavage%2520at%2520the%2520NS3%252F4%2520and%2520NS4%252F5%2520junctions%26jtitle%3DJ.%2520Virol.%26date%3D1993%26volume%3D67%26spage%3D3835%26epage%3D3844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Reed, K. E.; Rice, C. M.</span><span> </span><span class="NLM_article-title">Molecular Characterization of Hepatitis C Virus</span>. In  <span class="citation_source-book">Hepatitis C Virus</span>; <span class="NLM_contrib-group">Reesink, H. W.</span>, Ed.; <span class="NLM_publisher-name">Karger</span>: <span class="NLM_publisher-loc">Basel, Switzerland</span>,<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">37</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1159%2F000060472" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&pages=1-37&author=K.+E.+Reed&author=C.+M.+Riceauthor=H.+W.+Reesink&title=Hepatitis+C+Virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1159%2F000060472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1159%252F000060472%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DK.%2BE.%26atitle%3DMolecular%2520Characterization%2520of%2520Hepatitis%2520C%2520Virus%26btitle%3DHepatitis%2520C%2520Virus%26aulast%3DReesink%26aufirst%3DH.%2BW.%26pub%3DKarger%26date%3D1998%26spage%3D1%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindenbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Unravelling hepatitis C virus replication from genome to function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1038%2Fnature04077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=16107832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=933-938&author=B.+D.+Lindenbachauthor=C.+M.+Rice&title=Unravelling+hepatitis+C+virus+replication+from+genome+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Unravelling hepatitis C virus replication from genome to function</span></div><div class="casAuthors">Lindenbach, Brett D.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">7053</span>),
    <span class="NLM_cas:pages">933-938</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the hepatitis C virus over 15 years ago, scientists have raced to develop diagnostics, study the virus and find new therapies.  Yet virtually every attempt to dissect this pathogen has met with roadblocks that impeded progress.  Its replication was restricted to humans or exptl. infected chimpanzees, and efficient growth of the virus in cell culture failed until very recently.  Nevertheless hard-fought progress has been made and the first wave of antiviral drugs is entering clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vc6EOs8vLVg90H21EOLACvtfcHk0lhH31PzkmH5dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFent7o%253D&md5=553517cac32b797ef7a2d07f496a7b5c</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature04077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04077%26sid%3Dliteratum%253Aachs%26aulast%3DLindenbach%26aufirst%3DB.%2BD.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DUnravelling%2520hepatitis%2520C%2520virus%2520replication%2520from%2520genome%2520to%2520function%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D933%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=6-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=T.+S.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DT.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D18%26spage%3D6%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yip, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victor, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barket, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venable, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakulchik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarreal, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colacino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yumibe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebbe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munroe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-H.</span><span> </span><span class="NLM_article-title">Discovery of a novel bicycloproline P<sub>2</sub> bearing peptidyl [alpha]-ketoamide LY514962 as HCV protease inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=251-256&author=Y.+Yipauthor=F.+Victorauthor=J.+Lamarauthor=R.+Johnsonauthor=Q.+M.+Wangauthor=D.+Barketauthor=J.+Glassauthor=L.+Jinauthor=L.+Liuauthor=D.+Venableauthor=M.+Wakulchikauthor=C.+Xieauthor=B.+Heinzauthor=E.+Villarrealauthor=J.+Colacinoauthor=N.+Yumibeauthor=M.+Tebbeauthor=J.+Munroeauthor=S.-H.+Chen&title=Discovery+of+a+novel+bicycloproline+P2+bearing+peptidyl+%5Balpha%5D-ketoamide+LY514962+as+HCV+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DY.%26aulast%3DVictor%26aufirst%3DF.%26aulast%3DLamar%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DQ.%2BM.%26aulast%3DBarket%26aufirst%3DD.%26aulast%3DGlass%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenable%26aufirst%3DD.%26aulast%3DWakulchik%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DHeinz%26aufirst%3DB.%26aulast%3DVillarreal%26aufirst%3DE.%26aulast%3DColacino%26aufirst%3DJ.%26aulast%3DYumibe%26aufirst%3DN.%26aulast%3DTebbe%26aufirst%3DM.%26aulast%3DMunroe%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.-H.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520bicycloproline%2520P2%2520bearing%2520peptidyl%2520%255Balpha%255D-ketoamide%2520LY514962%2520as%2520HCV%2520protease%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D251%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Emerging therapies for hepatitis C infection</span> <span class="citation_source-journal">Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1517%2F14728214.6.1.13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=15989494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=13-42&author=B.+W.+Dymock&title=Emerging+therapies+for+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging therapies for hepatitis C virus infection</span></div><div class="casAuthors">Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Drugs</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-42</span>CODEN:
                <span class="NLM_cas:coden">EMDRFV</span>;
        ISSN:<span class="NLM_cas:issn">1361-9195</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 172 refs.  Hepatitis C virus (HCV) has infected millions of people worldwide and has emerged as a global health crisis.  The currently available therapy is interferon (IFN) either alone or in combination with ribavirin.  However, the disappointing efficacy of IFN has led to the considerable need for improved treatments and a no. of new therapies are under evaluation in clin. trials.  These include pegylated IFNs, which have altered physiochem. characteristics allowing once-weekly dosing.  Combination of pegylated IFN with ribavirin should further improve sustained response rates.  However, not all patients are successfully treated with IFNs, particularly those infected with genotype 1 of the virus, and it is likely that potent, specific drugs will be required.  The majority of new approaches currently trying to combat this viral disease are aimed at inhibition of viral targets.  Most effort has been directed towards inhibition of the NS3 serine protease, and potent inhibitors have now been described.  However, a clin. candidate is yet to emerge against this difficult target.  Considerable work by leading researchers has provided crystal structures of the key replicative enzymes, NS3 protease, NS3 helicase, NS5B polymerase and full-length NS3 protease-helicase, and there is much hope that such structural information will bear fruit.  More recently, inhibition of host targets, particularly inosine monophosphate dehydrogenase (IMPDH), has become of interest and there are on-going clin. trials with such inhibitors.  Research aimed at novel treatments for HCV disease is gathering pace and very recent developments in cell-based assay systems can only hasten the discovery of improved therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjm4y0XuTNLVg90H21EOLACvtfcHk0lgM0NTvsHSLAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1Srtbw%253D&md5=3f96a719833a9cf89bc565376fc7324e</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1517%2F14728214.6.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.6.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DEmerging%2520therapies%2520for%2520hepatitis%2520C%2520infection%26jtitle%3DEmerging%2520Drugs%26date%3D2001%26volume%3D6%26spage%3D13%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=De+Francesco%2C+R.%3B+Migliaccio%2C+G.Nature+2005%2C+436%2C+953%E2%80%93960"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Robison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Robisonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobison%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Brazil, M.</span><span> </span><span class="NLM_article-title">Antiviral drugs: macrocyclic inhibitor for hepatitis C</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2003&pages=945&author=M.+Brazil&title=Antiviral+drugs%3A+macrocyclic+inhibitor+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrazil%26aufirst%3DM.%26atitle%3DAntiviral%2520drugs%253A%2520macrocyclic%2520inhibitor%2520for%2520hepatitis%2520C%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D212%26spage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Youwei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjeev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinod, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohinder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licia, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raffaele, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhongguo, C.</span><span> </span><span class="NLM_article-title">Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 Å resolution structure in a hexagonal crystal form</span> <span class="citation_source-journal">Protein Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9568891" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=837-847&author=Y.+Youweiauthor=L.+Yingauthor=M.+Sanjeevauthor=S.+Vinodauthor=L.+C.+Jamesauthor=M.+Mohinderauthor=S.+Christianauthor=T.+Liciaauthor=D.+Raffaeleauthor=K.+C.+Lawrenceauthor=C.+Zhongguo&title=Complex+of+NS3+protease+and+NS4A+peptide+of+BK+strain+hepatitis+C+virus%3A+a+2.2+%C3%85+resolution+structure+in+a+hexagonal+crystal+form"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYouwei%26aufirst%3DY.%26aulast%3DYing%26aufirst%3DL.%26aulast%3DSanjeev%26aufirst%3DM.%26aulast%3DVinod%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DMohinder%26aufirst%3DM.%26aulast%3DChristian%26aufirst%3DS.%26aulast%3DLicia%26aufirst%3DT.%26aulast%3DRaffaele%26aufirst%3DD.%26aulast%3DLawrence%26aufirst%3DK.%2BC.%26aulast%3DZhongguo%26aufirst%3DC.%26atitle%3DComplex%2520of%2520NS3%2520protease%2520and%2520NS4A%2520peptide%2520of%2520BK%2520strain%2520hepatitis%2520C%2520virus%253A%2520a%25202.2%2520%25C3%2585%2520resolution%2520structure%2520in%2520a%2520hexagonal%2520crystal%2520form%26jtitle%3DProtein%2520Sci.%26date%3D1998%26volume%3D7%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Love, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichersham, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomsky, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moomaw, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostomska, Z.</span><span> </span><span class="NLM_article-title">The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=331-342&author=R.+A.+Loveauthor=H.+E.+Pargeauthor=J.+A.+Wichershamauthor=Z.+Hostomskyauthor=N.+Habukaauthor=E.+W.+Moomawauthor=T.+Adachiauthor=Z.+Hostomska&title=The+crystal+structure+of+hepatitis+C+virus+NS3+proteinase+reveals+a+trypsin-like+fold+and+a+structural+zinc+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BA.%26aulast%3DParge%26aufirst%3DH.%2BE.%26aulast%3DWichersham%26aufirst%3DJ.%2BA.%26aulast%3DHostomsky%26aufirst%3DZ.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DMoomaw%26aufirst%3DE.%2BW.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DHostomska%26aufirst%3DZ.%26atitle%3DThe%2520crystal%2520structure%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520proteinase%2520reveals%2520a%2520trypsin-like%2520fold%2520and%2520a%2520structural%2520zinc%2520binding%2520site%26jtitle%3DCell%26date%3D1996%26volume%3D87%26spage%3D331%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dweyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murcko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, P. R.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1016%2FS0969-2126%2898%2900010-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=9493270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVGltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=89-100&author=J.+L.+Kimauthor=K.+A.+Morgensternauthor=J.+P.+Griffithauthor=M.+D.+Dweyerauthor=J.+A.+Thomsonauthor=M.+A.+Murckoauthor=C.+Linauthor=P.+R.+Caron&title=Hepatitis+C+virus+NS3+RNA+helicase+domain+with+a+bound+oligonucleotide%3A+the+crystal+structure+provides+insights+into+the+mode+of+unwinding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding</span></div><div class="casAuthors">Kim, Joseph L.; Morgenstern, Kurt A.; Griffith, James P.; Dwyer, Maureen D.; Thomson, John A.; Murcko, Mark A.; Lin, Chao; Caron, Paul R.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) represents a major health concern as it is responsible for a significant no. of hepatitis cases worldwide.  Much research has focused on the replicative enzymes of HCV as possible targets for more effective therapeutic agents.  THe HCV NS3 helicase domain may provide one such suitable target.  Helicases are enzymes which can unwind double-stranded regions of DNA or RNA in an ATP-dependent reaction.  The structures of several helicases have been published but the structural details as to how ATP binding and hydrolysis are coupled to DNA unwinding are unknown.  Here, the structure of the HCV NS3 RNA helicase domain complexed with a single-stranded DNA oligonucleotide was solved to 2.2 Å resoln.  The protein consisted of 3 structural domains with the oligonucleotide lying in a groove between the 1st 2 domains and the 3rd.  The 1st 2 domains had an adenylate kinase-like fold, including a phosphate-binding loop in the 1st domain.  HCV NS3 helicase is a member of a superfamily of helicases, termed superfamily II.  Residues of NS3 helicase which are conserved among superfamily II helicases line an interdomain cleft between the 1st 2 domains.  The oligonucleotide bound in an orthogonal binding site and contacted relatively few conserved residues.  There were no strong sequence-specific interactions with the oligonucleotide bases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJtlmpwoM4bbVg90H21EOLACvtfcHk0lgQjXuNdkCpxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVGltLg%253D&md5=9cacf02ee275d0d0922b72099a32de2d</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900010-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900010-0%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DGriffith%26aufirst%3DJ.%2BP.%26aulast%3DDweyer%26aufirst%3DM.%2BD.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DCaron%26aufirst%3DP.%2BR.%26atitle%3DHepatitis%2520C%2520virus%2520NS3%2520RNA%2520helicase%2520domain%2520with%2520a%2520bound%2520oligonucleotide%253A%2520the%2520crystal%2520structure%2520provides%2520insights%2520into%2520the%2520mode%2520of%2520unwinding%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipovsek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raybuck, S. A.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1998&pages=1-18&author=A.+D.+Kwongauthor=J.+L.+Kimauthor=G.+Raoauthor=D.+Lipovsekauthor=S.+A.+Raybuck&title=Hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DRao%26aufirst%3DG.%26aulast%3DLipovsek%26aufirst%3DD.%26aulast%3DRaybuck%26aufirst%3DS.%2BA.%26atitle%3DHepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntiviral%2520Res.%26date%3D1998%26volume%3D40%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madision, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2-3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)-amino]carbonyl]amio]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatits C virus NS3 protease inhibitor: a potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=B.+L.+Madisionauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2-3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29-amino%5Dcarbonyl%5Damio%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatits+C+virus+NS3+protease+inhibitor%3A+a+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadision%26aufirst%3DB.%2BL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2-3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529-amino%255Dcarbonyl%255Damio%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatits%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520a%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span> </span><span class="NLM_article-title">A continuous spectrophotometric assay for the hepatitis C virus serine protease</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1999&pages=268-275&author=R.+Zhangauthor=B.+M.+Beyerauthor=J.+Durkinauthor=R.+Ingramauthor=F.+G.+Njorogeauthor=W.+T.+Windsorauthor=B.+A.+Malcolm&title=A+continuous+spectrophotometric+assay+for+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DWindsor%26aufirst%3DW.%2BT.%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26atitle%3DA%2520continuous%2520spectrophotometric%2520assay%2520for%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D270%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Morrison, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">The behavior and significance of slow binding enzyme inhibitors</span> <span class="citation_source-journal">Adv. Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1002%2F9780470123072.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=3281418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1988&pages=201-301&author=J.+F.+Morrisonauthor=C.+T.+Walsh&title=The+behavior+and+significance+of+slow+binding+enzyme+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The behavior and significance of slow-binding enzyme inhibitors</span></div><div class="casAuthors">Morrison, John F.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Enzymology and Related Areas of Molecular Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-301</span>CODEN:
                <span class="NLM_cas:coden">AERAAD</span>;
        ISSN:<span class="NLM_cas:issn">0065-258X</span>.
    </div><div class="casAbstract">A review with 112 refs. on the anal. and properties of slow-binding enzyme inhibitors.  The topics discussed include formation of complexes of enzymes and slow-binding inhibitors, slow-binding inhibitors as drugs, characteristics and anal. of progress curves for slow-binding inhibitors, and specific cases of slow-binding inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1MoW3TRk0ubVg90H21EOLACvtfcHk0ljo_0ju_9R4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhtlSrtbk%253D&md5=6c0d34ce86e49cd63c44b30d7fefa016</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1002%2F9780470123072.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470123072.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DJ.%2BF.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DThe%2520behavior%2520and%2520significance%2520of%2520slow%2520binding%2520enzyme%2520inhibitors%26jtitle%3DAdv.%2520Enzymol.%26date%3D1988%26volume%3D61%26spage%3D201%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0ljo_0ju_9R4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marchetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ontoria, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matassa, V. G.</span><span> </span><span class="NLM_article-title">Synthesis of two novel cyclic biphenyl ether analogs of an inhibitor of HCV NS3 protease</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=1000-1002&author=A.+Marchettiauthor=J.+M.+Ontoriaauthor=V.+G.+Matassa&title=Synthesis+of+two+novel+cyclic+biphenyl+ether+analogs+of+an+inhibitor+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DOntoria%26aufirst%3DJ.%2BM.%26aulast%3DMatassa%26aufirst%3DV.%2BG.%26atitle%3DSynthesis%2520of%2520two%2520novel%2520cyclic%2520biphenyl%2520ether%2520analogs%2520of%2520an%2520inhibitor%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DSynlett%26date%3D1999%26spage%3D1000%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tyndall, J. D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Macrocyclic mimic the extended peptide conformation recognized by aspartic, serine, cysteine, and metallo proteases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">893</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.2174%2F0929867013372715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=11375757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=893-907&author=J.+D.+A.+Tyndallauthor=D.+P.+Fairlie&title=Macrocyclic+mimic+the+extended+peptide+conformation+recognized+by+aspartic%2C+serine%2C+cysteine%2C+and+metallo+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span></div><div class="casAuthors">Tyndall, Joel D. A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with refs.  It has been previously demonstrated that aspartic, serine, metallo and cysteine proteases bind to their inhibitors and substrate analogs in a single conformation, the saw-tooth or extended beta-strand.  Consequently a generic approach to the development of protease inhibitors is the use of constraints that conformationally restrict putative inhibitor mols. to an extended form.  In this way the inhibitor is pre-organized for binding to a protease and does not need to rearrange its structure.  One constraining device that has proven to be effective for such pre-organization is macrocyclization.  This article illustrates the general principle that macrocycles, esp. those composed of 3-4 amino acids and usually 13-17 ring atoms, can effectively mimic the extended conformation of short peptide sequences.  Such structure-stabilizing macrocycles are stable to degrdn. by proteases, valuable components of potent protease inhibitors, and in many cases they are also bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuoMyDlMrlbVg90H21EOLACvtfcHk0ljo_0ju_9R4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D&md5=2525f64466090d8f371452ed9f0d676c</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.2174%2F0929867013372715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372715%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%2BA.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DMacrocyclic%2520mimic%2520the%2520extended%2520peptide%2520conformation%2520recognized%2520by%2520aspartic%252C%2520serine%252C%2520cysteine%252C%2520and%2520metallo%2520proteases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D893%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic Inhibitors of HCV NS3 protease; design and strucure activity relationship</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1290</span><span class="NLM_x">–</span> <span class="NLM_lpage">1301</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm800940u&amp;key=10.2174%2F156802607781212202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm800940u&amp;key=17627558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1290-1301&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+Inhibitors+of+HCV+NS3+protease%3B+design+and+strucure+activity+relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3-4A protease: design and structure activity relationship</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1290-1301</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HCV NS3, a serine protease, that when bound to NS-4A cofactor facilitates development of mature virons by catalyzing cleavage of a single polyprotein to form functional and structural proteins of HCV.  X-ray structure of the enzyme reveal a very shallow binding pocket at the catalytic site which makes development of inhibitors a daunting task.  Various novel approaches have been used to design, preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 residues and P1-P3 groups.  The design and structure activity relationship of these macrocyclic inhibitors are reviewed in the following article.  X-ray structure of inhibitor bound to the active site of the enzyme is also discussed.  Macrocyclization proved to be an effective tool for depeptidization of peptidic inhibitors, imparting enhanced metabolic stability and improved pharmacokinetic properties in the resultant mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKhDndFaOnLrVg90H21EOLACvtfcHk0ljo_0ju_9R4Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvP&md5=da704c17e2ed4f3780d550c1b81348fa</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.2174%2F156802607781212202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212202%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520Inhibitors%2520of%2520HCV%2520NS3%2520protease%253B%2520design%2520and%2520strucure%2520activity%2520relationship%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1290%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span> </span><span class="NLM_article-title">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">546</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=546-574&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+acid-based+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520acid-based%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D546%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis c NS3-4A protease using structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5088</span><span class="NLM_x">–</span> <span class="NLM_lpage">5091</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0489556" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5088-5091&author=S.+Venkatramanauthor=F.+G.+Njorogeauthor=V.+M.+Girijavallabhanauthor=V.+S.+Madisonauthor=N+H.+Yaoauthor=A.+J.+Prongayauthor=N.+Butkiewiczauthor=J.+Pichardo&title=Design+and+synthesis+of+depeptidized+macrocyclic+inhibitors+of+hepatitis+c+NS3-4A+protease+using+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm0489556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0489556%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DGirijavallabhan%26aufirst%3DV.%2BM.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DYao%26aufirst%3DN%2BH.%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520depeptidized%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520c%2520NS3-4A%2520protease%2520using%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5088%26epage%3D5091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim-Wilby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamura, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of SCH 446211(SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication NS3 serine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2750</span><span class="NLM_x">–</span> <span class="NLM_lpage">2757</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060077j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2750-2757&author=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=S.+Venkatramanauthor=W.+Panauthor=T.+Parekhauthor=R.+E.+Pikeauthor=S.+Ruanauthor=R.+Liuauthor=B.+Baroudyauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=A.+Prongayauthor=J.-M.+Brissonauthor=T.+Y.+Hsiehauthor=K.-C.+Chengauthor=S.+J.+Kempauthor=O.+E.+Levyauthor=M.+Lim-Wilbyauthor=S.+Y.+Tamuraauthor=A.+K.+Saksenaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+SCH+446211%28SCH6%29%3A+a+new+ketoamide+inhibitor+of+the+HCV+NS3+serine+protease+and+HCV+subgenomic+RNA+replication+NS3+serine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060077j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060077j%26sid%3Dliteratum%253Aachs%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPike%26aufirst%3DR.%2BE.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26aulast%3DLevy%26aufirst%3DO.%2BE.%26aulast%3DLim-Wilby%26aufirst%3DM.%26aulast%3DTamura%26aufirst%3DS.%2BY.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520SCH%2520446211%2528SCH6%2529%253A%2520a%2520new%2520ketoamide%2520inhibitor%2520of%2520the%2520HCV%2520NS3%2520serine%2520protease%2520and%2520HCV%2520subgenomic%2520RNA%2520replication%2520NS3%2520serine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2750%26epage%3D2757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Velázquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Application of ring-closing metathesis for the synthesis of macrocyclic peptidomimetics as inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">3061</span><span class="NLM_x">–</span> <span class="NLM_lpage">3064</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0711265" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3061-3064&author=F.+Vel%C3%A1zquezauthor=S.+Venkatramanauthor=W.+Wuauthor=M.+Blackmanauthor=A.+Prongayauthor=V.+Girijavallabhanauthor=N.-Y.+Shihauthor=F.+G.+Njoroge&title=Application+of+ring-closing+metathesis+for+the+synthesis+of+macrocyclic+peptidomimetics+as+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fol0711265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0711265%26sid%3Dliteratum%253Aachs%26aulast%3DVel%25C3%25A1zquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DApplication%2520of%2520ring-closing%2520metathesis%2520for%2520the%2520synthesis%2520of%2520macrocyclic%2520peptidomimetics%2520as%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26spage%3D3061%26epage%3D3064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schwab, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziller, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">A Series of Well-Defined Metathesis Catalysts-Synthesis of [RuCl<sub>2</sub>(CHR)(PR<sub>3</sub>)<sub>2</sub>] and its reactions</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2039</span><span class="NLM_x">–</span> <span class="NLM_lpage">2041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=2039-2041&author=P.+Schwabauthor=M.+B.+Franceauthor=J.+W.+Zillerauthor=R.+H.+Grubbs&title=A+Series+of+Well-Defined+Metathesis+Catalysts-Synthesis+of+%5BRuCl2%28CHR%29%28PR3%292%5D+and+its+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DP.%26aulast%3DFrance%26aufirst%3DM.%2BB.%26aulast%3DZiller%26aufirst%3DJ.%2BW.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DA%2520Series%2520of%2520Well-Defined%2520Metathesis%2520Catalysts-Synthesis%2520of%2520%255BRuCl2%2528CHR%2529%2528PR3%25292%255D%2520and%2520its%2520reactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1995%26volume%3D34%26spage%3D2039%26epage%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trnka, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">The Development of L2X2Ru=CHR Olefin Metathesis Catalysts: An Organometallic Success Story</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar000114f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslCqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2001&pages=18-29&author=T.+M.+Trnkaauthor=R.+H.+Grubbs&title=The+Development+of+L2X2Ru%3DCHR+Olefin+Metathesis+Catalysts%3A+An+Organometallic+Success+Story"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">The Development of L2X2Ru:CHR Olefin Metathesis Catalysts: An Organometallic Success Story</span></div><div class="casAuthors">Trnka, Tina M.; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-29</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with over 85 refs.  In recent years, the olefin metathesis reaction has attracted widespread attention as a versatile C-C bond-forming method.  Many new applications have become possible because of major advances in catalyst design.  State-of-the-art Ru catalysts are not only highly active but also compatible with most functional groups and easy to use.  This Account traces the ideas and discoveries that were instrumental in the development of these catalysts, with particular emphasis on (PCy3)2Cl2Ru:CHPh and its derivs.  The discussion includes an anal. of trends in catalyst activity, a description of catalysts coordinated with N-heterocyclic carbene ligands, and an overview of ongoing work to improve the activity, stability, and selectivity of this family of L2X2Ru:CHR complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAgjOFFNgww7Vg90H21EOLACvtfcHk0lhaM4fAqSUt2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslCqsb4%253D&md5=66a09fb9213ecdd4b7c22831c1c38ddb</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Far000114f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far000114f%26sid%3Dliteratum%253Aachs%26aulast%3DTrnka%26aufirst%3DT.%2BM.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DThe%2520Development%2520of%2520L2X2Ru%253DCHR%2520Olefin%2520Metathesis%2520Catalysts%253A%2520An%2520Organometallic%2520Success%2520Story%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2001%26volume%3D34%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burk, M. J.</span><span> </span><span class="NLM_article-title">C2-symmetric bis(phospholanes) and their use in highly enantioselective hydrogenation reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">8518</span><span class="NLM_x">–</span> <span class="NLM_lpage">8519</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00022a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=8518-8519&author=M.+J.+Burk&title=C2-symmetric+bis%28phospholanes%29+and+their+use+in+highly+enantioselective+hydrogenation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fja00022a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00022a047%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26atitle%3DC2-symmetric%2520bis%2528phospholanes%2529%2520and%2520their%2520use%2520in%2520highly%2520enantioselective%2520hydrogenation%2520reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D8518%26epage%3D8519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Burk, M. J.</span><span> </span><span class="NLM_article-title">Modular phospholane ligands in asymmetric catalysis</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar990085c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm800940u&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsl2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=363-372&author=M.+J.+Burk&title=Modular+phospholane+ligands+in+asymmetric+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Modular Phospholane Ligands in Asymmetric Catalysis</span></div><div class="casAuthors">Burk, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-372</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review contg. 51 refs. outlines the prepn. and application of a class of phosphine ligands based upon the trans-2,5-disubstituted phospholane moiety.  The modular nature of these ligands has allowed facile variation of both phospholane substituent and backbone structure, thus providing access to ligands.  Bidentate bis(phospholane) ligands are very useful in asym. catalytic hydrogenation reactions.  In particular, the authors highlight the versatility of highly efficient bis(phospholane)rhodium catalysts that allow enantioselective hydrogenation to produce a diverse range of compds. contg. C-N, C-O, and C-C stereogenic centers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvHWVq09cZe7Vg90H21EOLACvtfcHk0lgADYAegT1PWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsl2hu7s%253D&md5=b592ee7c317233753e93254fceb58d55</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Far990085c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far990085c%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26atitle%3DModular%2520phospholane%2520ligands%2520in%2520asymmetric%2520catalysis%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2000%26volume%3D33%26spage%3D363%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mamai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natarajan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madalengoitia, J. S.</span><span> </span><span class="NLM_article-title">Poly-<span class="smallcaps smallerCapital">l</span>-proline type-II peptide mimics based on the 3-azabicyclo[3.1.0]hexane system</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo001201o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=455-460&author=A.+Mamaiauthor=R.+Zhangauthor=A.+Natarajanauthor=J.+S.+Madalengoitia&title=Poly-l-proline+type-II+peptide+mimics+based+on+the+3-azabicyclo%5B3.1.0%5Dhexane+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Fjo001201o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001201o%26sid%3Dliteratum%253Aachs%26aulast%3DMamai%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DNatarajan%26aufirst%3DA.%26aulast%3DMadalengoitia%26aufirst%3DJ.%2BS.%26atitle%3DPoly-l-proline%2520type-II%2520peptide%2520mimics%2520based%2520on%2520the%25203-azabicyclo%255B3.1.0%255Dhexane%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D455%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madalengoitia, J. S.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of poly-<span class="smallcaps smallerCapital">l</span>-proline type-II peptide mimics based on the 3-azabicyclo[3.1.0]hexane system</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981814p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=330-331&author=R.+Zhangauthor=J.+S.+Madalengoitia&title=Design%2C+synthesis+and+evaluation+of+poly-l-proline+type-II+peptide+mimics+based+on+the+3-azabicyclo%5B3.1.0%5Dhexane+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjo981814p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981814p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DMadalengoitia%26aufirst%3DJ.%2BS.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520poly-l-proline%2520type-II%2520peptide%2520mimics%2520based%2520on%2520the%25203-azabicyclo%255B3.1.0%255Dhexane%2520system%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D330%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span> </span><span class="NLM_article-title">HATU = <i>O</i>-(7-azabenzotriazoll-yl-l,l,3,3-tetramethyluronium hexafluorophosphate</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">4397</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00063a082" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1993&pages=4397&author=L.+A.+Carpino&title=HATU+%3D+O-%287-azabenzotriazoll-yl-l%2Cl%2C3%2C3-tetramethyluronium+hexafluorophosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja00063a082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00063a082%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26atitle%3DHATU%2520%253D%2520O-%25287-azabenzotriazoll-yl-l%252Cl%252C3%252C3-tetramethyluronium%2520hexafluorophosphate%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1993%26volume%3D115%26spage%3D4397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">A useful 12-I-5 triacetoxyperiodinane (the Dess−Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 species</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">7277</span><span class="NLM_x">–</span> <span class="NLM_lpage">7287</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00019a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=7277-7287&author=D.+B.+Dessauthor=J.+C.+Martin&title=A+useful+12-I-5+triacetoxyperiodinane+%28the+Dess%E2%88%92Martin+periodinane%29+for+the+selective+oxidation+of+primary+or+secondary+alcohols+and+a+variety+of+related+12-I-5+species"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00019a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00019a027%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DA%2520useful%252012-I-5%2520triacetoxyperiodinane%2520%2528the%2520Dess%25E2%2588%2592Martin%2520periodinane%2529%2520for%2520the%2520selective%2520oxidation%2520of%2520primary%2520or%2520secondary%2520alcohols%2520and%2520a%2520variety%2520of%2520related%252012-I-5%2520species%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D7277%26epage%3D7287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">Rats were orally administered with 10 mg of compound in 0.4% HPMC. Blood was withdrawn periodically and pooled. AUC was calculated over a 0−6 h period.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Rats+were+orally+administered+with+10+mg+of+compound+in+0.4%25+HPMC.+Blood+was+withdrawn+periodically+and+pooled.+AUC+was+calculated+over+a+0%E2%88%926+h+period."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800940u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-2%3Barticle%3Aarticle%3A10.1021%2Fjm800940u%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800940u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                940KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a80b7fe28195b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
